<SUBMISSION>
<ACCESSION-NUMBER>0000950152-09-005701
<TYPE>8-K
<PUBLIC-DOCUMENT-COUNT>5
<PERIOD>20090527
<ITEMS>1.01
<ITEMS>8.01
<ITEMS>9.01
<FILING-DATE>20090529
<DATE-OF-FILING-DATE-CHANGE>20090529
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>ALLEGHENY TECHNOLOGIES INC
<CIK>0001018963
<ASSIGNED-SIC>3317
<IRS-NUMBER>251792394
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>8-K
<ACT>34
<FILE-NUMBER>001-12001
<FILM-NUMBER>09862158
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>1000 SIX PPG PLACE
<CITY>PITTSBURGH
<STATE>PA
<ZIP>15222
<PHONE>4123942800
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>100 SIX PPG PLACE
<CITY>PITTSBURGH
<STATE>PA
<ZIP>15222
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>ALLEGHENY TELEDYNE INC
<DATE-CHANGED>19960716
</FORMER-COMPANY>
</FILER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>l36642ae8vk.htm
<DESCRIPTION>8-K
<TEXT>
<HTML>
<HEAD>
<TITLE>8-K</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>




<DIV align="center" style="font-size: 14pt; margin-top: 12pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B>
</DIV>

<DIV align="center" style="font-size: 12pt"><B>Washington, DC 20549</B>
</DIV>

<DIV align="center" style="font-size: 18pt; margin-top: 12pt"><B>FORM 8-K</B>
</DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 12pt"><B>CURRENT REPORT<BR>
Pursuant to Section&nbsp;13 OR 15(d) of the Securities Exchange Act of 1934</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>
Date of Report (Date of earliest event reported) <u>May&nbsp;27, 2009</u></B>
</DIV>

<DIV align="center" style="font-size: 24pt; margin-top: 12pt"><B>Allegheny Technologies Incorporated</B>
</DIV>

<DIV align="center" style="font-size: 10pt"><DIV style="width: 100%; border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV>
(Exact name of registrant as specified in its charter)</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top">Delaware
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">1-12001
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">25-1792394</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="5" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">(State or other jurisdiction
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(Commission
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(IRS Employer</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">of incorporation)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">File Number)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Identification No.)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="47%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top">1000 Six PPG Place, Pittsburgh, Pennsylvania
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">15222-5479</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="3" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">(Address of principal executive offices)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(Zip Code)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt">Registrant&#146;s telephone number, including area code <U>(412)&nbsp;394-2800</U></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt">
N/A<BR>

<DIV style="width: 100%; border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV></DIV>


<DIV align="center" style="font-size: 10pt">(Former name or former address, if changed since last report).</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:</DIV>

<DIV align="left" style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>

<TR>
    <TD><FONT face="Wingdings">&#111;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)
</TD>
</TR>
</TABLE>
</DIV>

<DIV align="left" style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>

<TR>
    <TD><FONT face="Wingdings">&#111;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)
</TD>
</TR>
</TABLE>
</DIV>

<DIV align="left" style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>

<TR>
    <TD><FONT face="Wingdings">&#111;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
</TD>
</TR>
</TABLE>
</DIV>

<DIV align="left" style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>

<TR>
    <TD><FONT face="Wingdings">&#111;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>Pre-commencement communications pursuant to Rule&nbsp;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
</TD>
</TR>
</TABLE>
</DIV>


<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">










<!--TOC-->
<!--/TOC-->




<!-- link1 "Item&nbsp;1.01. Entry into a Material Definitive Agreement" -->

<DIV align="left" style="margin-top: 12pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left"><B>Item&nbsp;1.01.</B></TD>
    <TD>&nbsp;</TD>
    <TD><B>Entry into a Material Definitive Agreement.</B></TD>
</TR>
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On May&nbsp;27, 2009, Allegheny Technologies Incorporated (the &#147;Company&#148;) executed and delivered an
underwriting agreement (the &#147;Senior Notes Underwriting Agreement&#148;), by and among the Company and
Citigroup Global Markets Inc. and J.P. Morgan Securities Inc. on behalf of themselves and the other
underwriters named therein (the &#147;Senior Notes Underwriters&#148;), relating to the issuance and sale of
$350,000,000 aggregate principal amount of the Company&#146;s 9.375% Senior Notes due 2019 (the &#147;Senior
Notes&#148;). The offering and sale of the Senior Notes are expected to be completed on June&nbsp;1, 2009.
Under the terms of the Senior Notes Underwriting Agreement, the Company has agreed to indemnify the
Senior Notes Underwriters against certain liabilities, including liabilities under the Securities
Act of 1933, as amended (the &#147;Securities Act&#148;), or to contribute payments that the Senior Notes
Underwriters may be required to make because of any of those liabilities. The Senior Notes will be
issued pursuant to a base indenture expected to be dated as of June&nbsp;1, 2009, between the Company
and The Bank of New York Mellon, N.A., as trustee, as supplemented by a supplemental indenture
expected to be dated as of June&nbsp;1, 2009. A copy of the Senior Notes Underwriting Agreement is
filed herewith as Exhibit&nbsp;1.1.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On May&nbsp;27, 2009, the Company executed and delivered an underwriting agreement (the
&#147;Convertible Notes Underwriting Agreement&#148;), by and among the Company and J.P. Morgan Securities
Inc. and Citigroup Global Markets Inc. on behalf of themselves and the other underwriters named
therein (the &#147;Convertible Notes Underwriters&#148;), relating to the issuance and sale of $350,000,000
aggregate principal amount of the Company&#146;s 4.25% Convertible Senior Notes due 2014 (the
&#147;Convertible Notes&#148;). The Company has granted the Convertible Notes Underwriters a 30-day option
to acquire up to an additional $52,500,000 aggregate principal amount of Convertible Notes. The
offering and sale of the Convertible Notes are expected to be completed on June&nbsp;2, 2009. Under the
terms of the Convertible Notes Underwriting Agreement, the Company has agreed to indemnify the
Convertible Notes Underwriters against certain liabilities, including liabilities under the
Securities Act, or to contribute payments that the Convertible Notes Underwriters may be required
to make because of any of those liabilities. The Convertible Notes will be issued pursuant to a
base indenture expected to be dated as of June&nbsp;1, 2009, between the Company and The Bank of New
York Mellon, N.A., as trustee, as supplemented by a supplemental indenture expected to be dated as
of June&nbsp;2, 2009. A copy of the Convertible Notes Underwriting Agreement is filed herewith as
Exhibit&nbsp;1.2.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The foregoing is not a complete discussion of the Senior Notes Underwriting Agreement or the
Convertible Notes Underwriting Agreement. Accordingly, the foregoing is qualified in its entirety
by reference to the full text of the Senior Notes Underwriting Agreement and the Convertible Notes
Underwriting Agreement attached to this Current Report as Exhibits 1.1 and 1.2, respectively, which
are incorporated herein by reference.
</DIV>
<!-- link1 "Item&nbsp;8.01. Other Events" -->

<DIV align="left" style="margin-top: 12pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left"><B>Item&nbsp;8.01.</B></TD>
    <TD>&nbsp;</TD>
    <TD><B>Other Events.</B></TD>
</TR>
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On May&nbsp;27, 2009, the Company announced the respective pricings of its offerings of Senior
Notes and Convertible Notes. The Company&#146;s press release announcing the respective pricings of
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">its offerings of Senior Notes and Convertible Notes is set forth in its entirety and filed as
Exhibit&nbsp;99.1 to this Current Report on Form 8-K and is incorporated herein by reference.</DIV>

<!-- link1 "Item&nbsp;9.01. Financial Statements and Exhibits" -->

<DIV align="left" style="margin-top: 12pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left"><B>Item&nbsp;9.01.</B></TD>
    <TD>&nbsp;</TD>
    <TD><B>Financial Statements and Exhibits.</B></TD>
</TR>
</TABLE>
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>(d)&nbsp;Exhibits.</I></DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="85%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:20px; text-indent:-0px">Exhibit&nbsp;1.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Underwriting Agreement dated May&nbsp;27, 2009, among Allegheny Technologies
Incorporated and Citigroup Global Markets Inc. and J.P. Morgan Securities Inc., as
representatives of the several underwriters named therein.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:20px; text-indent:-0px">Exhibit&nbsp;1.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Underwriting Agreement dated May&nbsp;27, 2009, among Allegheny Technologies
Incorporated and J.P. Morgan Securities Inc. and Citigroup Global Markets Inc., as
representatives of the several underwriters named therein.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:20px; text-indent:-0px">Exhibit&nbsp;99.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Press release dated May&nbsp;27, 2009.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<!-- link1 "SIGNATURE" -->

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>SIGNATURE</B></U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">ALLEGHENY TECHNOLOGIES INCORPORATED<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">              <I>/s/ Jon D. Walton</I>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Jon D. Walton&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="left">Executive Vice President, Human Resources,<Br>
Chief Legal and Compliance Officer,<Br>
General Counsel and Corporate Secretary&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

</TABLE>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Dated:  May 29, 2009&nbsp;</div>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>

</TABLE>
<!-- link1 "EXHIBIT INDEX" -->

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>EXHIBIT INDEX</B></U>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="84%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Exhibit No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Description</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<tr><td>&nbsp;</td></tr>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;1.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Underwriting Agreement dated May&nbsp;27, 2009, among Allegheny
Technologies Incorporated and Citigroup Global Markets Inc.
and J.P. Morgan Securities Inc., as representatives of the
several underwriters named therein.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;1.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Underwriting Agreement dated May&nbsp;27, 2009, among Allegheny
Technologies Incorporated and J.P. Morgan Securities Inc. and
Citigroup Global Markets Inc., as representatives of the
several underwriters named therein.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;99.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Press release dated May&nbsp;27, 2009.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>l36642aexv1w1.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML>
<HEAD>
<TITLE>EX-1.1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>Exhibit&nbsp;1.1</B>
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>EXECUTION VERSION</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>J.P. MORGAN SECURITIES INC.<BR>
CITIGROUP GLOBAL MARKETS INC.</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>ALLEGHENY TECHNOLOGIES INCORPORATED</B>

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>9.375% Senior Notes due 2019</B>

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>Underwriting Agreement</B>

</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 12pt">May&nbsp;27, 2009
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">CITIGROUP GLOBAL MARKETS INC.<BR>
J.P. MORGAN SECURITIES INC.<BR>
As Representatives of the<BR>
several Underwriters listed in<BR>
Schedule&nbsp;I hereto

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">c/o Citigroup Global Markets Inc.<BR>
388 Greenwich Street<BR>
New York, New York 10013

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">J.P. Morgan Securities Inc.<BR>
270 Park Avenue<BR>
New York, New York 10017

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Ladies and Gentlemen:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Allegheny Technologies Incorporated, a Delaware corporation (the &#147;Company&#148;), proposes to issue
and sell to the several Underwriters listed in Schedule&nbsp;I hereto (the &#147;Underwriters&#148;), for whom you
are acting as Representatives (the &#147;Representatives&#148;), an aggregate of $350,000,000 principal
amount of its 9.375% Senior Notes due 2019 (the &#147;Securities&#148;). The Securities are to be issued
under a base indenture (the &#147;Base Indenture&#148;) to be dated as of June&nbsp;1, 2009, between the Company
and The Bank of New York Mellon, N.A., as trustee (the &#147;Trustee&#148;), as supplemented by a
supplemental indenture (the &#147;Supplemental Indenture&#148;, and together with the Base Indenture, the
&#147;Indenture&#148;), to be dated as of June&nbsp;1, 2009.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company hereby confirms its agreement with the several Underwriters concerning the
purchase and sale of the Securities (this &#147;Agreement&#148;), as follows:
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;<U>Registration Statement</U>. The Company has prepared and filed with the Securities and
Exchange Commission (the &#147;Commission&#148;) under the Securities Act of 1933, as amended, and the rules
and regulations of the Commission thereunder (collectively, the &#147;Securities Act&#148;), an automatic
shelf registration statement, as defined in Rule&nbsp;405 of the Securities Act, on Form S-3 (File No.
333-159479) including a base prospectus (the &#147;Base Prospectus&#148;), relating to various securities to
be issued from time to time by the Company, including the Securities. Such registration statement,
as amended at the time it becomes effective, including the information, if any, deemed pursuant to
Rule&nbsp;430A, 430B or 430C under the Securities Act to be part of the registration statement at the
time of its effectiveness (&#147;Rule&nbsp;430 Information&#148;), is referred to herein as the &#147;Registration
Statement&#148;; and as used herein, the term &#147;Preliminary Prospectus&#148; means the Base Prospectus and any
prospectus filed with the Commission pursuant to Rule 424(a) under the Securities Act that omits
Rule&nbsp;430 Information, and the term &#147;Prospectus&#148; means the prospectus in the form first used (or
made available upon request of purchasers pursuant to Rule&nbsp;173 under the Securities Act) in
connection with confirmation of sales of the Securities. Any reference in this Agreement to the
Registration Statement, any Preliminary Prospectus or the Prospectus shall be deemed to refer to
and include the documents incorporated by reference therein pursuant to Item&nbsp;12 of Form S-3 under
the Securities Act, as of the effective date of the Registration Statement or the date of such
Preliminary Prospectus or the Prospectus, as the case may be and any reference to &#147;amend&#148;,
&#147;amendment&#148; or &#147;supplement&#148; with respect to the Registration Statement, any Preliminary Prospectus
or the Prospectus shall be deemed to refer to and include any documents filed after such date under
the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission
thereunder (collectively, the &#147;Exchange Act&#148;) that are deemed to be incorporated by reference
therein. Capitalized terms used but not defined herein shall have the meanings given to such terms
in the Registration Statement and the Prospectus.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At or prior to the time when sales of the Securities were first made (the &#147;Time of Sale&#148;), the
Company had prepared the following information (collectively, the &#147;Time of Sale Information&#148;): a
Preliminary Prospectus dated May&nbsp;26, 2009, and each &#147;free-writing prospectus&#148; (as defined pursuant
to Rule&nbsp;405 under the Securities Act) listed on Schedule&nbsp;IIA hereto as constituting part of the
Time of Sale Information.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;<U>Purchase of the Securities by the Underwriters</U>. (a)&nbsp;The Company agrees to issue
and sell the Securities to the several Underwriters as provided in this Agreement, and each
Underwriter, on the basis of the representations, warranties and agreements set forth herein and
subject to the conditions set forth herein, agrees, severally and not jointly, to purchase from the
Company the respective principal amount of Securities set forth opposite such Underwriter&#146;s name in
Schedule&nbsp;I hereto at a price equal to 98.554% of the principal amount thereof plus accrued
interest, if any, from June&nbsp;1, 2009 (the &#147;Purchase Price&#148;) to the Closing Date (as defined below).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The Company understands that the Underwriters intend to make a public offering of the
Securities as soon after the effectiveness of this Agreement as in the judgment of the
Representatives is advisable. The Company acknowledges and agrees that the Underwriters may offer
and sell Securities to or through any affiliate of an
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Underwriter and that any such affiliate may offer and sell Securities purchased by it to or
through any Underwriter.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Payment for the Securities shall be made by wire transfer in immediately available funds
to the account specified by the Company to the Representatives against delivery of such Securities
for the respective accounts of the several Underwriters at the offices of Cravath, Swaine &#038; Moore
LLP at 10:00&nbsp;A.M. New York City time on June&nbsp;1, 2009, or at such other time or place on the same or
such other date, not later than the fifth (5th) business day thereafter, as the Representatives and
the Company may agree upon in writing. The time and date of such payment are referred to herein as
the &#147;Closing Date&#148;.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Delivery of the Securities shall be made through the facilities of The Depository Trust
Company and shall be in global form unless the Representatives shall instruct otherwise, with any
transfer taxes payable in connection with the sale of such Securities duly paid by the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;The Company acknowledges and agrees that the Underwriters are acting solely in the
capacity of an arm&#146;s length contractual counterparty to the Company with respect to the offering of
Securities contemplated hereby (including in connection with determining the terms of the offering)
and not as a financial advisor or a fiduciary to, or an agent of, the Company or any other person.
Additionally, neither the Representatives nor any other Underwriters is advising the Company or any
other person as to any legal, tax, investment, accounting or regulatory matters in any
jurisdiction. The Company shall consult with its own advisors concerning such matters and shall be
responsible for making its own independent investigation and appraisal of the transactions
contemplated hereby, and the Underwriters shall have no responsibility or liability to the Company
with respect thereto. Any review by the Underwriters of the Company, the transactions contemplated
hereby or other matters relating to such transactions will be performed solely for the benefit of
the Underwriters and shall not be on behalf of the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;<U>Representations and Warranties of the Company</U>. The Company represents and warrants
to each Underwriter that:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <I>Preliminary Prospectus. </I>No order preventing or suspending the use of any Preliminary
Prospectus has been issued by the Commission, and each Preliminary Prospectus, at the time of
filing thereof, complied in all material respects with the Securities Act and did not contain any
untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading; <U>provided</U> that the Company makes no representation and
warranty with respect to any statements or omissions made in reliance upon and in conformity with
information relating to any Underwriter furnished to the Company in writing by such Underwriter
through the Representatives expressly for use in any Preliminary Prospectus.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <I>Time of Sale Information. </I>The Time of Sale Information, at the Time of Sale did not, and
at the Closing Date will not, contain any untrue statement of a material fact or omit to state a
material fact necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading; <U>provided</U> that the Company makes no
representation and warranty with respect to any statements or omissions made in reliance upon and
in conformity with information relating to any Underwriter furnished to the Company in writing by
such Underwriter through the Representatives expressly for use in such Time of Sale Information.
No statement of material fact included in the Prospectus has been omitted from the Time of Sale
Information and no statement of material fact included in the Time of Sale Information that is
required to be included in the Prospectus has been omitted therefrom.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <I>Issuer Free Writing Prospectus. </I>The Company (including its agents and representatives,
other than the Underwriters in their capacity as such) has not prepared, made, used, authorized,
approved or referred to and will not prepare, make, use, authorize, approve or refer to any
&#147;written communication&#148; (as defined in Rule&nbsp;405 under the Securities Act) that constitutes an offer
to sell or solicitation of an offer to buy the Securities (each such communication by the Company
or its agents and representatives (other than a communication referred to in clauses (i) (ii)&nbsp;and
(iii)&nbsp;below) an &#147;Issuer Free Writing Prospectus&#148;) other than (i)&nbsp;any document not constituting a
prospectus pursuant to Section&nbsp;2(a)(10)(a) of the Securities Act or Rule&nbsp;134 under the Securities
Act, (ii)&nbsp;the Preliminary Prospectus, (iii)&nbsp;the Prospectus, (iv)&nbsp;the documents listed on Schedule
IIA hereto as constituting the Time of Sale Information and (v)&nbsp;any electronic road show or other
written communications, in each case approved in writing in advance by the Representative and,
other than any electronic road show listed on Schedule&nbsp;IIB hereto. Each such Issuer Free Writing
Prospectus complied in all material respects with the Securities Act, has been or will be (within
the time period specified in Rule&nbsp;433) filed in accordance with the Securities Act (to the extent
required thereby) and, when taken together with the Preliminary Prospectus filed prior to the first
use of such Issuer Free Writing Prospectus, did not, and at the Closing Date will not, contain any
untrue statement of a material fact or omit to state a material fact necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading;
<U>provided</U> that the Company makes no representation and warranty with respect to any
statements or omissions made in each such Issuer Free Writing Prospectus in reliance upon and in
conformity with information relating to any Underwriter furnished to the Company in writing by such
Underwriter through the Representative expressly for use in any Issuer Free Writing Prospectus.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <I>Registration Statement and Prospectus. </I>The Registration Statement is an &#147;automatic shelf
registration statement&#148; as defined under Rule&nbsp;405 of the Securities Act that has been filed with
the Commission not earlier than three years prior to the date hereof; and no notice of objection of
the Commission to the use of such registration statement or any post-effective amendment thereto
pursuant to Rule&nbsp;401(g)(2) under the Securities Act has been received by the Company. No order
suspending the effectiveness of the Registration Statement has been issued by the Commission and no
proceeding for that purpose or pursuant to Section&nbsp;8A of the Securities Act against the Company or
related to the offering has been initiated or, to the knowledge of the Company, threatened
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">by the Commission; as of each date and time the Registration Statement, and any post-effective
amendment or amendments thereto, became or becomes effective, the Registration Statement complied
and will comply in all material respects with the Securities Act and the Trust Indenture Act of
1939, as amended, and the rules and regulations of the Commission thereunder (collectively, the
&#147;Trust Indenture Act&#148;), and did not and will not contain any untrue statement of a material fact or
omit to state a material fact required to be stated therein or necessary in order to make the
statements therein not misleading; and as of the applicable filing date of the Prospectus and any
amendment or supplement thereto and as of the Closing Date, the Prospectus will not contain any
untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading; <U>provided</U> that the Company makes no representation and
warranty with respect to (i)&nbsp;that part of the Registration Statement that constitutes the Statement
of Eligibility and Qualification (Form T-1) of the Trustee under the Trust Indenture Act or (ii)
any statements or omissions made in reliance upon and in conformity with information relating to
any Underwriter furnished to the Company in writing by such Underwriter through the Representatives
expressly for use in the Registration Statement and the Prospectus and any amendment or supplement
thereto.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <I>Incorporated Documents. </I>The documents incorporated by reference in the Registration
Statement, the Time of Sale Information and the Prospectus, when they were filed with the
Commission conformed in all material respects to the requirements of the Securities Act or the
Exchange Act, as applicable, and none of such documents contained any untrue statement of a
material fact or omitted to state a material fact required to be stated therein or necessary to
make the statements therein, in the light of the circumstances under which they were made, not
misleading; and any further documents so filed and incorporated by reference in the Registration
Statement, the Time of Sale Information and the Prospectus, when such documents are filed with the
Commission will conform in all material respects to the requirements of the Securities Act or the
Exchange Act, as applicable, and will not contain any untrue statement of a material fact or omit
to state a material fact required to be stated therein or necessary to make the statements therein,
in the light of the circumstances under which they were made, not misleading.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <I>Financial Statements. </I>The financial statements and the related notes thereto of the
Company and its consolidated subsidiaries included or incorporated by reference in the Registration
Statement, the Time of Sale Information and the Prospectus comply in all material respects with the
applicable requirements of the Securities Act and the Exchange Act, as applicable, and present
fairly the financial position of the Company and its consolidated subsidiaries as of the dates
indicated and the results of their operations and the changes in their consolidated cash flows for
the periods specified; such financial statements have been prepared in conformity with U.S.
generally accepted accounting principles applied on a consistent basis throughout the periods
covered thereby (except that such financial statements do not give retroactive effect to the
adoption by the Company of <I>Statement of Financial Accounting Standard </I>160 as of January&nbsp;1, 2009),
and the supporting schedules included or incorporated by reference in
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">the Registration Statement present fairly the information required to be stated therein; and
the other financial information relating to the Company and its subsidiaries that is included or
incorporated by reference in the Registration Statement, the Time of Sale Information and the
Prospectus has been derived from the accounting records of the Company and its subsidiaries and
presents fairly the information shown thereby.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) <I>No Material Adverse Change. </I>Since the date of the most recent financial statements of the
Company included or incorporated by reference in the Registration Statement, the Time of Sale
Information and the Prospectus, (i)&nbsp;there has not been any material change in the capital stock
(other than the issuance of shares of common stock of the Company upon exercise of stock options
and warrants described as outstanding in, and the grant of options and awards under existing
employee or directors stock compensation plans, or long-term debt of the Company or any of its
subsidiaries, or, except in the case of dividends disclosed in the Company&#146;s Exchange Act Reports
or the Prospectus, any dividend or distribution of any kind paid or made by the Company on any
class of capital stock (other than the regular quarterly dividend paid on March&nbsp;27, 2009), or any
material adverse change, or any development involving a prospective material adverse change, in or
affecting the business, prospects, management, financial position, stockholders&#146; equity or results
of operations of the Company and its subsidiaries taken as a whole; and (ii)&nbsp;except in the ordinary
course of business or as disclosed in the Company&#146;s Exchange Act reports, neither the Company nor
any of its subsidiaries has entered into any transaction or agreement that is material to the
Company and its subsidiaries taken as a whole or incurred any liability or obligation, direct or
contingent, that is material to the Company and its subsidiaries taken as a whole; and (iii)
neither the Company nor any of its subsidiaries has sustained any material loss or interference
with its business from fire, explosion, flood or other calamity, whether or not covered by
insurance, or from any labor disturbance or dispute or any action, order or decree of any court or
arbitrator or governmental or regulatory authority, except in each case as otherwise disclosed in
the Registration Statement, the Time of Sale Information and the Prospectus.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) <I>Organization and Good Standing. </I>(i)&nbsp;The Company has been duly incorporated and is validly
existing and in good standing (to the extent such concept exists in the jurisdiction in question)
under the laws of its jurisdiction of incorporation, is duly qualified as a foreign corporation for
the transaction of business and is in good standing (to the extent such concept exists in the
jurisdiction in question) in each jurisdiction in which it owns or leases property or conducts
business, so as to require such qualification, and has all power and authority necessary to own or
hold its properties and to conduct the business in which it is engaged, except where the failure to
be so qualified or in good standing or to have such power or authority would not, individually or
in the aggregate, have a material adverse effect on the business, prospects, management, financial
position, stockholders&#146; equity or results of operations of the Company and its subsidiaries taken
as a whole (a &#147;Material Adverse Effect&#148;) and (ii)&nbsp;each of the Company&#146;s &#147;significant subsidiaries&#148;
(within the meaning of Rule&nbsp;1-02 of Regulation&nbsp;S-X) (collectively, the &#147;Significant Subsidiaries&#148;)
has been duly incorporated and is validly existing and in good standing under the laws of its
jurisdiction of incorporation, is duly qualified as a foreign corporation for the transaction of
business and is in good standing
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">in each jurisdiction in which it owns or leases property or conducts business, so as to
require such qualification, and has all power and authority necessary to own or hold its properties
and to conduct the business in which it is engaged, except where the failure to be so qualified or
in good standing or to have such power or authority would not, individually or in the aggregate,
have a Material Adverse Effect; and all outstanding shares of capital stock of each Significant
Subsidiary of the Company have been duly authorized and validly issued, are fully-paid and
non-assessable, and (except for any directors&#146; qualifying shares and minority interests) are owned
by the Company, directly or indirectly, free and clear of all liens, encumbrances, security
interests and claims.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) <I>Capitalization. </I>The Company has an authorized capitalization as set forth in the
Registration Statement, the Time of Sale Information and the Prospectus under the heading
&#147;Capitalization&#148;; all the outstanding shares of capital stock of the Company have been duly and
validly authorized and issued and are fully paid and non-assessable and are not subject to any
pre-emptive or similar rights; except as described in or expressly contemplated by the Registration
Statement, the Time of Sale Information and the Prospectus, there are no outstanding rights
(including, without limitation, pre-emptive rights), warrants or options to acquire, or instruments
convertible into or exchangeable for, any shares of capital stock or other equity interest in the
Company or any of its subsidiaries, or any contract, commitment, agreement, understanding or
arrangement of any kind relating to the issuance of any capital stock of the Company or any such
subsidiary, any such convertible or exchangeable securities or any such rights, warrants or
options.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) <I>Due Authorization. </I>The Company has all requisite corporate right, power and authority to
execute and deliver this (i)&nbsp;Agreement, the Securities and the Indenture, (ii)&nbsp;the dealer manager
agreement, the offer to purchase and the letter of transmittal related to the Company&#146;s tender
offer (the &#147;Tender Offer&#148;) for its 8.375% Notes due 2011 and (iii)&nbsp;the underwriting agreement, the
indenture and the securities related to the Company&#146;s offering of its 4.25% Convertible Senior
Notes due 2014 (the &#147;Convertible Notes Offering&#148;) (the documents referred to in clauses (i)-(iii)
being referred herein collectively as the &#147;Transaction Documents&#148;) and to perform its obligations
hereunder and thereunder; and all action required to be taken for the due and proper authorization,
execution and delivery of each of the Transaction Documents and the consummation of the
transactions contemplated thereby has been duly and validly taken.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k) <I>Underwriting Agreement. </I>This Agreement has been duly authorized, executed and delivered
by the Company and constitutes the valid and binding agreement of the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l) <I>The Securities. </I>The Securities to be issued and sold by the Company hereunder have been
duly authorized by the Company and, when duly executed, authenticated, issued and delivered as
provided in the Indenture and paid for as provided herein, will be duly and validly issued and
outstanding and will constitute valid and legally binding obligations of the Company enforceable
against the Company in accordance with their terms, subject to the Enforceability Exceptions (as
defined below),
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">will be entitled to the benefits of the Indenture and will conform in all material respects to
the descriptions thereof in the Registration Statement, the Time of Sale Information and the
Prospectus.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m) <I>The Indenture. </I>The Indenture has been duly authorized by the Company and upon
effectiveness of the Registration Statement was duly qualified under the Trust Indenture Act and,
when duly executed and delivered in accordance with its terms by each of the parties thereto, will
constitute a valid and legally binding agreement of the Company enforceable against the Company in
accordance with its terms, except as enforceability may be limited by applicable bankruptcy,
insolvency or similar laws affecting the enforcement of creditors&#146; rights generally or by equitable
principles relating to enforceability (collectively, the &#147;Enforceability Exceptions&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(n) <I>Description of Transaction Documents. </I>Each Transaction Document conforms in all material
respects to the description thereof, if any, contained in the Registration Statement, the Time of
Sale Information and the Prospectus.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(o) <I>No Violation or Default. </I>Neither the Company nor any of its subsidiaries is (i)&nbsp;in
violation of its charter or by-laws or similar organizational documents; (ii)&nbsp;in default, and no
event has occurred that, with notice or lapse of time or both, would constitute such a default, in
the due performance or observance of any term, covenant or condition contained in any indenture,
mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or
any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or
to which any of the property or assets of the Company or any of its subsidiaries is subject; or
(iii)&nbsp;in violation of any law or statute or any judgment, order, rule or regulation of any court or
arbitrator or governmental or regulatory authority, except, in the case of clauses (ii)&nbsp;and (iii)
above, for any such default or violation that would not, individually or in the aggregate, have a
Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(p) <I>No Conflicts. </I>The execution, delivery and performance by the Company of each of the
Transaction Documents, the issuance and sale of the Securities and compliance by the Company with
the terms thereof and the consummation of the transactions contemplated by the Transaction
Documents will not (i)&nbsp;conflict with or result in a breach or violation of any of the terms or
provisions of, or constitute a default under, or result in the creation or imposition of any lien,
charge or encumbrance upon any property or assets of the Company or any of its subsidiaries
pursuant to any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument
to which the Company or any of its subsidiaries is a party or by which the Company or any of its
subsidiaries is bound or to which any of the property or assets of the Company or any of its
subsidiaries is subject, (ii)&nbsp;result in any violation of the provisions of the charter or by-laws
or similar organizational documents of the Company or any of its subsidiaries or (iii)&nbsp;result in
the violation of any law or statute or any judgment, order, rule or regulation of any court or
arbitrator or governmental or regulatory authority, except, in the case of clauses (i)&nbsp;and (iii)
above, for any such conflict, breach or violation that would not, individually or in the aggregate,
have a (x)&nbsp;Material Adverse Effect or (y)&nbsp;material adverse effect on the issuance and sale of the
Securities and compliance by the Company
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">with the terms thereof and the consummation of the transactions contemplated by the
Transaction Documents.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(q) <I>No Consents Required. </I>No consent, approval, authorization, order, license, registration
or qualification of or with any court or arbitrator or governmental or regulatory authority is
required for the execution, delivery and performance by the Company of each of the Transaction
Documents, the issuance and sale of the Securities and compliance by the Company with the terms
thereof and the consummation of the transactions contemplated by the Transaction Documents, except
for registration of the Securities under the Securities Act, the qualification of the Indenture
under the Trust Indenture Act and such consents, approvals, authorizations, orders and
registrations or qualifications as may be required under applicable state securities laws in
connection with the purchase and distribution of the Securities by the Underwriters, and except for
such consents, approvals, authorizations, orders or filings the failure of which to obtain or make
would not reasonably be expected to have a Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(r) <I>Legal Proceedings. </I>Except as described in the Registration Statement, the Time of Sale
Information and the Prospectus, there are no legal, governmental or regulatory investigations,
actions, suits or proceedings pending to which the Company or any of its subsidiaries is or may be
a party or to which any property of the Company or any of its subsidiaries is or may be the subject
that, individually or in the aggregate, if determined adversely to the Company or any of its
subsidiaries, could reasonably be expected to have a Material Adverse Effect; and to the knowledge
of the Company, no such investigations, actions, suits or proceedings are threatened by any
governmental or regulatory authority or threatened by others; and (i)&nbsp;there are no current or
pending legal, governmental or regulatory actions, suits or proceedings that are required under the
Securities Act to be described in the Registration Statement and the Prospectus that are not so
described in the Registration Statement, the Time of Sale Information and the Prospectus and (ii)
there are no statutes, regulations or contracts or other documents that are required under the
Securities Act to be filed as exhibits to the Registration Statement or described in the
Registration Statement and the Prospectus that are not so filed as exhibits to the Registration
Statement or described in the Registration Statement, the Time of Sale Information and the
Prospectus.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(s) <I>Independent Accountants. </I>Ernst &#038; Young LLP, which has audited certain financial
statements of the Company and its subsidiaries, is an independent registered public accounting firm
with respect to the Company and its subsidiaries within the applicable rules and regulations
adopted by the Commission and the Public Company Accounting Oversight Board (United States) and as
required by the Securities Act.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(t) <I>Title to Real and Personal Property. </I>(i)&nbsp;The Company and its subsidiaries have good and
marketable title in fee simple (in the case of real property) to, or have valid rights to lease or
otherwise use, all items of real and personal property and assets that are material to the
respective businesses of the Company and its subsidiaries, in each case free and clear of all
liens, encumbrances, claims and defects and imperfections of title except those that (x)&nbsp;are
described or referred to in the Registration Statement, the Time of Sale Information and the
Prospectus, (y)&nbsp;do not materially affect
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">the value of such property and do not interfere with the use made and proposed to be made of
such property by the Company and its subsidiaries or (z)&nbsp;would not have a Material Adverse Effect,
and (ii)&nbsp;any material real property and buildings held under lease by the Company and its
subsidiaries are held by them under valid, existing and enforceable leases with such exceptions (x)
as are not material and do not interfere with the use made or proposed to be made of such real
property and buildings by the Company or its subsidiaries or (y)&nbsp;which would not have a Material
Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(u) <I>Title to Intellectual Property. </I>Except as would not, individually or in the aggregate,
have a Material Adverse Effect, the Company and its subsidiaries own, possess or can acquire on
reasonable terms, adequate rights to use all patents, patent applications, trademarks, service
marks, trade names, trademark registrations, service mark registrations, copyrights, licenses and
know-how (including trade secrets and other unpatented and/or unpatentable proprietary or
confidential information, systems or procedures) (collectively, &#147;Intellectual Property Rights&#148;)
reasonably necessary for the conduct of their respective businesses as currently conducted by them
or presently employed by them; and the Company and its subsidiaries have not received any written
notice of any claim of infringement or conflict with any asserted rights of others with respect to
any Intellectual Property Rights that, if determined adversely to the Company or any of its
subsidiaries, would, individually or in the aggregate, have a Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) <I>No Undisclosed Relationships. </I>No relationship, direct or indirect, exists between or
among the Company or any of its subsidiaries, on the one hand, and the directors, officers,
stockholders, customers or suppliers of the Company or any of its subsidiaries, on the other, that
is required by the Securities Act to be described in the Registration Statement and the Prospectus
and that is not so described in such documents and the Time of Sale Information.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(w) <I>Investment Company Act. </I>The Company is not and, after giving effect to the offering and
sale of the Securities and the consummation of the Convertible Notes Offering and the application
of the proceeds thereof as described in the Registration Statement, the Time of Sale Information
and the Prospectus and the consummation of the Tender Offer, will not be required to register as an
&#147;investment company&#148; or an entity &#147;controlled&#148; by an &#147;investment company&#148; within the meaning of the
Investment Company Act of 1940, as amended, and the rules and regulations of the Commission
thereunder (collectively, &#147;Investment Company Act&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(x) <I>Public Utility Holding Company Act. </I>Neither the Company nor any of its subsidiaries is a
&#147;holding company&#148; or a &#147;subsidiary company&#148; of a holding company or an &#147;affiliate&#148; thereof within
the meaning of the Public Utility Holding Company Act of 1935, as amended.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(y) <I>Taxes. </I>The Company and its subsidiaries have paid all material federal, state, local and
foreign taxes and all assessments received by them or any of them to the extent that such material
taxes have become due and are not being contested in good faith, except where the failure to so pay
or file would not have a Material Adverse
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Effect and filed all tax returns required to be paid or filed through the date hereof; and
except as otherwise disclosed in the Registration Statement, the Time of Sale Information and the
Prospectus, there is no tax deficiency that has been, or, to the Company&#146;s knowledge, could
reasonably be expected to be, asserted against the Company or any of its subsidiaries or any of
their respective properties or assets that would have a Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(z) <I>Licenses and Permits. </I>The Company and its subsidiaries possess all licenses,
certificates, permits and other authorizations issued by, and have made all declarations and
filings with, the appropriate federal, state, local or foreign governmental or regulatory
authorities that are necessary for the ownership or lease of their respective properties or the
conduct of their respective businesses as described in the Registration Statement, the Time of Sale
Information and the Prospectus, except where the failure to possess or make the same would not,
individually or in the aggregate, have a Material Adverse Effect; and neither the Company nor any
of its subsidiaries has received actual notice of any proceeding relating to revocation or
modification of any such license, certificate, permit or authorization, except as described in the
Registration Statement, the Time of Sale Information and the Prospectus; and each of the Company
and its subsidiaries is in compliance with all laws and regulations relating to the conduct of its
business as conducted as of the date hereof, except where the failure to possess such licenses,
certificates, permits and other authorizations, to make such declarations and filings, to be party
to any such proceedings, or to comply with such laws and regulations would not, singly or in the
aggregate, have a Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(aa) <I>No Labor Disputes. </I>No material labor disturbance by or dispute with employees of the
Company or any of its subsidiaries exists or, to the knowledge of the Company, is threatened.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(bb) <I>Compliance With Environmental Laws. </I>(i)&nbsp;The Company and its subsidiaries (x)&nbsp;are in
compliance with any and all applicable federal, state, local and foreign laws, rules and
regulations relating to the protection of human health and safety, the environment or hazardous or
toxic substances or wastes, pollutants or contaminants (collectively, &#147;Environmental Laws&#148;),
(y)&nbsp;have received and are in compliance with all permits, licenses or other approvals required of
them under applicable Environmental Laws to conduct their respective businesses, and (z)&nbsp;have not
received notice of any actual or potential liability for the investigation or remediation of any
disposal or release of hazardous or toxic substances or wastes, pollutants or contaminants, except
in any such case for any such failure to comply, or failure to receive required permits, licenses
or approvals, or liability as (i)&nbsp;is disclosed in the Registration Statement, the Time of Sale
Information and the Prospectus or (ii)&nbsp;would not, individually or in the aggregate, reasonably be
expected to have a Material Adverse Effect.
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) In the ordinary course of its business, the Company conducts a periodic review of
the effect of Environmental Laws on the business, operations and properties of the Company
and its subsidiaries, in the course of which it identifies and evaluates associated costs
and liabilities (including, without limitation, any capital or operating expenditures
required for clean-up, closure of
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">properties or compliance with Environmental Laws or any permit, license or approval,
any related constraints on operating activities and any potential liabilities to third
parties). On the basis of such review, the Company has reasonably concluded that such
associated costs and liabilities would not, singly or in the aggregate, have a Material
Adverse Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(cc) <I>Compliance With ERISA. </I>Each employee benefit plan, within the meaning of Section&nbsp;3(3) of
the Employee Retirement Income Security Act of 1974, as amended (&#147;ERISA&#148;), that is maintained,
administered or contributed to by the Company or any of its affiliates for employees or former
employees of the Company and its affiliates has been maintained in compliance in all material
respects with its terms and the requirements of any applicable statutes, orders, rules and
regulations, including but not limited to ERISA and the Internal Revenue Code of 1986, as amended
(the &#147;Code&#148;); no prohibited transaction, within the meaning of Section&nbsp;406 of ERISA or Section&nbsp;4975
of the Code, has occurred with respect to any such plan excluding transactions effected pursuant to
a statutory or administrative exemption that could reasonably be expected to result in a material
liability to the Company or its subsidiaries; and for each such plan that is subject to the funding
rules of Section&nbsp;412 of the Code or Section&nbsp;302 of ERISA, no &#147;accumulated funding deficiency&#148; as
defined in Section&nbsp;412 of the Code has been incurred, whether or not waived, and the fair market
value of the assets of each such plan (excluding for these purposes accrued but unpaid
contributions) exceeds the present value of all benefits accrued under such plan determined using
reasonable actuarial assumptions.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(dd) <I>Disclosure Controls. </I>The Company and its subsidiaries on a consolidated basis maintain
an effective system of &#147;disclosure controls and procedures&#148; (as defined in Rule&nbsp;13a-15(e) of the
Exchange Act) that is designed to ensure that information required to be disclosed by the Company
in reports that it files or submits under the Exchange Act is recorded, processed, summarized and
reported within the time periods specified in the Commission&#146;s rules and forms, including controls
and procedures designed to ensure that such information is accumulated and communicated to the
Company&#146;s management as appropriate to allow timely decisions regarding required disclosure. The
Company and its subsidiaries on a consolidated basis have carried out evaluations of the
effectiveness of their disclosure controls and procedures as required by Rule&nbsp;13a-15 of the
Exchange Act.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ee) <I>Accounting Controls. </I>The Company and its subsidiaries on a consolidated basis maintain
systems of &#147;internal controls over financial reporting&#148; (as defined in Rule&nbsp;13a-15(f) of the
Exchange Act) that comply with the requirements of the Exchange Act and have been designed by, or
under the supervision of, their respective principal executive and principal financial officers, or
persons performing similar functions, to provide reasonable assurance regarding reliability of
financial reporting and the preparation of financial statements for external purposes in accordance
with generally accepted accounting principles, including but not limited to internal accounting
controls sufficient to provide reasonable assurance that (i)&nbsp;transactions are executed in
accordance with management&#146;s general or specific authorizations; (ii)&nbsp;transactions are recorded as
necessary to permit preparation of financial statements in conformity with generally
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">accepted accounting principles and to maintain asset accountability; (iii)&nbsp;access to assets is
permitted only in accordance with management&#146;s general or specific authorization; and (iv)&nbsp;the
recorded accountability for assets is compared with the existing assets at reasonable intervals and
appropriate action is taken with respect to any differences. Except as disclosed in the
Registration Statement, the Time of Sale Information and the Prospectus, there are no material
weaknesses in the Company&#146;s internal controls.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ff) <I>Insurance. </I>The Company and its subsidiaries have insurance covering their respective
properties, operations, personnel and businesses, including business interruption insurance, which
insurance is in such amounts and insures against such losses and risks as are reasonable and
consistent with sound business practice; and neither the Company nor any of its subsidiaries has
(i)&nbsp;received notice from any insurer or agent of such insurer that capital improvements or other
expenditures are required or necessary to be made in order to continue such insurance or (ii)&nbsp;any
reason to believe that it will not be able to renew its existing insurance coverage as and when
such coverage expires or to obtain similar coverage at reasonable cost from similar insurers as may
be necessary to continue its business.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(gg) <I>No Unlawful Payments. </I>Neither the Company nor any of its subsidiaries nor, to the
knowledge of the Company, any director, officer, agent, employee or other person associated with or
acting on behalf of the Company or any of its subsidiaries has (i)&nbsp;used any corporate funds for any
unlawful contribution, gift, entertainment or other unlawful expense relating to political
activity; (ii)&nbsp;made any direct or indirect unlawful payment to any foreign or domestic government
official or employee from corporate funds; (iii)&nbsp;violated or is in violation of any provision of
the Foreign Corrupt Practices Act of 1977; or (iv)&nbsp;made any bribe, rebate, payoff, influence
payment, kickback or other unlawful payment.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(hh) <I>Compliance with Money Laundering Laws. </I>The operations of the Company and its
subsidiaries are and have been conducted at all times in compliance with applicable financial
recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of
1970, as amended, the money laundering statutes of all jurisdictions, the rules and regulations
thereunder and any related or similar rules, regulations or guidelines, issued, administered or
enforced by any governmental agency (collectively, the &#147;Money Laundering Laws&#148;) and no action, suit
or proceeding by or before any court or governmental agency, authority or body or any arbitrator
involving the Company or any of its subsidiaries with respect to the Money Laundering Laws is
pending or, to the knowledge of the Company, threatened.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) <I>Compliance with OFAC. </I>None of the Company, any of its subsidiaries or, to the knowledge
of the Company, any director, officer, agent, employee or affiliate of the Company or any of its
subsidiaries is currently subject to any U.S. sanctions administered by the Office of Foreign
Assets Control of the U.S. Department of the Treasury (&#147;OFAC&#148;); and the Company will not, directly
or indirectly, use the proceeds of the offering of the Securities hereunder, or lend, contribute or
otherwise make available such proceeds to any subsidiary, joint venture partner or other person or
entity, for the
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">purpose of financing the activities of any person currently subject to any U.S. sanctions
administered by OFAC.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(jj) <I>No Restrictions on Subsidiaries</I>. No subsidiary of the Company is currently prohibited,
directly or indirectly, under any agreement or other instrument to which it is a party or is
subject, from paying any dividends to the Company, from making any other distribution on such
subsidiary&#146;s capital stock, from repaying to the Company any loans or advances to such subsidiary
from the Company or from transferring any of such subsidiary&#146;s properties or assets to the Company
or any other subsidiary of the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(kk) <I>No Broker&#146;s Fees. </I>Neither the Company nor any of its subsidiaries is a party to any
contract, agreement or understanding with any person (other than this Agreement) that would give
rise to a valid claim against the Company or any of its subsidiaries or any Underwriter for a
brokerage commission, finder&#146;s fee or like payment in connection with the offering and sale of the
Securities.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ll) <I>No Registration Rights</I>. No person has the right to require the Company or any of its
subsidiaries to register any securities for sale under the Securities Act by reason of the filing
of the Registration Statement with the Commission or the issuance and sale of the Securities.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(mm) <I>No Stabilization. </I>The Company has not taken, directly or indirectly, any action designed
to or that could reasonably be expected to cause or result in any stabilization or manipulation of
the price of the Securities.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(nn) <I>Business With Cuba. </I>The Company has complied with all provisions of Section&nbsp;517.075,
Florida Statutes (Chapter&nbsp;92-198, Laws of Florida) relating to doing business with the Government
of Cuba or with any person or affiliate located in Cuba.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(oo) <I>Margin Rules</I>. Neither the issuance, sale and delivery of the Securities nor the
application of the proceeds thereof by the Company as described in the Registration Statement, the
Time of Sale Information and the Prospectus will violate Regulation&nbsp;T, U or X of the Board of
Governors of the Federal Reserve System or any other regulation of such Board of Governors.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(pp) <I>Forward-Looking Statements. </I>No forward-looking statement (within the meaning of Section
27A of the Securities Act and Section&nbsp;21E of the Exchange Act) contained in the Registration
Statement, the Time of Sale Information and the Prospectus has been made or reaffirmed without a
reasonable basis or has been disclosed other than in good faith.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(qq) <I>Statistical and Market Data. </I>Nothing has come to the attention of the Company that has
caused the Company to believe that the statistical and market-related data included in the
Registration Statement, the Time of Sale Information and the Prospectus is not based on or derived
from sources that are reliable and accurate in all material respects.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(rr) <I>Sarbanes-Oxley Act</I>. There is and has been no failure on the part of the Company or any
of the Company&#146;s directors or officers, in their capacities as such, to comply with any provision
of the Sarbanes-Oxley Act of 2002 and the rules and regulations promulgated in connection therewith
(the &#147;Sarbanes-Oxley Act&#148;), including Section&nbsp;402 related to loans and Sections&nbsp;302 and 906 related
to certifications.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ss) <I>Senior Indebtedness. </I>The Securities constitute &#147;senior indebtedness&#148; as such term is
defined in any indenture or agreement governing any outstanding subordinated indebtedness of the
Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(tt) <I>Status under the Securities Act. </I>The Company is not an ineligible issuer and is a
well-known seasoned issuer, in each case, as defined under the Securities Act, in each case at the
times specified in the Securities Act in connection with the offering of the Securities.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;<U>Further Agreements of the Company</U>. The Company covenants and agrees with each
Underwriter that:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <I>Effectiveness of the Registration Statement. </I>The Company will file the final Prospectus
with the Commission within the time periods specified by Rule 424(b) and Rule&nbsp;430A, 430B or 430C
under the Securities Act, will file any Issuer Free Writing Prospectus (including the Term Sheet in
the form of Schedule&nbsp;III hereto) to the extent required by Rule&nbsp;433 under the Securities Act and
will file promptly all reports and any definitive proxy or information statements required to be
filed by the Company with the Commission pursuant to Section&nbsp;13(a), 13(c), 14 or 15(d) of the
Exchange Act subsequent to the date of the Prospectus and for so long as the delivery of a
prospectus is required in connection with the offering or sale of the Securities; and the Company
will furnish copies of the Prospectus and each Issuer Free Writing Prospectus (to the extent not
previously delivered) to the Underwriters in New York City prior to 10:00&nbsp;A.M., New York City time,
on the business day next succeeding the date of this Agreement in such quantities as the
Representatives may reasonably request. The Company will pay the registration fees for this
offering within the time period required by Rule&nbsp;456(b)(1)(i) under the Securities Act (without
giving effect to the proviso therein) and in any event prior to the Closing Date.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <I>Delivery of Copies. </I>The Company will deliver, without charge, (i)&nbsp;to the Representatives,
three signed copies of the Registration Statement as originally filed and each amendment thereto,
in each case including all exhibits and consents filed therewith; and (ii)&nbsp;to each Underwriter (A)
a conformed copy of the Registration Statement as originally filed and each amendment thereto
(without exhibits) and (B)&nbsp;during the Prospectus Delivery Period (as defined below), as many copies
of the Prospectus (including all amendments and supplements thereto and documents incorporated by
reference therein) and each Issuer Free Writing Prospectus as the Representatives may reasonably
request. As used herein, the term &#147;Prospectus Delivery Period&#148; means such period of time after the
first date of the public offering of the Securities as in the opinion of counsel for the
Underwriters a prospectus relating to the Securities is required by law to be delivered (or
required to be delivered but for Rule&nbsp;172
under the Securities Act) in connection with sales of the Securities by any Underwriter or
dealer.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <I>Amendments or Supplements; Issuer Free Writing Prospectuses. </I>Before making, preparing,
using, authorizing, approving, referring to or filing any Issuer Free Writing Prospectus, and
before filing any amendment or supplement to the Registration Statement or the Prospectus during
the Prospectus Delivery Period, the Company will furnish to the Representatives and counsel for the
Underwriters a copy of the proposed Issuer Free Writing Prospectus, amendment or supplement for
review and will not make, prepare, use authorize, approve, refer to or file any such Issuer Free
Writing Prospectus or file any such proposed amendment or supplement to which the Representatives
reasonably object.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <I>Notice to the Representatives. </I>The Company will advise the Representatives promptly, and
confirm such advice in writing, (i)&nbsp;when any amendment to the Registration Statement has been filed
or becomes effective; (ii)&nbsp;when any supplement to the Prospectus or any amendment to the Prospectus
or any Issuer Free Writing Prospectus has been filed; (iii)&nbsp;of any request by the Commission for
any amendment to the Registration Statement or any amendment or supplement to the Prospectus or the
receipt of any comments from the Commission relating to the Registration Statement or any other
request by the Commission for any additional information; (iv)&nbsp;of the issuance by the Commission of
any order suspending the effectiveness of the Registration Statement or preventing or suspending
the use of any Preliminary Prospectus or the Prospectus or the initiation or threatening of any
proceeding for that purpose or pursuant to Section&nbsp;8A of the Securities Act; (v)&nbsp;of the occurrence
of any event within the Prospectus Delivery Period as a result of which the Prospectus, the Time of
Sale Information or any Issuer Free Writing Prospectus as then amended or supplemented would
include any untrue statement of a material fact or omit to state a material fact required to be
stated therein or necessary in order to make the statements therein, in the light of the
circumstances existing when the Prospectus, the Time of Sale Information or any Issuer Free Writing
Prospectus is delivered to a purchaser, not misleading; (vi)&nbsp;of the receipt by the Company of any
notice of objection of the Commission to the use of the Registration Statement or any
post-effective amendment thereto pursuant to Rule&nbsp;401(g)(2) under the Securities Act; and (vii)&nbsp;of
the receipt by the Company of any notice with respect to any suspension of the qualification of the
Securities for offer and sale in any jurisdiction or the initiation or threatening of any
proceeding for such purpose; and the Company will use its reasonable best efforts to prevent the
issuance of any such order suspending the effectiveness of the Registration Statement, preventing
or suspending the use of any Preliminary Prospectus or the Prospectus or suspending any such
qualification of the Securities and, if any such order is issued, will use its reasonable best
efforts to obtain as soon as possible the withdrawal thereof.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <I>Time of Sale Information. </I>If at any time prior to the Closing Date (i)&nbsp;any event shall
occur or condition shall exist as a result of which the Time of Sale Information as then amended or
supplemented would include any untrue statement of a material fact or omit to state any material
fact necessary in order to make the statements
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">therein, in the light of the circumstances, not misleading or (ii)&nbsp;it is necessary to amend or
supplement the Time of Sale Information to comply with law, the Company will as promptly as
practicable notify the Underwriters thereof and forthwith prepare and, subject to paragraph (c)
above, file with the Commission (to the extent required) and furnish to the Underwriters and to
such dealers as the Representative may designate, such amendments or supplements to the Time of
Sale Information as may be necessary so that the statements in the Time of Sale Information as so
amended or supplemented will not, in the light of the circumstances, be misleading or so that the
Time of Sale Information will comply with law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <I>Ongoing Compliance of the Prospectus. </I>If during the Prospectus Delivery Period (i)&nbsp;any
event shall occur or condition shall exist as a result of which the Prospectus as then amended or
supplemented would include an untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary in order to make the statements therein, in the light of
the circumstances existing when the Prospectus is delivered to a purchaser, not misleading or (ii)
it is necessary to amend or supplement the Prospectus to comply with law, the Company will
immediately notify the Underwriters thereof and forthwith prepare and, subject to paragraph (c)
above, file with the Commission and furnish to the Underwriters and to such dealers as the
Representatives may designate, such amendments or supplements to the Prospectus as may be necessary
so that the statements in the Prospectus as so amended or supplemented will not, in the light of
the circumstances existing when the Prospectus is delivered to a purchaser, be misleading or so
that the Prospectus will comply with law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) <I>Blue Sky Compliance. </I>The Company will qualify the Securities for offer and sale under the
securities or Blue Sky laws of such jurisdictions as the Representatives shall reasonably request
and will continue such qualifications in effect so long as required for distribution of the
Securities; <U>provided</U> that the Company shall not be required to (i)&nbsp;qualify as a foreign
corporation or other entity or as a dealer in securities in any such jurisdiction where it would
not otherwise be required to so qualify, (ii)&nbsp;file any general consent to service of process in any
such jurisdiction or (iii)&nbsp;subject itself to taxation in any such jurisdiction if it is not
otherwise so subject.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) <I>Earning Statement. </I>The Company will make generally available to its security holders and
the Representatives as soon as practicable an earning statement that satisfies the provisions of
Section 11(a) of the Securities Act and Rule&nbsp;158 of the Commission promulgated thereunder covering
a period of at least twelve months beginning with the first fiscal quarter of the Company occurring
after the &#147;effective date&#148; (as defined in Rule&nbsp;158) of the Registration Statement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) <I>Use of Proceeds. </I>The Company will apply the net proceeds from the sale of the Securities
as described in the Registration Statement, the Time of Sale Information and the Prospectus under
the heading &#147;Use of Proceeds&#148;.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) <I>No Stabilization. </I>The Company will not take, directly or indirectly, any action designed
to or that could reasonably be expected to cause or result in any stabilization or manipulation of
the price of the Securities.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k) <I>Reports. </I>So long as the Securities are outstanding, the Company will furnish to the
Representatives, as soon as they are available, copies of all reports or other communications
(financial or other) furnished to holders of the Securities, and copies of any reports and
financial statements furnished to or filed with the Commission or any national securities exchange
or automatic quotation system; <U>provided</U>, <U>however</U>, in no event shall the Company be
required to furnish copies of any such documents which are filed and publicly accessible via the
EDGAR database.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l) <I>Record Retention. </I>The Company will, pursuant to reasonable procedures developed in good
faith, retain copies of each Issuer Free Writing Prospectus that is not filed with the Commission
in accordance with Rule&nbsp;433 under the Securities Act.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;<U>Certain Agreements of the Underwriters</U>. Each Underwriter hereby represents and
agrees that it has not and will not use, authorize use of, refer to, or participate in the planning
for use of, any &#147;free writing prospectus&#148;, as defined in Rule&nbsp;405 under the Securities Act (which
term includes use of any written information furnished to the Commission by the Company and not
incorporated by reference into the Registration Statement and any press release issued by the
Company) other than (i)&nbsp;a free writing prospectus that, solely as a result of use by such
underwriter, would not trigger an obligation to file such free writing prospectus with the
Commission pursuant to Rule&nbsp;433, (ii)&nbsp;any Issuer Free Writing Prospectus listed on Schedule&nbsp;IIA or
prepared pursuant to Section 3(c) or Section 4(c) above (including any electronic road show other
than any electronic road listed on Schedule&nbsp;IIB hereto), or (iii)&nbsp;any free writing prospectus
prepared by such underwriter and approved by the Company in advance in writing (each such free
writing prospectus referred to in clauses (i)&nbsp;or (iii), an &#147;Underwriter Free Writing Prospectus&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.&nbsp;<U>Conditions of Underwriters&#146; Obligations</U>. The obligation of each Underwriter to
purchase the Securities on the Closing Date as provided herein is subject to the performance by the
Company of its covenants and other obligations hereunder and to the following additional
conditions:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <I>Registration Compliance; No Stop Order. </I>No order suspending the effectiveness of the
Registration Statement shall be in effect, and no proceeding for such purpose shall be pending
before or overtly threatened by the Commission; the Prospectus and each Issuer Free Writing
Prospectus shall have been timely filed with the Commission under the Securities Act (in the case
of a Issuer Free Writing Prospectus, to the extent required by Rule&nbsp;433 under the Securities Act)
and in accordance with Section 4(a) hereof; and all requests by the Commission for additional
information shall have been complied with to the reasonable satisfaction of the Representatives.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <I>Representations and Warranties. </I>The representations and warranties of the Company
contained herein shall be true and correct on the date hereof and on and as of the Closing Date;
and the statements of the Company and its officers made in any certificates delivered pursuant to
this Agreement shall be true and correct on and as of the Closing Date.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <I>No Downgrade. </I>Subsequent to the earlier of (i)&nbsp;the Time of Sale and (ii)&nbsp;the execution
and delivery of this Agreement, (A)&nbsp;no downgrading shall have occurred in the rating accorded the
Securities or any other debt securities or preferred stock of or guaranteed by the Company or any
of its subsidiaries by any &#147;nationally recognized statistical rating organization&#148;, as such term is
defined by the Commission for purposes of Rule&nbsp;436(g)(2) under the Securities Act and (B)&nbsp;no such
organization shall have publicly announced that it has under surveillance or review, or has changed
its outlook with respect to, its rating of the Securities or any other debt securities or preferred
stock of or guaranteed by the Company or any of its subsidiaries (other than an announcement with
positive implications of a possible upgrading).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <I>No Material Adverse Change. </I>Subsequent to the execution and delivery of this Agreement,
no event or condition of a type described in Section 3(g) hereof shall have occurred or shall
exist, which event or condition is not described in the Time of Sale Information (excluding any
amendment or supplement thereto) and the Prospectus (excluding any amendment or supplement thereto)
and the effect of which in the judgment of the Representatives makes it impracticable or
inadvisable to proceed with the offering, sale or delivery of the Securities on the Closing Date on
the terms and in the manner contemplated by this Agreement, the Time of Sale Information and the
Prospectus.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <I>Officer&#146;s Certificate. </I>The Representatives shall have received on and as of the Closing
Date a certificate of the chief financial officer or chief accounting officer of the Company and
one additional senior executive officer of the Company who is satisfactory to the Representatives
(i)&nbsp;confirming that such officers have carefully reviewed the Registration Statement, the Time of
Sale Information and the Prospectus and, to the best knowledge of such officers, the
representations set forth in Sections 3(b) and 3(d) hereof are true and correct, (ii)&nbsp;confirming
that the other representations and warranties of the Company in this Agreement are true and correct
and that the Company has complied with all agreements and satisfied all conditions on its part to
be performed or satisfied hereunder at or prior to the Closing Date and (iii)&nbsp;to the effect set
forth in paragraphs (a), (c)&nbsp;and (d)&nbsp;above.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <I>Comfort Letters. </I>On the date of this Agreement and on the Closing Date, Ernst &#038; Young LLP
shall have furnished to the Representatives, at the request of the Company, letters, dated the
respective dates of delivery thereof and addressed to the Underwriters, in form and substance
reasonably satisfactory to the Representatives, containing statements and information of the type
customarily included in accountants&#146; &#147;comfort letters&#148; to underwriters with respect to the
financial statements and certain financial information contained or incorporated by reference in
the Registration Statement, the Prospectus and Time of Sale Information; <U>provided</U> that the
letter delivered on the Closing Date shall use a &#147;cut-off&#148; date no more than three business days
prior to the Closing Date.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) <I>Opinion of Counsel for the Company. </I>(i)&nbsp;Jon D. Walton, Executive Vice President, Human
Resources, Chief Legal and Compliance Officer, General Counsel and Corporate Secretary of the
Company, shall have furnished to the
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Representatives, at the request of the Company, his written opinion, dated the Closing Date,
and addressed to the Underwriters, in form and substance reasonably satisfactory to the
Representatives, to the effect set forth in Annex A hereto and (ii)&nbsp;K&#038;L Gates LLP, counsel for the
Company, shall have furnished to the Representatives, at the request of the Company, their written
opinion, dated the Closing Date, and addressed to the Underwriters, in form and substance
reasonably satisfactory to the Representatives, to the effect set forth in Annex B hereto.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) <I>Opinion of Counsel for the Underwriters. </I>The Representatives shall have received on and
as of the Closing Date an opinion of Cravath, Swaine &#038; Moore LLP, counsel for the Underwriters,
with respect to such matters as the Representatives may reasonably request, and such counsel shall
have received such documents and information as they may reasonably request to enable them to pass
upon such matters.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) <I>No Legal Impediment to Issuance. </I>No action shall have been taken and no statute, rule,
regulation or order shall have been enacted, adopted or issued by any federal, state or foreign
governmental or regulatory authority that would, as of the Closing Date, prevent the issuance or
sale of the Securities; and no injunction or order of any federal, state or foreign court shall
have been issued that would, as of the Closing Date, prevent the issuance or sale of the
Securities.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) <I>Good Standing</I>. The Representatives shall have received on and as of the Closing Date
satisfactory evidence of the good standing of the Company and its Significant Subsidiaries in their
respective jurisdictions of organization and their good standing as foreign entities in such other
jurisdictions as the Representatives may reasonably request, in each case in writing or any
standard form of telecommunication from the appropriate governmental authorities of such
jurisdictions.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k) <I>Additional Documents. </I>On or prior to the Closing Date, the Company shall have furnished
to the Representatives such further certificates and documents as the Representatives may
reasonably request.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All opinions, letters, certificates and evidence mentioned above or elsewhere in this
Agreement shall be deemed to be in compliance with the provisions hereof only if they are in form
and substance reasonably satisfactory to counsel for the Underwriters.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.&nbsp;<U>Indemnification and Contribution</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <I>Indemnification of the Underwriters. </I>The Company agrees to indemnify and hold harmless
each Underwriter, its affiliates, directors and officers and each person, if any, who controls such
Underwriter within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange
Act, from and against any and all losses, claims, damages and liabilities (including, without
limitation, reasonable legal fees and other expenses incurred in connection with any suit, action
or proceeding or any claim asserted, as such fees and expenses are incurred), joint or several,
that arise out of, or are based upon, (i)&nbsp;any untrue statement or alleged untrue statement of a
material fact contained in the Registration Statement or caused by any omission or alleged omission
to
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">state therein a material fact required to be stated therein or necessary in order to make the
statements therein, not misleading or (ii)&nbsp;any untrue statement or alleged untrue statement of a
material fact contained in the Prospectus (or any amendment or supplement thereto), any Issuer Free
Writing Prospectus or any Preliminary Prospectus, or caused by any omission or alleged omission to
state therein a material fact necessary in order to make the statements therein, in light of the
circumstances under which they were made, not misleading, in each case except insofar as such
losses, claims, damages or liabilities arise out of, or are based upon, any untrue statement or
omission or alleged untrue statement or omission made in reliance upon and in conformity with any
information relating to any Underwriter furnished to the Company in writing by such Underwriter
through the Representatives expressly for use therein, it being understood and agreed that the only
such information furnished by any Underwriter consists of the information described as such in
subsection (b)&nbsp;below.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <I>Indemnification of the Company. </I>Each Underwriter agrees, severally and not jointly, to
indemnify and hold harmless the Company, its directors, its officers who signed the Registration
Statement and each person, if any, who controls the Company within the meaning of Section&nbsp;15 of the
Securities Act or Section&nbsp;20 of the Exchange Act to the same extent as the indemnity set forth in
paragraph (a)&nbsp;above, but only with respect to any losses, claims, damages or liabilities that arise
out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission
made in reliance upon and in conformity with any information relating to such Underwriter furnished
to the Company in writing by such Underwriter through the Representatives expressly for use in the
Registration Statement, the Prospectus (or any amendment or supplement thereto), any Issuer Free
Writing Prospectus or any Preliminary Prospectus, it being understood and agreed upon that the only
such information furnished by any Underwriter consists of the following information in the
Preliminary Prospectus and Prospectus furnished on behalf of each Underwriter: the discount
figures appearing in the third paragraph under the caption &#147;Underwriting&#148; and the information
contained in the sixth and seventh paragraphs under the caption &#147;Underwriting&#148;.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <I>Notice and Procedures. </I>If any suit, action, proceeding (including any governmental or
regulatory investigation), claim or demand shall be brought or asserted against any person in
respect of which indemnification may be sought pursuant to either paragraph (a)&nbsp;or (b)&nbsp;above, such
person (the &#147;Indemnified Person&#148;) shall promptly notify the person against whom such
indemnification may be sought (the &#147;Indemnifying Person&#148;) in writing; <U>provided</U> that the
failure to notify the Indemnifying Person shall not relieve it from any liability that it may have
under this Section&nbsp;7 except to the extent that it has been materially prejudiced (through the
forfeiture of substantive rights or defenses) by such failure; and <U>provided</U>,
<U>further</U>, that the failure to notify the Indemnifying Person shall not relieve it from any
liability that it may have to an Indemnified Person otherwise than under this Section&nbsp;7. If any
such proceeding shall be brought or asserted against an Indemnified Person and it shall have
notified the Indemnifying Person thereof, the Indemnifying Person shall retain counsel reasonably
satisfactory to the Indemnified Person to represent the Indemnified Person and any others entitled
to indemnification pursuant to this Section&nbsp;7 that the Indemnifying Person may designate in such
proceeding
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">and shall pay the fees and expenses of such counsel related to such proceeding, as incurred.
In any such proceeding, any Indemnified Person shall have the right to retain its own counsel, but
the fees and expenses of such counsel shall be at the expense of such Indemnified Person unless (i)
the Indemnifying Person and the Indemnified Person shall have mutually agreed to the contrary; (ii)
the Indemnifying Person has failed within a reasonable time to retain counsel reasonably
satisfactory to the Indemnified Person; (iii)&nbsp;the Indemnified Person shall have reasonably
concluded that there may be legal defenses available to it that are different from or in addition
to those available to the Indemnifying Person; or (iv)&nbsp;the named parties in any such proceeding
(including any impleaded parties) include both the Indemnifying Person and the Indemnified Person
and representation of both parties by the same counsel would be inappropriate due to actual or
potential differing interests between them. It is understood and agreed that the Indemnifying
Person shall not, in connection with any proceeding or related proceeding in the same jurisdiction,
be liable for the fees and expenses of more than one separate firm (in addition to any local
counsel) for all Indemnified Persons, and that all such fees and expenses shall be paid or
reimbursed as they are incurred. Any such separate firm for any Underwriter, its affiliates,
directors and officers and any control persons of such Underwriter shall be designated in writing
by the Representatives and any such separate firm for the Company, its directors, its officers who
signed the Registration Statement and any control persons of the Company shall be designated in
writing by the Company. The Indemnifying Person shall not be liable for any settlement of any
proceeding effected without its written consent, but if settled with such consent or if there be a
final judgment for the plaintiff, the Indemnifying Person agrees to indemnify each Indemnified
Person from and against any loss or liability by reason of such settlement or judgment.
Notwithstanding the foregoing sentence, if at any time an Indemnified Person shall have requested
that an Indemnifying Person reimburse the Indemnified Person for fees and expenses of counsel as
contemplated by this paragraph, the Indemnifying Person shall be liable for any settlement of any
proceeding effected without its written consent if (i)&nbsp;such settlement is entered into more than 30
days after receipt by the Indemnifying Person of such request and (ii)&nbsp;the Indemnifying Person
shall not have reimbursed the Indemnified Person in accordance with such request prior to the date
of such settlement. No Indemnifying Person shall, without the written consent of the Indemnified
Person, effect any settlement of any pending or threatened proceeding in respect of which any
Indemnified Person is or could have been a party and indemnification could have been sought
hereunder by such Indemnified Person, unless such settlement (x)&nbsp;includes an unconditional release
of such Indemnified Person, in form and substance reasonably satisfactory to such Indemnified
Person, from all liability on claims that are the subject matter of such proceeding and (y)&nbsp;does
not include any statement as to or any admission of fault, culpability or a failure to act by or on
behalf of any Indemnified Person.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <I>Contribution. </I>If the indemnification provided for in paragraphs (a)and (b)&nbsp;above is
unavailable to an Indemnified Person or insufficient in respect of any losses, claims, damages or
liabilities referred to therein, then each Indemnifying Person under such paragraph, in lieu of
indemnifying such Indemnified Person thereunder, shall contribute to the amount paid or payable by
such Indemnified Person as a result of such losses, claims, damages or liabilities (i)&nbsp;in such
proportion as is appropriate to reflect the relative benefits received by the Company on the one
hand and the Underwriters on the
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">other from the offering of the Securities or (ii)&nbsp;if the allocation provided by clause (i)&nbsp;is
not permitted by applicable law, in such proportion as is appropriate to reflect not only the
relative benefits referred to in clause (i)&nbsp;but also the relative fault of the Company on the one
hand and the Underwriters on the other in connection with the statements or omissions that resulted
in such losses, claims, damages or liabilities, as well as any other relevant equitable
considerations. The relative benefits received by the Company on the one hand and the Underwriters
on the other shall be deemed to be in the same respective proportions as the net proceeds (before
deducting expenses) received by the Company from the sale of the Securities and the total
underwriting discounts and commissions received by the Underwriters in connection therewith, in
each case as set forth in the table on the cover of the Prospectus, bear to the aggregate offering
price of the Securities. The relative fault of the Company on the one hand and the Underwriters on
the other shall be determined by reference to, among other things, whether the untrue or alleged
untrue statement of a material fact or the omission or alleged omission to state a material fact
relates to information supplied by the Company or by the Underwriters and the parties&#146; relative
intent, knowledge, access to information and opportunity to correct or prevent such statement or
omission.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <I>Limitation on Liability. </I>The Company and the Underwriters agree that it would not be just
and equitable if contribution pursuant to this Section&nbsp;7 were determined by <U>pro</U>
<U>rata</U> allocation (even if the Underwriters were treated as one entity for such purpose) or
by any other method of allocation that does not take account of the equitable considerations
referred to in paragraph (d)&nbsp;above. The amount paid or payable by an Indemnified Person as a
result of the losses, claims, damages and liabilities referred to in paragraph (d)&nbsp;above shall be
deemed to include, subject to the limitations set forth above, any legal or other expenses incurred
by such Indemnified Person in connection with any such action or claim. Notwithstanding the
provisions of this Section&nbsp;7, in no event shall an Underwriter be required to contribute any amount
in excess of the amount by which the total underwriting discounts and commissions received by such
Underwriter with respect to the offering of the Securities exceeds the amount of any damages that
such Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue
statement or omission or alleged omission. No person guilty of fraudulent misrepresentation
(within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from
any person who was not guilty of such fraudulent misrepresentation. The Underwriters&#146; obligations
to contribute pursuant to this Section&nbsp;7 are several in proportion to their respective purchase
obligations hereunder and not joint.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <I>Non-Exclusive Remedies. </I>The remedies provided for in this Section&nbsp;6 are not exclusive and
shall not limit any rights or remedies which may otherwise be available to any Indemnified Person
at law or in equity.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.&nbsp;<U>Effectiveness of Agreement</U>. This Agreement shall become effective upon the
execution and delivery hereof by the parties hereto.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9. <U>Termination</U>. This Agreement may be terminated in the absolute discretion of the
Representatives, by notice to the Company, if after the execution and delivery of this Agreement
and prior to the Closing Date: (i)&nbsp;trading generally shall have
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">been suspended or materially limited on or by the Exchange; (ii)&nbsp;trading of any securities
issued or guaranteed by the Company shall have been suspended on any exchange or in any
over-the-counter market; (iii)&nbsp;a general moratorium on commercial banking activities shall have
been declared by federal or New York State authorities; or (iv)&nbsp;there shall have occurred any
outbreak or escalation of hostilities or any change in financial markets or any calamity or crisis,
either within or outside the United States, that, in the judgment of the Representatives, is
material and adverse and makes it impracticable or inadvisable to proceed with the offering, sale
or delivery of the Securities on the Closing Date on the terms and in the manner contemplated by
this Agreement, the Time of Sale Information and the Prospectus.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.&nbsp;<U>Defaulting Underwriter</U>. (a)&nbsp;If, on the Closing Date, any Underwriter defaults on
its obligation to purchase the Securities that it has agreed to purchase hereunder, the
non-defaulting Underwriters may in their discretion arrange for the purchase of such Securities by
other persons satisfactory to the Company on the terms contained in this Agreement. If, within
thirty-six (36)&nbsp;hours after any such default by any Underwriter, the non-defaulting Underwriters do
not arrange for the purchase of such Securities, then the Company shall be entitled to a further
period of thirty-six (36)&nbsp;hours within which to procure other persons satisfactory to the
non-defaulting Underwriters to purchase such Securities on such terms. If other persons become
obligated or agree to purchase the Securities of a defaulting Underwriter, either the
non-defaulting Underwriters or the Company may postpone the Closing Date for up to five (5)&nbsp;full
business days in order to effect any changes that in the opinion of counsel for the Company or
counsel for the Underwriters may be necessary in the Registration Statement and the Prospectus or
in any other document or arrangement, and the Company agrees to promptly prepare any amendment or
supplement to the Registration Statement and the Prospectus that effects any such changes. As used
in this Agreement, the term &#147;Underwriter&#148; includes, for all purposes of this Agreement unless the
context otherwise requires, any person not listed in Schedule&nbsp;I hereto that, pursuant to this
Section&nbsp;10, purchases Securities that a defaulting Underwriter agreed but failed to purchase.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;If, after giving effect to any arrangements for the purchase of the Securities of a
defaulting Underwriter or Underwriters by the non-defaulting Underwriters and the Company as
provided in paragraph (a)&nbsp;above, the aggregate principal amount of such Securities that remains
unpurchased on the Closing Date does not exceed one-eleventh of the aggregate principal amount of
all the Securities, then the Company shall have the right to require each non-defaulting
Underwriter to purchase the principal amount of Securities that such Underwriter agreed to purchase
hereunder plus such Underwriter&#146;s pro rata share (based on the principal amount of Securities that
such Underwriter agreed to purchase hereunder) of the Securities of such defaulting Underwriter or
Underwriters for which such arrangements have not been made.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;If, after giving effect to any arrangements for the purchase of the Securities of a
defaulting Underwriter or Underwriters by the non-defaulting Underwriters and the Company as
provided in paragraph (a)&nbsp;above, the aggregate principal amount of such Securities that remains
unpurchased exceeds one-eleventh of the aggregate principal amount of all the Securities, or if the
Company shall not exercise
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">the right described in paragraph (b)&nbsp;above, then this Agreement shall terminate without
liability on the part of the non-defaulting Underwriters. Any termination of this Agreement
pursuant to this Section&nbsp;10 shall be without liability on the part of the Company, except that the
Company will continue to be liable for the payment of expenses as set forth in Section&nbsp;11 hereof
and except that the provisions of Section&nbsp;7 hereof shall not terminate and shall remain in effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Nothing contained herein shall relieve a defaulting Underwriter of any liability it may
have to the Company or any non-defaulting Underwriter for damages caused by its default.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.&nbsp;<U>Payment of Expenses</U>. (a)&nbsp;Whether or not the transactions contemplated by this
Agreement are consummated or this Agreement is terminated, the Company will pay or cause to be paid
all costs and expenses incident to the performance of its obligations hereunder, including without
limitation, (i)&nbsp;the costs incident to the authorization, issuance, sale, preparation and delivery
of the Securities and any taxes payable in that connection; (ii)&nbsp;the costs incident to the
preparation, printing and filing under the Securities Act of the Registration Statement, the
Preliminary Prospectus, any Issuer Free Writing Prospectus, any Time of Sale Information and the
Prospectus (including all exhibits, amendments and supplements thereto) and the distribution
thereof; (iii)&nbsp;the costs of reproducing and distributing each of the Transaction Documents; (iv)
the fees and expenses of the Company&#146;s counsel and independent accountants; (v)&nbsp;the fees and
expenses incurred in connection with the registration or qualification and determination of
eligibility for investment of the Securities under the laws of such jurisdictions as the
Representatives may designate and the preparation, printing and distribution of a Blue Sky
Memorandum (including the related fees and expenses of counsel for the Underwriters); (vi)&nbsp;any fees
charged by the rating agencies for rating the Securities; (vii)&nbsp;the fees and expenses of the
Trustee and the paying agent (including related fees and expenses of any counsel to such parties);
(viii)&nbsp;all expenses and application fees incurred in connection with any filing with, and clearance
of the offering by, the Financial Industry Regulatory Authority; and (ix)&nbsp;all expenses incurred by
the Company in connection with any &#147;road show&#148; presentation to potential investors;
<U>provided</U>, <U>however</U>, that except as provided in Section&nbsp;7 or this Section&nbsp;11, the
Underwriters shall pay their own costs and expenses, including without limitation the fees and
disbursements of their counsel and any advertising expenses (other than with respect to any road
show presentation) connected with any offers they make.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;If (i)&nbsp;this Agreement is terminated pursuant to Section&nbsp;9, (ii)&nbsp;the Company for any reason
fails to tender the Securities for delivery to the Underwriters or (iii)&nbsp;the Underwriters decline
to purchase the Securities for any reason permitted under this Agreement, the Company agrees to
reimburse the Underwriters for all out-of-pocket costs and expenses (including the fees and
expenses of their counsel) reasonably incurred by the Underwriters in connection with this
Agreement and the offering contemplated hereby.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12. <U>Persons Entitled to Benefit of Agreement</U>. This Agreement shall inure to the
benefit of and be binding upon the parties hereto and their respective successors and
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">the officers and directors and any controlling persons referred to herein, and the affiliates
of each Underwriter referred to in Section&nbsp;7 hereof. Nothing in this Agreement is intended or
shall be construed to give any other person any legal or equitable right, remedy or claim under or
in respect of this Agreement or any provision contained herein. No purchaser of Securities from
any Underwriter shall be deemed to be a successor merely by reason of such purchase.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13.&nbsp;<U>Survival</U>. The respective indemnities, rights of contribution, representations,
warranties and agreements of the Company and the Underwriters contained in this Agreement or made
by or on behalf of the Company or the Underwriters pursuant to this Agreement or any certificate
delivered pursuant hereto shall survive the delivery of and payment for the Securities and shall
remain in full force and effect, regardless of any termination of this Agreement or any
investigation made by or on behalf of the Company or the Underwriters.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14.&nbsp;<U>Certain Defined Terms</U>. For purposes of this Agreement, (a)&nbsp;except where otherwise
expressly provided, the term &#147;affiliate&#148; has the meaning set forth in Rule&nbsp;405 under the Securities
Act; (b)&nbsp;the term &#147;business day&#148; means any day other than a day on which banks are permitted or
required to be closed in New York City; and (c)&nbsp;the term &#147;subsidiary&#148; has the meaning set forth in
Rule&nbsp;405 under the Securities Act.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.&nbsp;<U>Miscellaneous</U>. (a) <I>Authority of the Representatives. </I>Any action by the
Underwriters hereunder may be taken by the Representatives on behalf of the Underwriters, and any
such action taken by the Representatives shall be binding upon the Underwriters.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <I>Notices. </I>All notices and other communications hereunder shall be in writing and shall be
deemed to have been duly given if mailed or transmitted and confirmed by any standard form of
telecommunication. Notices to the Underwriters shall be given to the Representatives c/o Citigroup
Global Markets Inc., General Counsel, 388 Greenwich Street, New York, New York 10013 (fax: (212)
816-7912; Attention: General Counsel) and J.P. Morgan Securities Inc., High Grade Debt Capital
Markets, 270 Park Avenue, New York, New York 10017 (fax: (212)&nbsp;270-1063; Attention: High Grade
Debt Capital Markets). Notices to the Company shall be given to it at 1000 Six PPG Place,
Pittsburgh, Pennsylvania 15222, (fax: (412)&nbsp;394-2837); Attention: Jon D. Walton.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <I>Governing Law. </I>This Agreement shall be governed by and construed in accordance with the
laws of the State of New York.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <I>Counterparts. </I>This Agreement may be signed in counterparts (which may include
counterparts delivered by any standard form of telecommunication), each of which shall be an
original and all of which together shall constitute one and the same instrument.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <I>Amendments or Waivers. </I>No amendment or waiver of any provision of this Agreement, nor any
consent or approval to any departure therefrom, shall in any event be effective unless the same
shall be in writing and signed by the parties hereto.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <I>Headings. </I>The headings herein are included for convenience of reference only and are not
intended to be part of, or to affect the meaning or interpretation of, this Agreement.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;<I>signature page follows</I>&#093;
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">If the foregoing is in accordance with your understanding, please indicate your acceptance of this
Agreement by signing in the space provided below.
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="35%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="40%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Very truly yours,</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">ALLEGHENY TECHNOLOGIES <Br>INCORPORATED,</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">by:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Jon D. Walton
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Name: Jon D. Walton
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title: Executive Vice President, Human<Br> Resources, Chief Legal
and Compliance<Br> Officer, General Counsel and Corporate Secretary</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Accepted as of the date first written above.

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">J.P. MORGAN SECURITIES INC.
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="40%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">By:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Maria Sramek
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Authorized Signatory
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">CITIGROUP GLOBAL MARKETS INC.
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="40%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">By:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Brian D. Bednarski
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Authorized Signatory
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Each for itself and on behalf of the<BR>
several Underwriters listed<BR>
in Schedule&nbsp;I hereto.

</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;<I>signature page to the Senior Notes Underwriting Agreement</I>&#093;
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><U>Schedule&nbsp;I</U>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="69%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="13%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="13%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left">Underwriters</TD>
    <TD>&nbsp;</TD>
    <TD align="center" colspan="3">Principal Amount of Securities to be Purchased</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="5" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Citigroup Global Markets Inc.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">116,725,000</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">J.P. Morgan Securities Inc.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">116,725,000</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Banc of America Securities LLC</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">35,000,000</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">PNC Capital Markets LLC</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">20,300,000</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">BNY Mellon Capital Markets, LLC</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">12,250,000</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Mitsubishi UFJ Securities (USA), Inc.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">12,250,000</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Credit Suisse Securities (USA)&nbsp;LLC</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">12,250,000</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Morgan Stanley &#038; Co. Incorporated</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">12,250,000</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Wachovia Capital Markets, LLC</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">12,250,000</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Total</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">350,000,000</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><U>Schedule&nbsp;IIA</U>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>Issuer Free Writing Prospectuses</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">A. Free writing prospectus filed with the Commission on May&nbsp;27, 2009, substantially in the form of
Schedule&nbsp;III.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><U>Schedule&nbsp;IIB</U>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>Electronic Road Shows</B></U>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><U>Schedule&nbsp;III</U>
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Filed Pursuant to Rule&nbsp;433<BR>
Registration Statement No.&nbsp;333-159479
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Pricing Term Sheet</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>Allegheny Technologies Incorporated</B>

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>$350,000,000</B>

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>9.375% Senior Notes due 2019</B>

</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">This term sheet to the preliminary prospectus supplement dated May&nbsp;26, 2009 should be read together
with the preliminary prospectus supplement before making a decision in connection with an
investment in the securities. The information in this term sheet supersedes the information
contained in the preliminary prospectus supplement to the extent that it is inconsistent therewith.
Terms used but not defined herein have the meaning ascribed to them in the preliminary prospectus
supplement.
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="35%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="60%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Issuer:</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Allegheny Technologies Incorporated</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Security:</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9.375% Senior Notes due 2019</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Principal Amount:</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">$350,000,000&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Trade Date:</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">May&nbsp;27, 2009</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Settlement Date:</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">June&nbsp;1, 2009 (T&#043;3)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Maturity:</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">June&nbsp;1, 2019</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Coupon:</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9.375%&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Public Offering Price:</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">99.204%&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Yield to Maturity:</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9.500%</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Benchmark Treasury:</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.125% due May&nbsp;15, 2019</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Benchmark Treasury Price:</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">95-04</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Benchmark Treasury Yield:</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.715%</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Spread to Benchmark Treasury:</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&#043;578.5 bps</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Interest payment dates:</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">June 1 and December&nbsp;1, commencing December&nbsp;1, 2009</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Net Proceeds to Issuer
(before expenses):</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">$344,939,000</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="35%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="60%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Optional Redemption:</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Greater of par and make whole at Treasury plus 50 basis
points, plus accrued and unpaid interest to the date of
redemption</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Change of Control:</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">After a &#147;Change of Control Repurchase Event&#148;, the
Company will offer to repurchase notes at a price equal
to 101% of principal amount, plus accrued and unpaid
interest.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Denominations:</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">$2,000 and integral multiples of $1,000 in excess thereof</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>CUSIP/ISIN:</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">01741R AC6 / US01741RAC60</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Joint Book-Running Managers:</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">Citigroup Global Markets Inc. <Br>
J.P. Morgan Securities Inc.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Joint Lead Manager:</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Banc of America Securities LLC</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Co-Managers:</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PNC Capital Markets LLC</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BNY Mellon Capital Markets, LLC <Br>
Credit Suisse Securities (USA)&nbsp;LLC <Br>
Mitsubishi UFJ Securities (USA), Inc. <Br>
Morgan Stanley &#038; Co. Incorporated <Br>
Wachovia Capital Markets, LLC</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>We have filed a registration statement (including a preliminary prospectus supplement) with the SEC
for the offering to which this communication relates. Before you invest, you should read the
preliminary prospectus supplement included in that registration statement and other documents we
have filed with the SEC for more complete information about us and this offering. You may get
these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, we or
the underwriters will arrange to send you the prospectus if you request it by calling Citigroup
Global Markets Inc. toll-free at 1-877-858-5407 or J.P. Morgan Securities Inc. collect at
212-834-4533.</B>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.2
<SEQUENCE>3
<FILENAME>l36642aexv1w2.htm
<DESCRIPTION>EX-1.2
<TEXT>
<HTML>
<HEAD>
<TITLE>EX-1.2</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>Exhibit&nbsp;1.2</B>
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>EXECUTION VERSION</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>J.P. MORGAN SECURITIES INC.<BR>
CITIGROUP GLOBAL MARKETS INC.</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>ALLEGHENY TECHNOLOGIES INCORPORATED</B>

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>4.25% Convertible Senior Notes due 2014</B>

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>Underwriting Agreement</B>

</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 12pt">May&nbsp;27, 2009
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">J.P. MORGAN SECURITIES INC.<BR>
CITIGROUP GLOBAL MARKETS INC.<BR>
As Representatives of the<BR>
several Underwriters listed in<BR>
Schedule&nbsp;I hereto

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">c/o J.P. Morgan Securities Inc.<BR>
383 Madison Avenue<BR>
New York, New York 10179

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Citigroup Global Markets Inc.<BR>
390 Greenwich Street<BR>
New York, New York 10013

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Ladies and Gentlemen:

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Allegheny Technologies Incorporated, a Delaware corporation (the &#147;Company&#148;), proposes to issue
and sell to the several Underwriters listed in Schedule&nbsp;I hereto (the &#147;Underwriters&#148;), for whom you
are acting as Representatives (the &#147;Representatives&#148;), an aggregate of $350,000,000 principal
amount of its 4.25% Convertible Senior Notes due 2014 (the &#147;Underwritten Securities&#148;). The Company
also proposes to grant to the Underwriters an option to purchase up to an additional $52,500,000
principal amount of its 4.25% Convertible Senior Notes due 2014 to cover over-allotments (the
&#147;Option Securities&#148;, and together with the Underwritten Securities, the &#147;Securities&#148;). The
Securities are convertible into shares (the &#147;Underlying Shares&#148;) of common stock, par value $0.10
per share (the &#147;Common Stock&#148;), of the Company at the conversion price set forth in the Prospectus
(as defined below). The Securities are to be issued under a base indenture (the &#147;Base Indenture&#148;)
to be dated as of June&nbsp;1, 2009, between the Company and The Bank of New York Mellon, N.A., as
trustee (the &#147;Trustee&#148;), as supplemented by a supplemental indenture (the &#147;Supplemental Indenture&#148;, and together with the Base Indenture,
the &#147;Indenture&#148;), to be dated as of June&nbsp;2, 2009.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company hereby confirms its agreement with the several Underwriters concerning the
purchase and sale of the Securities (this &#147;Agreement&#148;), as follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. <U>Registration Statement</U>. The Company has prepared and filed with the Securities and
Exchange Commission (the &#147;Commission&#148;) under the Securities Act of 1933, as amended, and the rules
and regulations of the Commission thereunder (collectively, the &#147;Securities Act&#148;), an automatic
shelf registration statement, as defined in Rule&nbsp;405 of the Securities Act, on Form S-3 (File No.
333-159479) including a base prospectus (the &#147;Base Prospectus&#148;), relating to various securities to
be issued from time to time by the Company, including the Securities. Such registration statement,
as amended at the time it becomes effective, including the information, if any, deemed pursuant to
Rule&nbsp;430A, 430B or 430C under the Securities Act to be part of the registration statement at the
time of its effectiveness (&#147;Rule&nbsp;430 Information&#148;), is referred to herein as the &#147;Registration
Statement&#148;; and as used herein, the term &#147;Preliminary Prospectus&#148; means the Base Prospectus and any
prospectus filed with the Commission pursuant to Rule 424(a) under the Securities Act that omits
Rule&nbsp;430 Information, and the term &#147;Prospectus&#148; means the prospectus in the form first used (or
made available upon request of purchasers pursuant to Rule&nbsp;173 under the Securities Act) in
connection with confirmation of sales of the Securities. Any reference in this Agreement to the
Registration Statement, any Preliminary Prospectus or the Prospectus shall be deemed to refer to
and include the documents incorporated by reference therein pursuant to Item&nbsp;12 of Form S-3 under
the Securities Act, as of the effective date of the Registration Statement or the date of such
Preliminary Prospectus or the Prospectus, as the case may be and any reference to &#147;amend&#148;,
&#147;amendment&#148; or &#147;supplement&#148; with respect to the Registration Statement, any Preliminary Prospectus
or the Prospectus shall be deemed to refer to and include any documents filed after such date under
the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission
thereunder (collectively, the &#147;Exchange Act&#148;) that are deemed to be incorporated by reference
therein. Capitalized terms used but not defined herein shall have the meanings given to such terms
in the Registration Statement and the Prospectus.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At or prior to the time when sales of the Securities were first made (the &#147;Time of Sale&#148;), the
Company had prepared the following information (collectively, the &#147;Time of Sale Information&#148;): a
Preliminary Prospectus dated May&nbsp;26, 2009, and each &#147;free-writing prospectus&#148; (as defined pursuant
to Rule&nbsp;405 under the Securities Act) listed on Schedule&nbsp;IIA hereto as constituting part of the
Time of Sale Information.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. <U>Purchase of the Securities by the Underwriters</U>. (a)(i) The Company agrees to issue
and sell the Underwritten Securities to the several Underwriters as provided in this Agreement, and
each Underwriter, on the basis of the representations, warranties and agreements set forth herein
and subject to the conditions set forth herein, agrees, severally and not jointly, to purchase from
the Company the respective principal amount of Underwritten Securities set forth opposite such
Underwriter&#146;s name in Schedule&nbsp;I hereto at a price equal to 97.0% of the principal amount thereof
plus accrued interest, if any, from June&nbsp;2, 2009 (the &#147;Purchase Price&#148;) to the Closing Date (as defined
below).
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">





<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 4%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) In addition, on the basis of the representations, warranties and agreements set
forth herein and subject to the conditions set forth herein, the Company hereby grants an
option to the several Underwriters to purchase, severally and not jointly, from the Company
up to $52,500,000 aggregate principal amount of Option Securities at the Purchase Price to
cover any over-allotments in the sale of the Underwritten Securities by the Underwriters.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If any Option Securities are to be purchased, the principal amount of Option Securities to be
purchased by each Underwriter shall be the principal amount of Option Securities which bears the
same ratio to the aggregate principal amount of Option Securities being purchased as the principal
amount of Underwritten Securities set forth opposite the name of such Underwriter in Schedule&nbsp;I
hereto (or such number increased as set forth in Section&nbsp;10 hereof) bears to the aggregate
principal amount of Underwritten Securities being purchased from the Company by the several
Underwriters, subject, however, to such adjustments as the Representatives in their sole discretion
shall make to ensure that the Securities are not issued in minimum denominations of less than
$2,000 or whole multiples of $1,000.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Underwriters may exercise the option to purchase the Option Securities at any time in
whole, or from time to time in part, on or before the thirtieth (30th) day following the date of
this Agreement, by written notice from the Representatives to the Company. Such notice shall set
forth the aggregate principal amount of Option Securities as to which the option is being exercised
and the date and time when the Option Securities are to be delivered and paid for which may be the
same date and time as the Closing Date (as hereinafter defined) but shall not be earlier than the
Closing Date nor later than the tenth (10th) full business day (as hereinafter defined) after the
date of such notice (unless such time and date are postponed in accordance with the provisions of
Section&nbsp;10 hereof). Any such notice shall be given at least two (2)&nbsp;business days prior to the
date and time of delivery specified therein. The Company will not be obligated to deliver any of
the Securities except upon payment for all Securities to be purchased as provided herein.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The Company understands that the Underwriters intend to make a public offering of the
Securities as soon after the effectiveness of this Agreement as in the judgment of the
Representatives is advisable. The Company acknowledges and agrees that the Underwriters may offer
and sell Securities to or through any affiliate of an Underwriter and that any such affiliate may
offer and sell Securities purchased by it to or through any Underwriter.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Payment for the Underwritten Securities (and the Option Securities, if the option provided
for in Section&nbsp;2(a)(ii) hereof shall be exercised on or before the third (3rd) business day
immediately preceding the Closing Date) shall be made by wire transfer in immediately available
funds to the account specified by the Company to the Representatives against delivery of such
Underwritten Securities and Option Securities, if applicable, for the respective accounts of the several Underwriters at the offices of Cravath,
Swaine &#038; Moore LLP at 10:00&nbsp;A.M. New York City time on June&nbsp;2, 2009, or at such other time or place
on the same or such other date, not later than the fifth (5th)
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->3<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">business day thereafter, as the
Representatives and the Company may agree upon in writing. The time and date of such payment are
referred to herein as the &#147;Closing Date&#148;.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the option provided for in Section&nbsp;2(a)(ii) hereof shall be exercised after the third (3rd)
business day immediately preceding the Closing Date, payment for any Option Securities shall be
made by the Company in immediately available funds to the account specified by the Company to the
Representatives against delivery of such Option Securities for the respective accounts of the
several Underwriters at the offices of Cravath, Swaine &#038; Moore LLP at 10:00&nbsp;A.M. New York City time
on date specified in the corresponding notice delivered pursuant to Section&nbsp;2(a)(ii) hereof or at
such other time on the same or such other date, not later than June&nbsp;2, 2009, as shall be designated
in writing by the Representatives and the time and date for such payment for the Option Securities,
if other than the Closing Date, is herein referred to as the &#147;Additional Closing Date&#148;.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Delivery of the Underwritten Securities and Option Securities, if any, shall be made
through the facilities of The Depository Trust Company and shall be in global form unless, in each
case, the Representatives shall instruct otherwise, with any transfer taxes payable in connection
with the sale of such Securities duly paid by the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;The Company acknowledges and agrees that the Underwriters are acting solely in the
capacity of an arm&#146;s length contractual counterparty to the Company with respect to the offering of
Securities contemplated hereby (including in connection with determining the terms of the offering)
and not as a financial advisor or a fiduciary to, or an agent of, the Company or any other person.
Additionally, neither the Representatives nor any other Underwriters is advising the Company or any
other person as to any legal, tax, investment, accounting or regulatory matters in any
jurisdiction. The Company shall consult with its own advisors concerning such matters and shall be
responsible for making its own independent investigation and appraisal of the transactions
contemplated hereby, and the Underwriters shall have no responsibility or liability to the Company
with respect thereto. Any review by the Underwriters of the Company, the transactions contemplated
hereby or other matters relating to such transactions will be performed solely for the benefit of
the Underwriters and shall not be on behalf of the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. <U>Representations and Warranties of the Company</U>. The Company represents and warrants
to each Underwriter that:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <I>Preliminary Prospectus. </I>No order preventing or suspending the use of any Preliminary
Prospectus has been issued by the Commission, and each Preliminary Prospectus, at the time of
filing thereof, complied in all material respects with the Securities Act and did not contain any
untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading;
<U>provided</U> that the Company makes no representation and warranty with respect to any
statements or omissions made in reliance upon and in conformity with information
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->4<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">relating to any
Underwriter furnished to the Company in writing by such Underwriter through the Representatives
expressly for use in any Preliminary Prospectus.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;<I>Time of Sale Information. </I>The Time of Sale Information, at the Time of Sale did not, and
at the Closing Date will not, contain any untrue statement of a material fact or omit to state a
material fact necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading; <U>provided</U> that the Company makes no
representation and warranty with respect to any statements or omissions made in reliance upon and
in conformity with information relating to any Underwriter furnished to the Company in writing by
such Underwriter through the Representatives expressly for use in such Time of Sale Information.
No statement of material fact included in the Prospectus has been omitted from the Time of Sale
Information and no statement of material fact included in the Time of Sale Information that is
required to be included in the Prospectus has been omitted therefrom.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;<I>Issuer Free Writing Prospectus. </I>The Company (including its agents and representatives,
other than the Underwriters in their capacity as such) has not prepared, made, used, authorized,
approved or referred to and will not prepare, make, use, authorize, approve or refer to any
&#147;written communication&#148; (as defined in Rule&nbsp;405 under the Securities Act) that constitutes an offer
to sell or solicitation of an offer to buy the Securities (each such communication by the Company
or its agents and representatives (other than a communication referred to in clauses (i) (ii)&nbsp;and
(iii)&nbsp;below) an &#147;Issuer Free Writing Prospectus&#148;) other than (i)&nbsp;any document not constituting a
prospectus pursuant to Section&nbsp;2(a)(10)(a) of the Securities Act or Rule&nbsp;134 under the Securities
Act, (ii)&nbsp;the Preliminary Prospectus, (iii)&nbsp;the Prospectus, (iv)&nbsp;the documents listed on Schedule
IIA hereto as constituting the Time of Sale Information and (v)&nbsp;any electronic road show or other
written communications, in each case approved in writing in advance by the Representative and,
other than any electronic road show listed on Schedule&nbsp;IIB hereto. Each such Issuer Free Writing
Prospectus complied in all material respects with the Securities Act, has been or will be (within
the time period specified in Rule&nbsp;433) filed in accordance with the Securities Act (to the extent
required thereby) and, when taken together with the Preliminary Prospectus filed prior to the first
use of such Issuer Free Writing Prospectus, did not, and at the Closing Date will not, contain any
untrue statement of a material fact or omit to state a material fact necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading;
<U>provided</U> that the Company makes no representation and warranty with respect to any
statements or omissions made in each such Issuer Free Writing Prospectus in reliance upon and in
conformity with information relating to any Underwriter furnished to the Company in writing by such
Underwriter through the Representative expressly for use in any Issuer Free Writing Prospectus.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;<I>Registration Statement and Prospectus. </I>The Registration Statement is an &#147;automatic shelf
registration statement&#148; as defined under Rule&nbsp;405 of the Securities Act that has been filed with
the Commission not earlier than three years prior to the date hereof; and no notice of objection of the Commission to the use of such registration statement
or any post-effective amendment thereto pursuant to Rule&nbsp;401(g)(2) under the Securities Act has
been received by the Company. No order suspending the effectiveness
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->5<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">of the Registration Statement
has been issued by the Commission and no proceeding for that purpose or pursuant to Section&nbsp;8A of
the Securities Act against the Company or related to the offering has been initiated or, to the
knowledge of the Company, threatened by the Commission; as of each date and time the Registration
Statement, and any post-effective amendment or amendments thereto, became or becomes effective, the
Registration Statement complied and will comply in all material respects with the Securities Act
and the Trust Indenture Act of 1939, as amended, and the rules and regulations of the Commission
thereunder (collectively, the &#147;Trust Indenture Act&#148;), and did not and will not contain any untrue
statement of a material fact or omit to state a material fact required to be stated therein or
necessary in order to make the statements therein not misleading; and as of the applicable filing
date of the Prospectus and any amendment or supplement thereto and as of the Closing Date and as of
the Additional Closing Date, as the case may be, the Prospectus will not contain any untrue
statement of a material fact or omit to state a material fact required to be stated therein or
necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading; <U>provided</U> that the Company makes no representation and
warranty with respect to (i)&nbsp;that part of the Registration Statement that constitutes the Statement
of Eligibility and Qualification (Form T-1) of the Trustee under the Trust Indenture Act or (ii)
any statements or omissions made in reliance upon and in conformity with information relating to
any Underwriter furnished to the Company in writing by such Underwriter through the Representatives
expressly for use in the Registration Statement and the Prospectus and any amendment or supplement
thereto.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;<I>Incorporated Documents. </I>The documents incorporated by reference in the Registration
Statement, the Time of Sale Information and the Prospectus, when they were filed with the
Commission conformed in all material respects to the requirements of the Securities Act or the
Exchange Act, as applicable, and none of such documents contained any untrue statement of a
material fact or omitted to state a material fact required to be stated therein or necessary to
make the statements therein, in the light of the circumstances under which they were made, not
misleading; and any further documents so filed and incorporated by reference in the Registration
Statement, the Time of Sale Information and the Prospectus, when such documents are filed with the
Commission will conform in all material respects to the requirements of the Securities Act or the
Exchange Act, as applicable, and will not contain any untrue statement of a material fact or omit
to state a material fact required to be stated therein or necessary to make the statements therein,
in the light of the circumstances under which they were made, not misleading.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <I>Financial Statements. </I>The financial statements and the related notes thereto of the
Company and its consolidated subsidiaries included or incorporated by reference in the Registration
Statement, the Time of Sale Information and the Prospectus comply in all material respects with the
applicable requirements of the Securities Act and the Exchange Act, as applicable, and present
fairly the financial position of the Company and its consolidated subsidiaries as of the dates
indicated and the results of their operations and the changes in their consolidated cash flows for the periods specified; such
financial statements have been prepared in conformity with U.S. generally accepted accounting
principles applied on a consistent basis throughout the periods covered
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->6<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">thereby (except that such financial statements do not give retroactive effect to the adoption by the Company of <I>Statement of
Financial Accounting Standard </I>160 as of January&nbsp;1, 2009), and the supporting schedules included or
incorporated by reference in the Registration Statement present fairly the information required to
be stated therein; and the other financial information relating to the Company and its subsidiaries
that is included or incorporated by reference in the Registration Statement, the Time of Sale
Information and the Prospectus has been derived from the accounting records of the Company and its
subsidiaries and presents fairly the information shown thereby.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;<I>No Material Adverse Change. </I>Since the date of the most recent financial statements of the
Company included or incorporated by reference in the Registration Statement, the Time of Sale
Information and the Prospectus, (i)&nbsp;there has not been any material change in the capital stock
(other than the issuance of shares of Common Stock upon exercise of stock options and warrants
described as outstanding in, and the grant of options and awards under existing employee or
directors stock compensation plans, or long-term debt of the Company or any of its subsidiaries,
or, except in the case of dividends disclosed in the Company&#146;s Exchange Act Reports or the
Prospectus, any dividend or distribution of any kind paid or made by the Company on any class of
capital stock (other than the regular quarterly dividend paid on March&nbsp;27, 2009), or any material
adverse change, or any development involving a prospective material adverse change, in or affecting
the business, prospects, management, financial position, stockholders&#146; equity or results of
operations of the Company and its subsidiaries taken as a whole; and (ii)&nbsp;except in the ordinary
course of business or as disclosed in the Company&#146;s Exchange Act reports, neither the Company nor
any of its subsidiaries has entered into any transaction or agreement that is material to the
Company and its subsidiaries taken as a whole or incurred any liability or obligation, direct or
contingent, that is material to the Company and its subsidiaries taken as a whole; and (iii)
neither the Company nor any of its subsidiaries has sustained any material loss or interference
with its business from fire, explosion, flood or other calamity, whether or not covered by
insurance, or from any labor disturbance or dispute or any action, order or decree of any court or
arbitrator or governmental or regulatory authority, except in each case as otherwise disclosed in
the Registration Statement, the Time of Sale Information and the Prospectus.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) <I>Organization and Good Standing. </I>(i)&nbsp;The Company has been duly incorporated and is validly
existing and in good standing (to the extent such concept exists in the jurisdiction in question)
under the laws of its jurisdiction of incorporation, is duly qualified as a foreign corporation for
the transaction of business and is in good standing (to the extent such concept exists in the
jurisdiction in question) in each jurisdiction in which it owns or leases property or conducts
business, so as to require such qualification, and has all power and authority necessary to own or
hold its properties and to conduct the business in which it is engaged, except where the failure to
be so qualified or in good standing or to have such power or authority would not, individually or
in the aggregate, have a material adverse effect on the business, prospects, management,
financial position, stockholders&#146; equity or results of operations of the Company and its
subsidiaries taken as a whole (a &#147;Material Adverse Effect&#148;) and (ii)&nbsp;each of the Company&#146;s
&#147;significant subsidiaries&#148; (within the meaning of Rule&nbsp;1-02 of Regulation S-X)
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->7<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">(collectively, the
&#147;Significant Subsidiaries&#148;) has been duly incorporated and is validly existing and in good standing
under the laws of its jurisdiction of incorporation, is duly qualified as a foreign corporation for
the transaction of business and is in good standing in each jurisdiction in which it owns or leases
property or conducts business, so as to require such qualification, and has all power and authority
necessary to own or hold its properties and to conduct the business in which it is engaged, except
where the failure to be so qualified or in good standing or to have such power or authority would
not, individually or in the aggregate, have a Material Adverse Effect; and all outstanding shares
of capital stock of each Significant Subsidiary of the Company have been duly authorized and
validly issued, are fully-paid and non-assessable, and (except for any directors&#146; qualifying shares
and minority interests) are owned by the Company, directly or indirectly, free and clear of all
liens, encumbrances, security interests and claims.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;<I>Capitalization. </I>The Company has an authorized capitalization as set forth in the
Registration Statement, the Time of Sale Information and the Prospectus under the heading
&#147;Capitalization&#148;; all the outstanding shares of capital stock of the Company have been duly and
validly authorized and issued and are fully paid and non-assessable and are not subject to any
pre-emptive or similar rights; except as described in or expressly contemplated by the Registration
Statement, the Time of Sale Information and the Prospectus, there are no outstanding rights
(including, without limitation, pre-emptive rights), warrants or options to acquire, or instruments
convertible into or exchangeable for, any shares of capital stock or other equity interest in the
Company or any of its subsidiaries, or any contract, commitment, agreement, understanding or
arrangement of any kind relating to the issuance of any capital stock of the Company or any such
subsidiary, any such convertible or exchangeable securities or any such rights, warrants or
options; the capital stock of the Company conforms in all material respects to the description
thereof contained in the Registration Statement, the Time of Sale Information and the Prospectus.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)&nbsp;<I>Due Authorization. </I>The Company has all requisite corporate right, power and authority to
execute and deliver this (i)&nbsp;Agreement, the Securities and the Indenture, (ii)&nbsp;the dealer manager
agreement, the offer to purchase and the letter of transmittal related to the Company&#146;s tender
offer (the &#147;Tender Offer&#148;) for its 8.375% Notes due 2011 and (iii)&nbsp;the underwriting agreement, the
indenture and the securities related to the Company&#146;s offering of its 9.375% Senior Notes due 2019
(the &#147;Senior Notes Offering&#148;) (the documents referred to in clauses (i)-(iii) being referred herein
collectively as the &#147;Transaction Documents&#148;) and to perform its obligations hereunder and
thereunder; and all action required to be taken for the due and proper authorization, execution and
delivery of each of the Transaction Documents and the consummation of the transactions contemplated
thereby has been duly and validly taken.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k)&nbsp;<I>Underwriting Agreement. </I>This Agreement has been duly authorized, executed and delivered
by the Company and constitutes the valid and binding agreement of the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l)&nbsp;<I>The Securities. </I>The Securities to be issued and sold by the Company hereunder have been
duly authorized by the Company and, when duly executed,
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->8<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">authenticated, issued and delivered as provided in the Indenture and paid for as provided herein, will be duly and validly issued and
outstanding and will constitute valid and legally binding obligations of the Company enforceable
against the Company in accordance with their terms, subject to the Enforceability Exceptions (as
defined below), will be entitled to the benefits of the Indenture and will conform in all material
respects to the descriptions thereof in the Registration Statement, the Time of Sale Information
and the Prospectus; and the issuance of the Securities is not subject to any preemptive or similar
rights.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m)&nbsp;<I>The Indenture. </I>The Indenture has been duly authorized by the Company and upon
effectiveness of the Registration Statement was duly qualified under the Trust Indenture Act and,
when duly executed and delivered in accordance with its terms by each of the parties thereto, will
constitute a valid and legally binding agreement of the Company enforceable against the Company in
accordance with its terms, except as enforceability may be limited by applicable bankruptcy,
insolvency or similar laws affecting the enforcement of creditors&#146; rights generally or by equitable
principles relating to enforceability (collectively, the &#147;Enforceability Exceptions&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(n)&nbsp;<I>Description of Transaction Documents. </I>Each Transaction Document conforms in all material
respects to the description thereof, if any, contained in the Registration Statement, the Time of
Sale Information and the Prospectus.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(o)&nbsp;<I>No Violation or Default. </I>Neither the Company nor any of its subsidiaries is (i)&nbsp;in
violation of its charter or by-laws or similar organizational documents; (ii)&nbsp;in default, and no
event has occurred that, with notice or lapse of time or both, would constitute such a default, in
the due performance or observance of any term, covenant or condition contained in any indenture,
mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or
any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or
to which any of the property or assets of the Company or any of its subsidiaries is subject; or
(iii)&nbsp;in violation of any law or statute or any judgment, order, rule or regulation of any court or
arbitrator or governmental or regulatory authority, except, in the case of clauses (ii)&nbsp;and (iii)
above, for any such default or violation that would not, individually or in the aggregate, have a
Material Adverse Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(p)&nbsp;<I>No Conflicts. </I>The execution, delivery and performance by the Company of each of the
Transaction Documents, the issuance and sale of the Securities and compliance by the Company with
the terms thereof and the consummation of the transactions contemplated by the Transaction
Documents will not (i)&nbsp;conflict with or result in a breach or violation of any of the terms or
provisions of, or constitute a default under, or result in the creation or imposition of any lien,
charge or encumbrance upon any property or assets of the Company or any of its subsidiaries
pursuant to any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument
to which the Company or any of its subsidiaries is a party or by which the Company or any of its
subsidiaries is bound or to which any of the property or assets of the Company or any of
its subsidiaries is subject, (ii)&nbsp;result in any violation of the provisions of the charter or
by-laws or similar organizational documents of the Company or any of its subsidiaries or
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->9<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">(iii)&nbsp;result in the violation of any law or statute or any judgment, order, rule or regulation of any
court or arbitrator or governmental or regulatory authority, except, in the case of clauses (i)&nbsp;and
(iii)&nbsp;above, for any such conflict, breach or violation that would not, individually or in the
aggregate, have a (x)&nbsp;Material Adverse Effect or (y)&nbsp;material adverse effect on the issuance and
sale of the Securities and compliance by the Company with the terms thereof and the consummation of
the transactions contemplated by the Transaction Documents.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(q)&nbsp;<I>No Consents Required. </I>No consent, approval, authorization, order, license, registration
or qualification of or with any court or arbitrator or governmental or regulatory authority is
required for the execution, delivery and performance by the Company of each of the Transaction
Documents, the issuance and sale of the Securities and compliance by the Company with the terms
thereof and the consummation of the transactions contemplated by the Transaction Documents, except
for registration of the Securities under the Securities Act, the qualification of the Indenture
under the Trust Indenture Act and such consents, approvals, authorizations, orders and
registrations or qualifications as may be required under applicable state securities laws in
connection with the purchase and distribution of the Securities by the Underwriters, and except for
such consents, approvals, authorizations, orders or filings the failure of which to obtain or make
would not reasonably be expected to have a Material Adverse Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(r)&nbsp;<I>Legal Proceedings. </I>Except as described in the Registration Statement, the Time of Sale
Information and the Prospectus, there are no legal, governmental or regulatory investigations,
actions, suits or proceedings pending to which the Company or any of its subsidiaries is or may be
a party or to which any property of the Company or any of its subsidiaries is or may be the subject
that, individually or in the aggregate, if determined adversely to the Company or any of its
subsidiaries, could reasonably be expected to have a Material Adverse Effect; and to the knowledge
of the Company, no such investigations, actions, suits or proceedings are threatened by any
governmental or regulatory authority or threatened by others; and (i)&nbsp;there are no current or
pending legal, governmental or regulatory actions, suits or proceedings that are required under the
Securities Act to be described in the Registration Statement and the Prospectus that are not so
described in the Registration Statement, the Time of Sale Information and the Prospectus and (ii)
there are no statutes, regulations or contracts or other documents that are required under the
Securities Act to be filed as exhibits to the Registration Statement or described in the
Registration Statement and the Prospectus that are not so filed as exhibits to the Registration
Statement or described in the Registration Statement, the Time of Sale Information and the
Prospectus.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(s)&nbsp;<I>Independent Accountants. </I>Ernst &#038; Young LLP, which has audited certain financial
statements of the Company and its subsidiaries, is an independent registered public accounting firm
with respect to the Company and its subsidiaries within the applicable rules and regulations
adopted by the Commission and the Public Company Accounting Oversight Board (United States) and as
required by the Securities Act.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(t) <I>Title to Real and Personal Property. </I>(i)&nbsp;The Company and its subsidiaries have good and
marketable title in fee simple (in the case of real property) to,
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->10<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">or have valid rights to lease or otherwise use, all items of real and personal property and assets that are material to the
respective businesses of the Company and its subsidiaries, in each case free and clear of all
liens, encumbrances, claims and defects and imperfections of title except those that (x)&nbsp;are
described or referred to in the Registration Statement, the Time of Sale Information and the
Prospectus, (y)&nbsp;do not materially affect the value of such property and do not interfere with the
use made and proposed to be made of such property by the Company and its subsidiaries or (z)&nbsp;would
not have a Material Adverse Effect, and (ii)&nbsp;any material real property and buildings held under
lease by the Company and its subsidiaries are held by them under valid, existing and enforceable
leases with such exceptions (x)&nbsp;as are not material and do not interfere with the use made or
proposed to be made of such real property and buildings by the Company or its subsidiaries or (y)
which would not have a Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(u)&nbsp;<I>Title to Intellectual Property. </I>Except as would not, individually or in the aggregate,
have a Material Adverse Effect, the Company and its subsidiaries own, possess or can acquire on
reasonable terms, adequate rights to use all patents, patent applications, trademarks, service
marks, trade names, trademark registrations, service mark registrations, copyrights, licenses and
know-how (including trade secrets and other unpatented and/or unpatentable proprietary or
confidential information, systems or procedures) (collectively, &#147;Intellectual Property Rights&#148;)
reasonably necessary for the conduct of their respective businesses as currently conducted by them
or presently employed by them; and the Company and its subsidiaries have not received any written
notice of any claim of infringement or conflict with any asserted rights of others with respect to
any Intellectual Property Rights that, if determined adversely to the Company or any of its
subsidiaries, would, individually or in the aggregate, have a Material Adverse Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v)&nbsp;<I>No Undisclosed Relationships. </I>No relationship, direct or indirect, exists between or
among the Company or any of its subsidiaries, on the one hand, and the directors, officers,
stockholders, customers or suppliers of the Company or any of its subsidiaries, on the other, that
is required by the Securities Act to be described in the Registration Statement and the Prospectus
and that is not so described in such documents and the Time of Sale Information.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(w)&nbsp;<I>Investment Company Act. </I>The Company is not and, after giving effect to the offering and
sale of the Securities and the consummation of the Senior Notes Offering and the application of the
proceeds thereof as described in the Registration Statement, the Time of Sale Information and the
Prospectus and the consummation of the Tender Offer, will not be required to register as an
&#147;investment company&#148; or an entity &#147;controlled&#148; by an &#147;investment company&#148; within the meaning of the
Investment Company Act of 1940, as amended, and the rules and regulations of the Commission
thereunder (collectively, &#147;Investment Company Act&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(x) <I>Public Utility Holding Company Act. </I>Neither the Company nor any of its subsidiaries is a
&#147;holding company&#148; or a &#147;subsidiary company&#148; of a holding company or an &#147;affiliate&#148; thereof within the meaning of the Public Utility Holding Company Act of
1935, as amended.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->11<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(y)&nbsp;<I>Taxes. </I>The Company and its subsidiaries have paid all material federal, state, local and
foreign taxes and all assessments received by them or any of them to the extent that such material
taxes have become due and are not being contested in good faith, except where the failure to so pay
or file would not have a Material Adverse Effect and filed all tax returns required to be paid or
filed through the date hereof; and except as otherwise disclosed in the Registration Statement, the
Time of Sale Information and the Prospectus, there is no tax deficiency that has been, or, to the
Company&#146;s knowledge, could reasonably be expected to be, asserted against the Company or any of its
subsidiaries or any of their respective properties or assets that would have a Material Adverse
Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(z)&nbsp;<I>Licenses and Permits. </I>The Company and its subsidiaries possess all licenses,
certificates, permits and other authorizations issued by, and have made all declarations and
filings with, the appropriate federal, state, local or foreign governmental or regulatory
authorities that are necessary for the ownership or lease of their respective properties or the
conduct of their respective businesses as described in the Registration Statement, the Time of Sale
Information and the Prospectus, except where the failure to possess or make the same would not,
individually or in the aggregate, have a Material Adverse Effect; and neither the Company nor any
of its subsidiaries has received actual notice of any proceeding relating to revocation or
modification of any such license, certificate, permit or authorization, except as described in the
Registration Statement, the Time of Sale Information and the Prospectus; and each of the Company
and its subsidiaries is in compliance with all laws and regulations relating to the conduct of its
business as conducted as of the date hereof, except where the failure to possess such licenses,
certificates, permits and other authorizations, to make such declarations and filings, to be party
to any such proceedings, or to comply with such laws and regulations would not, singly or in the
aggregate, have a Material Adverse Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(aa)&nbsp;<I>No Labor Disputes. </I>No material labor disturbance by or dispute with employees of the
Company or any of its subsidiaries exists or, to the knowledge of the Company, is threatened.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(bb) <I>Compliance With Environmental Laws. </I>(i)&nbsp;The Company and its subsidiaries (x)&nbsp;are in
compliance with any and all applicable federal, state, local and foreign laws, rules and
regulations relating to the protection of human health and safety, the environment or hazardous or
toxic substances or wastes, pollutants or contaminants (collectively, &#147;Environmental Laws&#148;),
(y)&nbsp;have received and are in compliance with all permits, licenses or other approvals required of
them under applicable Environmental Laws to conduct their respective businesses, and (z)&nbsp;have not
received notice of any actual or potential liability for the investigation or remediation of any
disposal or release of hazardous or toxic substances or wastes, pollutants or contaminants, except
in any such case for any such failure to comply, or failure to receive required permits, licenses
or approvals, or liability as (i)&nbsp;is disclosed in the Registration Statement, the Time of Sale
Information and the Prospectus or (ii)&nbsp;would not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->12<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 4%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) In the ordinary course of its business, the Company conducts a periodic review of
the effect of Environmental Laws on the business, operations and properties of the Company
and its subsidiaries, in the course of which it identifies and evaluates associated costs
and liabilities (including, without limitation, any capital or operating expenditures
required for clean-up, closure of properties or compliance with Environmental Laws or any
permit, license or approval, any related constraints on operating activities and any
potential liabilities to third parties). On the basis of such review, the Company has
reasonably concluded that such associated costs and liabilities would not, singly or in the
aggregate, have a Material Adverse Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(cc)&nbsp;<I>Compliance With ERISA. </I>Each employee benefit plan, within the meaning of Section&nbsp;3(3) of
the Employee Retirement Income Security Act of 1974, as amended (&#147;ERISA&#148;), that is maintained,
administered or contributed to by the Company or any of its affiliates for employees or former
employees of the Company and its affiliates has been maintained in compliance in all material
respects with its terms and the requirements of any applicable statutes, orders, rules and
regulations, including but not limited to ERISA and the Internal Revenue Code of 1986, as amended
(the &#147;Code&#148;); no prohibited transaction, within the meaning of Section&nbsp;406 of ERISA or Section&nbsp;4975
of the Code, has occurred with respect to any such plan excluding transactions effected pursuant to
a statutory or administrative exemption that could reasonably be expected to result in a material
liability to the Company or its subsidiaries; and for each such plan that is subject to the funding
rules of Section&nbsp;412 of the Code or Section&nbsp;302 of ERISA, no &#147;accumulated funding deficiency&#148; as
defined in Section&nbsp;412 of the Code has been incurred, whether or not waived, and the fair market
value of the assets of each such plan (excluding for these purposes accrued but unpaid
contributions) exceeds the present value of all benefits accrued under such plan determined using
reasonable actuarial assumptions.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(dd)&nbsp;<I>Disclosure Controls. </I>The Company and its subsidiaries on a consolidated basis maintain
an effective system of &#147;disclosure controls and procedures&#148; (as defined in Rule&nbsp;13a-15(e) of the
Exchange Act) that is designed to ensure that information required to be disclosed by the Company
in reports that it files or submits under the Exchange Act is recorded, processed, summarized and
reported within the time periods specified in the Commission&#146;s rules and forms, including controls
and procedures designed to ensure that such information is accumulated and communicated to the
Company&#146;s management as appropriate to allow timely decisions regarding required disclosure. The
Company and its subsidiaries on a consolidated basis have carried out evaluations of the
effectiveness of their disclosure controls and procedures as required by Rule&nbsp;13a-15 of the
Exchange Act.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ee) <I>Accounting Controls. </I>The Company and its subsidiaries on a consolidated basis maintain
systems of &#147;internal controls over financial reporting&#148; (as defined in Rule&nbsp;13a-15(f) of the
Exchange Act) that comply with the requirements of the
Exchange Act and have been designed by, or under the supervision of, their respective
principal executive and principal financial officers, or persons performing similar functions, to
provide reasonable assurance regarding reliability of financial reporting and the
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->13<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">preparation of financial statements for external purposes in accordance with generally accepted accounting
principles, including but not limited to internal accounting controls sufficient to provide
reasonable assurance that (i)&nbsp;transactions are executed in accordance with management&#146;s general or
specific authorizations; (ii)&nbsp;transactions are recorded as necessary to permit preparation of
financial statements in conformity with generally accepted accounting principles and to maintain
asset accountability; (iii)&nbsp;access to assets is permitted only in accordance with management&#146;s
general or specific authorization; and (iv)&nbsp;the recorded accountability for assets is compared with
the existing assets at reasonable intervals and appropriate action is taken with respect to any
differences. Except as disclosed in the Registration Statement, the Time of Sale Information and
the Prospectus, there are no material weaknesses in the Company&#146;s internal controls.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ff)&nbsp;<I>Insurance. </I>The Company and its subsidiaries have insurance covering their respective
properties, operations, personnel and businesses, including business interruption insurance, which
insurance is in such amounts and insures against such losses and risks as are reasonable and
consistent with sound business practice; and neither the Company nor any of its subsidiaries has
(i)&nbsp;received notice from any insurer or agent of such insurer that capital improvements or other
expenditures are required or necessary to be made in order to continue such insurance or (ii)&nbsp;any
reason to believe that it will not be able to renew its existing insurance coverage as and when
such coverage expires or to obtain similar coverage at reasonable cost from similar insurers as may
be necessary to continue its business.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(gg)&nbsp;<I>No Unlawful Payments. </I>Neither the Company nor any of its subsidiaries nor, to the
knowledge of the Company, any director, officer, agent, employee or other person associated with or
acting on behalf of the Company or any of its subsidiaries has (i)&nbsp;used any corporate funds for any
unlawful contribution, gift, entertainment or other unlawful expense relating to political
activity; (ii)&nbsp;made any direct or indirect unlawful payment to any foreign or domestic government
official or employee from corporate funds; (iii)&nbsp;violated or is in violation of any provision of
the Foreign Corrupt Practices Act of 1977; or (iv)&nbsp;made any bribe, rebate, payoff, influence
payment, kickback or other unlawful payment.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(hh)&nbsp;<I>Compliance with Money Laundering Laws. </I>The operations of the Company and its
subsidiaries are and have been conducted at all times in compliance with applicable financial
recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of
1970, as amended, the money laundering statutes of all jurisdictions, the rules and regulations
thereunder and any related or similar rules, regulations or guidelines, issued, administered or
enforced by any governmental agency (collectively, the &#147;Money Laundering Laws&#148;) and no action, suit
or proceeding by or before any court or governmental agency, authority or body or any arbitrator
involving the Company or any of its subsidiaries with respect to the Money Laundering Laws is
pending or, to the knowledge of the Company, threatened.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;<I>Compliance with OFAC. </I>None of the Company, any of its subsidiaries or, to the knowledge
of the Company, any director, officer, agent, employee or affiliate of the Company or any of its
subsidiaries is currently subject to any U.S. sanctions
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->14<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury (&#147;OFAC&#148;); and the Company will not, directly
or indirectly, use the proceeds of the offering of the Securities hereunder, or lend, contribute or
otherwise make available such proceeds to any subsidiary, joint venture partner or other person or
entity, for the purpose of financing the activities of any person currently subject to any U.S.
sanctions administered by OFAC.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(jj)&nbsp;<I>No Restrictions on Subsidiaries</I>. No subsidiary of the Company is currently prohibited,
directly or indirectly, under any agreement or other instrument to which it is a party or is
subject, from paying any dividends to the Company, from making any other distribution on such
subsidiary&#146;s capital stock, from repaying to the Company any loans or advances to such subsidiary
from the Company or from transferring any of such subsidiary&#146;s properties or assets to the Company
or any other subsidiary of the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(kk)&nbsp;<I>No Broker&#146;s Fees. </I>Neither the Company nor any of its subsidiaries is a party to any
contract, agreement or understanding with any person (other than this Agreement) that would give
rise to a valid claim against the Company or any of its subsidiaries or any Underwriter for a
brokerage commission, finder&#146;s fee or like payment in connection with the offering and sale of the
Securities.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ll)&nbsp;<I>No Registration Rights</I>. No person has the right to require the Company or any of its
subsidiaries to register any securities for sale under the Securities Act by reason of the filing
of the Registration Statement with the Commission or the issuance and sale of the Securities.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(mm)&nbsp;<I>No Stabilization. </I>The Company has not taken, directly or indirectly, any action designed
to or that could reasonably be expected to cause or result in any stabilization or manipulation of
the price of the Securities.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(nn)&nbsp;<I>Business With Cuba. </I>The Company has complied with all provisions of Section&nbsp;517.075,
Florida Statutes (Chapter&nbsp;92-198, Laws of Florida) relating to doing business with the Government
of Cuba or with any person or affiliate located in Cuba.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(oo)&nbsp;<I>Margin Rules</I>. Neither the issuance, sale and delivery of the Securities nor the
application of the proceeds thereof by the Company as described in the Registration Statement, the
Time of Sale Information and the Prospectus will violate Regulation&nbsp;T, U or X of the Board of
Governors of the Federal Reserve System or any other regulation of such Board of Governors.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(pp)&nbsp;<I>Forward-Looking Statements. </I>No forward-looking statement (within the meaning of Section
27A of the Securities Act and Section&nbsp;21E of the Exchange Act) contained in the Registration
Statement, the Time of Sale Information and the Prospectus has been made or reaffirmed without a reasonable basis or has been disclosed other than in
good faith.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(qq) <I>Statistical and Market Data. </I>Nothing has come to the attention of the Company that has
caused the Company to believe that the statistical and market-related
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->15<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">data included in the Registration Statement, the Time of Sale Information and the Prospectus is not based on or derived
from sources that are reliable and accurate in all material respects.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(rr)&nbsp;<I>Sarbanes-Oxley Act</I>. There is and has been no failure on the part of the Company or any
of the Company&#146;s directors or officers, in their capacities as such, to comply with any provision
of the Sarbanes-Oxley Act of 2002 and the rules and regulations promulgated in connection therewith
(the &#147;Sarbanes-Oxley Act&#148;), including Section&nbsp;402 related to loans and Sections&nbsp;302 and 906 related
to certifications.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ss)&nbsp;<I>Senior Indebtedness. </I>The Securities constitute &#147;senior indebtedness&#148; as such term is
defined in any indenture or agreement governing any outstanding subordinated indebtedness of the
Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(tt)&nbsp;<I>Status under the Securities Act. </I>The Company is not an ineligible issuer and is a
well-known seasoned issuer, in each case, as defined under the Securities Act, in each case at the
times specified in the Securities Act in connection with the offering of the Securities.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. <U>Further Agreements of the Company</U>. The Company covenants and agrees with each
Underwriter that:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;<I>Effectiveness of the Registration Statement. </I>The Company will file the final Prospectus
with the Commission within the time periods specified by Rule 424(b) and Rule&nbsp;430A, 430B or 430C
under the Securities Act, will file any Issuer Free Writing Prospectus (including the Term Sheet in
the form of Schedule&nbsp;III hereto) to the extent required by Rule&nbsp;433 under the Securities Act and
will file promptly all reports and any definitive proxy or information statements required to be
filed by the Company with the Commission pursuant to Section&nbsp;13(a), 13(c), 14 or 15(d) of the
Exchange Act subsequent to the date of the Prospectus and for so long as the delivery of a
prospectus is required in connection with the offering or sale of the Securities; and the Company
will furnish copies of the Prospectus and each Issuer Free Writing Prospectus (to the extent not
previously delivered) to the Underwriters in New York City prior to 10:00&nbsp;A.M., New York City time,
on the business day next succeeding the date of this Agreement in such quantities as the
Representatives may reasonably request. The Company will pay the registration fees for this
offering within the time period required by Rule&nbsp;456(b)(1)(i) under the Securities Act (without
giving effect to the proviso therein) and in any event prior to the Closing Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <I>Delivery of Copies. </I>The Company will deliver, without charge, (i)&nbsp;to the Representatives,
three signed copies of the Registration Statement as originally filed and each amendment thereto,
in each case including all exhibits and consents filed therewith; and (ii)&nbsp;to each Underwriter (A)&nbsp;a conformed copy of the Registration Statement as
originally filed and each amendment thereto (without exhibits) and (B)&nbsp;during the Prospectus
Delivery Period (as defined below), as many copies of the Prospectus (including all amendments and
supplements thereto and documents incorporated by reference therein) and each Issuer Free Writing
Prospectus as the
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->16<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Representatives may reasonably request. As used herein, the term &#147;Prospectus
Delivery Period&#148; means such period of time after the first date of the public offering of the
Securities as in the opinion of counsel for the Underwriters a prospectus relating to the
Securities is required by law to be delivered (or required to be delivered but for Rule&nbsp;172 under
the Securities Act) in connection with sales of the Securities by any Underwriter or dealer.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;<I>Amendments or Supplements; Issuer Free Writing Prospectuses. </I>Before making, preparing,
using, authorizing, approving, referring to or filing any Issuer Free Writing Prospectus, and
before filing any amendment or supplement to the Registration Statement or the Prospectus during
the Prospectus Delivery Period, the Company will furnish to the Representatives and counsel for the
Underwriters a copy of the proposed Issuer Free Writing Prospectus, amendment or supplement for
review and will not make, prepare, use authorize, approve, refer to or file any such Issuer Free
Writing Prospectus or file any such proposed amendment or supplement to which the Representatives
reasonably object.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <I>Notice to the Representatives. </I>The Company will advise the Representatives promptly, and
confirm such advice in writing, (i)&nbsp;when any amendment to the Registration Statement has been filed
or becomes effective; (ii)&nbsp;when any supplement to the Prospectus or any amendment to the Prospectus
or any Issuer Free Writing Prospectus has been filed; (iii)&nbsp;of any request by the Commission for
any amendment to the Registration Statement or any amendment or supplement to the Prospectus or the
receipt of any comments from the Commission relating to the Registration Statement or any other
request by the Commission for any additional information; (iv)&nbsp;of the issuance by the Commission of
any order suspending the effectiveness of the Registration Statement or preventing or suspending
the use of any Preliminary Prospectus or the Prospectus or the initiation or threatening of any
proceeding for that purpose or pursuant to Section&nbsp;8A of the Securities Act; (v)&nbsp;of the occurrence
of any event within the Prospectus Delivery Period as a result of which the Prospectus, the Time of
Sale Information or any Issuer Free Writing Prospectus as then amended or supplemented would
include any untrue statement of a material fact or omit to state a material fact required to be
stated therein or necessary in order to make the statements therein, in the light of the
circumstances existing when the Prospectus, the Time of Sale Information or any Issuer Free Writing
Prospectus is delivered to a purchaser, not misleading; (vi)&nbsp;of the receipt by the Company of any
notice of objection of the Commission to the use of the Registration Statement or any
post-effective amendment thereto pursuant to Rule&nbsp;401(g)(2) under the Securities Act; and (vii)&nbsp;of
the receipt by the Company of any notice with respect to any suspension of the qualification of the
Securities for offer and sale in any jurisdiction or the initiation or threatening of any
proceeding for such purpose; and the Company will use its reasonable best efforts to prevent the
issuance of any such order suspending the effectiveness of the Registration Statement, preventing or suspending the use of any Preliminary Prospectus or the Prospectus or
suspending any such qualification of the Securities and, if any such order is issued, will use its
reasonable best efforts to obtain as soon as possible the withdrawal thereof.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->17<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;<I>Time of Sale Information. </I>If at any time prior to the Closing Date (i)&nbsp;any event shall
occur or condition shall exist as a result of which the Time of Sale Information as then amended or
supplemented would include any untrue statement of a material fact or omit to state any material
fact necessary in order to make the statements therein, in the light of the circumstances, not
misleading or (ii)&nbsp;it is necessary to amend or supplement the Time of Sale Information to comply
with law, the Company will as promptly as practicable notify the Underwriters thereof and forthwith
prepare and, subject to paragraph (c)&nbsp;above, file with the Commission (to the extent required) and
furnish to the Underwriters and to such dealers as the Representative may designate, such
amendments or supplements to the Time of Sale Information as may be necessary so that the
statements in the Time of Sale Information as so amended or supplemented will not, in the light of
the circumstances, be misleading or so that the Time of Sale Information will comply with law.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;<I>Ongoing Compliance of the Prospectus. </I>If during the Prospectus Delivery Period (i)&nbsp;any
event shall occur or condition shall exist as a result of which the Prospectus as then amended or
supplemented would include an untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary in order to make the statements therein, in the light of
the circumstances existing when the Prospectus is delivered to a purchaser, not misleading or (ii)
it is necessary to amend or supplement the Prospectus to comply with law, the Company will
immediately notify the Underwriters thereof and forthwith prepare and, subject to paragraph (c)
above, file with the Commission and furnish to the Underwriters and to such dealers as the
Representatives may designate, such amendments or supplements to the Prospectus as may be necessary
so that the statements in the Prospectus as so amended or supplemented will not, in the light of
the circumstances existing when the Prospectus is delivered to a purchaser, be misleading or so
that the Prospectus will comply with law.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;<I>Blue Sky Compliance. </I>The Company will qualify the Securities for offer and sale under the
securities or Blue Sky laws of such jurisdictions as the Representatives shall reasonably request
and will continue such qualifications in effect so long as required for distribution of the
Securities; <U>provided</U> that the Company shall not be required to (i)&nbsp;qualify as a foreign
corporation or other entity or as a dealer in securities in any such jurisdiction where it would
not otherwise be required to so qualify, (ii)&nbsp;file any general consent to service of process in any
such jurisdiction or (iii)&nbsp;subject itself to taxation in any such jurisdiction if it is not
otherwise so subject.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;<I>Earning Statement. </I>The Company will make generally available to its security holders and
the Representatives as soon as practicable an earning statement that satisfies the provisions of
Section 11(a) of the Securities Act and Rule&nbsp;158 of the Commission promulgated thereunder covering
a period of at least twelve months beginning with the first fiscal quarter of the Company occurring after the &#147;effective date&#148;
(as defined in Rule&nbsp;158) of the Registration Statement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;<I>Clear Market. </I>For a period of ninety (90)&nbsp;days after the date of the Prospectus, the
Company will not, without the prior written consent of the Representatives, (i)&nbsp;offer, pledge,
announce the intention to sell, sell, contract to sell, sell
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->18<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase or
otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any
securities convertible into or exercisable or exchangeable for Common Stock or (ii)&nbsp;enter into any
swap or other agreement that transfers, in whole or in part, any of the economic consequences of
ownership of the Common Stock, whether any such transaction described in clause (i)&nbsp;or (ii)&nbsp;above
is to be settled by delivery of Common Stock or such other securities, in cash or otherwise,
without the prior written consent of the Representatives, other than (A)&nbsp;the Securities to be sold
hereunder, (B)&nbsp;the grant of options, awards of restricted stock and restricted stock units or the
issuance of shares of Common Stock to employees or directors by the Company in the ordinary course
of business or pursuant to any of the Company&#146;s existing employee or director stock compensation
plans and (C)&nbsp;the issuance by the Company of shares of Common Stock upon the exercise of options
granted under the Company&#146;s existing employee or directors stock compensation plans.
Notwithstanding the foregoing, if (1)&nbsp;during the last 17&nbsp;days of the 90-day restricted period, the
Company issues an earnings release or material news or a material event relating to the Company
occurs; or (2)&nbsp;prior to the expiration of the 90-day restricted period, the Company announces that
it will release earnings results during the 16-day period beginning on the last day of the 90-day
period, the restrictions imposed by this Agreement shall continue to apply until the expiration of
the 18-day period beginning on the issuance of the earnings release or the occurrence of the
material news or material event.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)&nbsp;<I>Use of Proceeds. </I>The Company will apply the net proceeds from the sale of the Securities
as described in the Registration Statement, the Time of Sale Information and the Prospectus under
the heading &#147;Use of Proceeds&#148;.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k)&nbsp;<I>No Stabilization. </I>The Company will not take, directly or indirectly, any action designed
to or that could reasonably be expected to cause or result in any stabilization or manipulation of
the price of the Securities or the Common Stock.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l)&nbsp;<I>Reports. </I>So long as the Securities are outstanding, the Company will furnish to the
Representatives, as soon as they are available, copies of all reports or other communications
(financial or other) furnished to holders of the Securities, and copies of any reports and
financial statements furnished to or filed with the Commission or any national securities exchange
or automatic quotation system; <U>provided</U>, <U>however</U>, in no event shall the Company be
required to furnish copies of any such documents which are filed and publicly accessible via the
EDGAR database.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m)&nbsp;<I>Underlying Shares. </I>The Company will reserve and keep available at all times, free of
preemptive rights, the full number of Underlying Shares issuable upon conversion of the Securities.
The Company will use its reasonable best efforts to list, subject to notice of issuance, the Underlying Shares on the New York Stock Exchange (the
&#147;Exchange&#148;) on or prior to the Closing Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(n)&nbsp;<I>Conversion Price. </I>Between the date hereof and the Closing Date, the Company will not do
or authorize any act or thing that would result in an adjustment of the conversion price of the
Securities pursuant to the terms of the Securities described in
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->19<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">the Preliminary Prospectus under the caption &#147;Description of Notes&#151;Conversion Rights&#151;Conversion Rate Adjustments&#148;.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(o)&nbsp;<I>Record Retention. </I>The Company will, pursuant to reasonable procedures developed in good
faith, retain copies of each Issuer Free Writing Prospectus that is not filed with the Commission
in accordance with Rule&nbsp;433 under the Securities Act.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. <U>Certain Agreements of the Underwriters</U>. Each Underwriter hereby represents and
agrees that it has not and will not use, authorize use of, refer to, or participate in the planning
for use of, any &#147;free writing prospectus&#148;, as defined in Rule&nbsp;405 under the Securities Act (which
term includes use of any written information furnished to the Commission by the Company and not
incorporated by reference into the Registration Statement and any press release issued by the
Company) other than (i)&nbsp;a free writing prospectus that, solely as a result of use by such
underwriter, would not trigger an obligation to file such free writing prospectus with the
Commission pursuant to Rule&nbsp;433, (ii)&nbsp;any Issuer Free Writing Prospectus listed on Schedule&nbsp;IIA or
prepared pursuant to Section 3(c) or Section 4(c) above (including any electronic road show other
than any electronic road listed on Schedule&nbsp;IIB hereto), or (iii)&nbsp;any free writing prospectus
prepared by such underwriter and approved by the Company in advance in writing (each such free
writing prospectus referred to in clauses (i)&nbsp;or (iii), an &#147;Underwriter Free Writing Prospectus&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. <U>Conditions of Underwriters&#146; Obligations</U>. The obligation of each Underwriter to
purchase the Underwritten Securities on the Closing Date or the Option Securities on the Additional
Closing Date, as the case may be, as provided herein is subject to the performance by the Company
of its covenants and other obligations hereunder and to the following additional conditions:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;<I>Registration Compliance; No Stop Order. </I>No order suspending the effectiveness of the
Registration Statement shall be in effect, and no proceeding for such purpose shall be pending
before or overtly threatened by the Commission; the Prospectus and each Issuer Free Writing
Prospectus shall have been timely filed with the Commission under the Securities Act (in the case
of a Issuer Free Writing Prospectus, to the extent required by Rule&nbsp;433 under the Securities Act)
and in accordance with Section 4(a) hereof; and all requests by the Commission for additional
information shall have been complied with to the reasonable satisfaction of the Representatives.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;<I>Representations and Warranties. </I>The representations and warranties of the Company
contained herein shall be true and correct on the date hereof and on and as of the Closing Date or
the Additional Closing Date, as the case may be; and the statements of the Company and its officers made in any certificates delivered pursuant to this
Agreement shall be true and correct on and as of the Closing Date or the Additional Closing Date,
as the case may be.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <I>No Downgrade. </I>Subsequent to the earlier of (i)&nbsp;the Time of Sale and (ii)&nbsp;the execution
and delivery of this Agreement, (A)&nbsp;no downgrading shall have
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->20<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">occurred in the rating accorded the Securities or any other debt securities or preferred stock of or guaranteed by the Company or any
of its subsidiaries by any &#147;nationally recognized statistical rating organization&#148;, as such term is
defined by the Commission for purposes of Rule&nbsp;436(g)(2) under the Securities Act and (B)&nbsp;no such
organization shall have publicly announced that it has under surveillance or review, or has changed
its outlook with respect to, its rating of the Securities or any other debt securities or preferred
stock of or guaranteed by the Company or any of its subsidiaries (other than an announcement with
positive implications of a possible upgrading).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;<I>No Material Adverse Change. </I>Subsequent to the execution and delivery of this Agreement,
no event or condition of a type described in Section 3(g) hereof shall have occurred or shall
exist, which event or condition is not described in the Time of Sale Information (excluding any
amendment or supplement thereto) and the Prospectus (excluding any amendment or supplement thereto)
and the effect of which in the judgment of the Representatives makes it impracticable or
inadvisable to proceed with the offering, sale or delivery of the Underwritten Securities on the
Closing Date or the Option Securities the Additional Closing Date, as the case may be, on the terms
and in the manner contemplated by this Agreement, the Time of Sale Information and the Prospectus.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;<I>Officer&#146;s Certificate. </I>The Representatives shall have received on and as of the Closing
Date or the Additional Closing Date, as the case may be, a certificate of the chief financial
officer or chief accounting officer of the Company and one additional senior executive officer of
the Company who is satisfactory to the Representatives (i)&nbsp;confirming that such officers have
carefully reviewed the Registration Statement, the Time of Sale Information and the Prospectus and,
to the best knowledge of such officers, the representations set forth in Sections 3(b) and 3(d)
hereof are true and correct, (ii)&nbsp;confirming that the other representations and warranties of the
Company in this Agreement are true and correct and that the Company has complied with all
agreements and satisfied all conditions on its part to be performed or satisfied hereunder at or
prior to the Closing Date or the Additional Closing Date, as the case may be, and (iii)&nbsp;to the
effect set forth in paragraphs (a), (c)&nbsp;and (d)&nbsp;above.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <I>Comfort Letters. </I>On the date of this Agreement and on the Closing Date or the Additional
Closing Date, as the case may be, Ernst &#038; Young LLP shall have furnished to the Representatives, at
the request of the Company, letters, dated the respective dates of delivery thereof and addressed
to the Underwriters, in form and substance reasonably satisfactory to the Representatives,
containing statements and information of the type customarily included in accountants&#146; &#147;comfort
letters&#148; to underwriters with respect to the financial statements and certain financial information
contained or incorporated by reference in the Registration Statement, the Prospectus and Time of Sale Information; <U>provided</U> that the letter delivered on the Closing Date or
the Additional Closing Date, as the case may be, shall use a &#147;cut-off&#148; date no more than three
business days prior to such Closing Date or such Additional Closing Date, as the case may be.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->21<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;<I>Opinion of Counsel for the Company. </I>(i)&nbsp;Jon D. Walton, Executive Vice President, Human
Resources, Chief Legal and Compliance Officer, General Counsel and Corporate Secretary of the
Company, shall have furnished to the Representatives, at the request of the Company, his written
opinion, dated the Closing Date or the Additional Closing Date, as the case may be, and addressed
to the Underwriters, in form and substance reasonably satisfactory to the Representatives, to the
effect set forth in Annex A hereto and (ii)&nbsp;K&#038;L Gates LLP, counsel for the Company, shall have
furnished to the Representatives, at the request of the Company, their written opinion, dated the
Closing Date or the Additional Closing Date, as the case may be, and addressed to the Underwriters,
in form and substance reasonably satisfactory to the Representatives, to the effect set forth in
Annex B hereto.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;<I>Opinion of Counsel for the Underwriters. </I>The Representatives shall have received on and
as of the Closing Date or the Additional Closing Date, as the case may be, an opinion of Cravath,
Swaine &#038; Moore LLP, counsel for the Underwriters, with respect to such matters as the
Representatives may reasonably request, and such counsel shall have received such documents and
information as they may reasonably request to enable them to pass upon such matters.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;<I>No Legal Impediment to Issuance. </I>No action shall have been taken and no statute, rule,
regulation or order shall have been enacted, adopted or issued by any federal, state or foreign
governmental or regulatory authority that would, as of the Closing Date or the Additional Closing
Date, as the case may be, prevent the issuance or sale of the Securities; and no injunction or
order of any federal, state or foreign court shall have been issued that would, as of the Closing
Date or the Additional Closing Date, as the case may be, prevent the issuance or sale of the
Securities.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)&nbsp;<I>Good Standing</I>. The Representatives shall have received on and as of the Closing Date or
the Additional Closing Date, as the case may be, satisfactory evidence of the good standing of the
Company and its Significant Subsidiaries in their respective jurisdictions of organization and
their good standing as foreign entities in such other jurisdictions as the Representatives may
reasonably request, in each case in writing or any standard form of telecommunication from the
appropriate governmental authorities of such jurisdictions.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k)&nbsp;<I>Lock-up Agreements</I>. The &#147;lock-up&#148; agreements, each substantially in the form of Exhibit&nbsp;A
hereto, between you and the persons listed in Schedule&nbsp;IV hereto relating to sales and certain
other dispositions of shares of Common Stock or certain other securities, delivered to you on or
before the date hereof, shall be full force and effect on the Closing Date or Additional Closing
Date, as the case may be.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l)&nbsp;<I>Exchange Listing. </I>The Underlying Shares shall have been approved for listing on the
Exchange, subject to official notice of issuance.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m)&nbsp;<I>Additional Documents. </I>On or prior to the Closing Date or the Additional Closing Date, as
the case may be, the Company shall have furnished to the
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->22<!-- /Folio -->
</DIV>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Representatives such further certificates and documents as the Representatives may reasonably
request.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All opinions, letters, certificates and evidence mentioned above or elsewhere in this
Agreement shall be deemed to be in compliance with the provisions hereof only if they are in form
and substance reasonably satisfactory to counsel for the Underwriters.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.&nbsp;<U>Indemnification and Contribution</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <I>Indemnification of the Underwriters. </I>The Company agrees to indemnify and hold harmless
each Underwriter, its affiliates, directors and officers and each person, if any, who controls such
Underwriter within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange
Act, from and against any and all losses, claims, damages and liabilities (including, without
limitation, reasonable legal fees and other expenses incurred in connection with any suit, action
or proceeding or any claim asserted, as such fees and expenses are incurred), joint or several,
that arise out of, or are based upon, (i)&nbsp;any untrue statement or alleged untrue statement of a
material fact contained in the Registration Statement or caused by any omission or alleged omission
to state therein a material fact required to be stated therein or necessary in order to make the
statements therein, not misleading or (ii)&nbsp;any untrue statement or alleged untrue statement of a
material fact contained in the Prospectus (or any amendment or supplement thereto), any Issuer Free
Writing Prospectus or any Preliminary Prospectus, or caused by any omission or alleged omission to
state therein a material fact necessary in order to make the statements therein, in light of the
circumstances under which they were made, not misleading, in each case except insofar as such
losses, claims, damages or liabilities arise out of, or are based upon, any untrue statement or
omission or alleged untrue statement or omission made in reliance upon and in conformity with any
information relating to any Underwriter furnished to the Company in writing by such Underwriter
through the Representatives expressly for use therein, it being understood and agreed that the only
such information furnished by any Underwriter consists of the information described as such in
subsection (b)&nbsp;below.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <I>Indemnification of the Company. </I>Each Underwriter agrees, severally and not jointly, to
indemnify and hold harmless the Company, its directors, its officers who signed the Registration
Statement and each person, if any, who controls the Company within the meaning of Section&nbsp;15 of the
Securities Act or Section&nbsp;20 of the Exchange Act to the same extent as the indemnity set forth in
paragraph (a)&nbsp;above, but only with respect to any losses, claims, damages or liabilities that arise
out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission
made in reliance upon and in conformity with any information relating to such Underwriter furnished
to the Company in writing by such Underwriter through the Representatives expressly for use in the
Registration Statement, the Prospectus (or any amendment or supplement thereto), any Issuer Free
Writing Prospectus or any Preliminary Prospectus, it being understood and agreed upon that the only
such information furnished by any Underwriter consists of the following information in the
Preliminary Prospectus and Prospectus furnished on behalf of each Underwriter: the discount
figures appearing in the third paragraph under the caption &#147;Underwriting&#148; and
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->23<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">the information contained in the eighth, ninth and tenth paragraphs under the caption
&#147;Underwriting&#148;.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <I>Notice and Procedures. </I>If any suit, action, proceeding (including any governmental or
regulatory investigation), claim or demand shall be brought or asserted against any person in
respect of which indemnification may be sought pursuant to either paragraph (a)&nbsp;or (b)&nbsp;above, such
person (the &#147;Indemnified Person&#148;) shall promptly notify the person against whom such
indemnification may be sought (the &#147;Indemnifying Person&#148;) in writing; <U>provided</U> that the
failure to notify the Indemnifying Person shall not relieve it from any liability that it may have
under this Section&nbsp;7 except to the extent that it has been materially prejudiced (through the
forfeiture of substantive rights or defenses) by such failure; and <U>provided</U>,
<U>further</U>, that the failure to notify the Indemnifying Person shall not relieve it from any
liability that it may have to an Indemnified Person otherwise than under this Section&nbsp;7. If any
such proceeding shall be brought or asserted against an Indemnified Person and it shall have
notified the Indemnifying Person thereof, the Indemnifying Person shall retain counsel reasonably
satisfactory to the Indemnified Person to represent the Indemnified Person and any others entitled
to indemnification pursuant to this Section&nbsp;7 that the Indemnifying Person may designate in such
proceeding and shall pay the fees and expenses of such counsel related to such proceeding, as
incurred. In any such proceeding, any Indemnified Person shall have the right to retain its own
counsel, but the fees and expenses of such counsel shall be at the expense of such Indemnified
Person unless (i)&nbsp;the Indemnifying Person and the Indemnified Person shall have mutually agreed to
the contrary; (ii)&nbsp;the Indemnifying Person has failed within a reasonable time to retain counsel
reasonably satisfactory to the Indemnified Person; (iii)&nbsp;the Indemnified Person shall have
reasonably concluded that there may be legal defenses available to it that are different from or in
addition to those available to the Indemnifying Person; or (iv)&nbsp;the named parties in any such
proceeding (including any impleaded parties) include both the Indemnifying Person and the
Indemnified Person and representation of both parties by the same counsel would be inappropriate
due to actual or potential differing interests between them. It is understood and agreed that the
Indemnifying Person shall not, in connection with any proceeding or related proceeding in the same
jurisdiction, be liable for the fees and expenses of more than one separate firm (in addition to
any local counsel) for all Indemnified Persons, and that all such fees and expenses shall be paid
or reimbursed as they are incurred. Any such separate firm for any Underwriter, its affiliates,
directors and officers and any control persons of such Underwriter shall be designated in writing
by the Representatives and any such separate firm for the Company, its directors, its officers who
signed the Registration Statement and any control persons of the Company shall be designated in
writing by the Company. The Indemnifying Person shall not be liable for any settlement of any
proceeding effected without its written consent, but if settled with such consent or if there be a
final judgment for the plaintiff, the Indemnifying Person agrees to indemnify each Indemnified
Person from and against any loss or liability by reason of such settlement or judgment.
Notwithstanding the foregoing sentence, if at any time an Indemnified Person shall have requested
that an Indemnifying Person reimburse the Indemnified Person for fees and expenses of counsel as
contemplated by this paragraph, the Indemnifying Person shall be liable for any settlement of any
proceeding effected without its written consent if (i)&nbsp;such settlement is entered into more than 30
days after receipt by the Indemnifying Person of
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->24<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">such request and (ii)&nbsp;the Indemnifying Person shall not have reimbursed the Indemnified Person
in accordance with such request prior to the date of such settlement. No Indemnifying Person
shall, without the written consent of the Indemnified Person, effect any settlement of any pending
or threatened proceeding in respect of which any Indemnified Person is or could have been a party
and indemnification could have been sought hereunder by such Indemnified Person, unless such
settlement (x)&nbsp;includes an unconditional release of such Indemnified Person, in form and substance
reasonably satisfactory to such Indemnified Person, from all liability on claims that are the
subject matter of such proceeding and (y)&nbsp;does not include any statement as to or any admission of
fault, culpability or a failure to act by or on behalf of any Indemnified Person.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <I>Contribution. </I>If the indemnification provided for in paragraphs (a)and (b)&nbsp;above is
unavailable to an Indemnified Person or insufficient in respect of any losses, claims, damages or
liabilities referred to therein, then each Indemnifying Person under such paragraph, in lieu of
indemnifying such Indemnified Person thereunder, shall contribute to the amount paid or payable by
such Indemnified Person as a result of such losses, claims, damages or liabilities (i)&nbsp;in such
proportion as is appropriate to reflect the relative benefits received by the Company on the one
hand and the Underwriters on the other from the offering of the Securities or (ii)&nbsp;if the
allocation provided by clause (i)&nbsp;is not permitted by applicable law, in such proportion as is
appropriate to reflect not only the relative benefits referred to in clause (i)&nbsp;but also the
relative fault of the Company on the one hand and the Underwriters on the other in connection with
the statements or omissions that resulted in such losses, claims, damages or liabilities, as well
as any other relevant equitable considerations. The relative benefits received by the Company on
the one hand and the Underwriters on the other shall be deemed to be in the same respective
proportions as the net proceeds (before deducting expenses) received by the Company from the sale
of the Securities and the total underwriting discounts and commissions received by the Underwriters
in connection therewith, in each case as set forth in the table on the cover of the Prospectus,
bear to the aggregate offering price of the Securities. The relative fault of the Company on the
one hand and the Underwriters on the other shall be determined by reference to, among other things,
whether the untrue or alleged untrue statement of a material fact or the omission or alleged
omission to state a material fact relates to information supplied by the Company or by the
Underwriters and the parties&#146; relative intent, knowledge, access to information and opportunity to
correct or prevent such statement or omission.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <I>Limitation on Liability. </I>The Company and the Underwriters agree that it would not be just
and equitable if contribution pursuant to this Section&nbsp;7 were determined by <U>pro</U>
<U>rata</U> allocation (even if the Underwriters were treated as one entity for such purpose) or
by any other method of allocation that does not take account of the equitable considerations
referred to in paragraph (d)&nbsp;above. The amount paid or payable by an Indemnified Person as a
result of the losses, claims, damages and liabilities referred to in paragraph (d)&nbsp;above shall be
deemed to include, subject to the limitations set forth above, any legal or other expenses incurred
by such Indemnified Person in connection with any such action or claim. Notwithstanding the
provisions of this Section&nbsp;7, in no event shall an Underwriter be required to contribute any amount
in excess of the amount by which the total underwriting discounts and commissions received by such
Underwriter
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->25<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">with respect to the offering of the Securities exceeds the amount of any damages that such
Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement
or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the
meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person
who was not guilty of such fraudulent misrepresentation. The Underwriters&#146; obligations to
contribute pursuant to this Section&nbsp;7 are several in proportion to their respective purchase
obligations hereunder and not joint.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <I>Non-Exclusive Remedies. </I>The remedies provided for in this Section&nbsp;6 are not exclusive and
shall not limit any rights or remedies which may otherwise be available to any Indemnified Person
at law or in equity.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.&nbsp;<U>Effectiveness of Agreement</U>. This Agreement shall become effective upon the
execution and delivery hereof by the parties hereto.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.&nbsp;<U>Termination</U>. This Agreement may be terminated in the absolute discretion of the
Representatives, by notice to the Company, if after the execution and delivery of this Agreement
and prior to the Closing Date or, in the case of the Option Securities, prior to the Additional
Closing Date (i)&nbsp;trading generally shall have been suspended or materially limited on or by the
Exchange; (ii)&nbsp;trading of any securities issued or guaranteed by the Company shall have been
suspended on any exchange or in any over-the-counter market; (iii)&nbsp;a general moratorium on
commercial banking activities shall have been declared by federal or New York State authorities; or
(iv)&nbsp;there shall have occurred any outbreak or escalation of hostilities or any change in financial
markets or any calamity or crisis, either within or outside the United States, that, in the
judgment of the Representatives, is material and adverse and makes it impracticable or inadvisable
to proceed with the offering, sale or delivery of the Securities on the Closing Date or the
Additional Closing Date, as the case may be, on the terms and in the manner contemplated by this
Agreement, the Time of Sale Information and the Prospectus.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.&nbsp;<U>Defaulting Underwriter</U>. (a)&nbsp;If, on the Closing Date or the Additional Closing
Date, as the case may be, any Underwriter defaults on its obligation to purchase the Securities
that it has agreed to purchase hereunder on such date, the non-defaulting Underwriters may in their
discretion arrange for the purchase of such Securities by other persons satisfactory to the Company
on the terms contained in this Agreement. If, within thirty-six (36)&nbsp;hours after any such default
by any Underwriter, the non-defaulting Underwriters do not arrange for the purchase of such
Securities, then the Company shall be entitled to a further period of thirty-six (36)&nbsp;hours within
which to procure other persons satisfactory to the non-defaulting Underwriters to purchase such
Securities on such terms. If other persons become obligated or agree to purchase the Securities of
a defaulting Underwriter, either the non-defaulting Underwriters or the Company may postpone the
Closing Date or the Additional Closing Date, as the case may be, for up to five (5)&nbsp;full business
days in order to effect any changes that in the opinion of counsel for the Company or counsel for
the Underwriters may be necessary in the Registration Statement and the Prospectus or in any other
document or arrangement, and the Company agrees to promptly prepare any amendment or supplement to
the Registration Statement and the Prospectus that effects any such changes. As used in this
Agreement, the term
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->26<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&#147;Underwriter&#148; includes, for all purposes of this Agreement unless the context otherwise
requires, any person not listed in Schedule&nbsp;I hereto that, pursuant to this Section&nbsp;10, purchases
Securities that a defaulting Underwriter agreed but failed to purchase.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;If, after giving effect to any arrangements for the purchase of the Securities of a
defaulting Underwriter or Underwriters by the non-defaulting Underwriters and the Company as
provided in paragraph (a)&nbsp;above, the aggregate principal amount of such Securities that remain
unpurchased on the Closing Date or the Additional Closing Date, as the case may be does not exceed
one-eleventh of the aggregate principal amount of the Securities to be purchased on such date, then
the Company shall have the right to require each non-defaulting Underwriter to purchase the
principal amount of Securities that such Underwriter agreed to purchase hereunder on such date plus
such Underwriter&#146;s pro rata share (based on the principal amount of Securities that such
Underwriter agreed to purchase on such date) of the Securities of such defaulting Underwriter or
Underwriters for which such arrangements have not been made.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;If, after giving effect to any arrangements for the purchase of the Securities of a
defaulting Underwriter or Underwriters by the non-defaulting Underwriters and the Company as
provided in paragraph (a)&nbsp;above, the aggregate principal amount of such Securities that remains
unpurchased on the Closing Date or the Additional Closing Date, as the case may be, exceeds
one-eleventh of the aggregate principal amount of all the Securities to be purchased on such date,
or if the Company shall not exercise the right described in paragraph (b)&nbsp;above, then this
Agreement or, with respect to any Additional Closing Date, the obligation of the Underwriters to
purchase Securities on the Additional Closing Date, as the case may be, shall terminate without
liability on the part of the non-defaulting Underwriters. Any termination of this Agreement
pursuant to this Section&nbsp;10 shall be without liability on the part of the Company, except that the
Company will continue to be liable for the payment of expenses as set forth in Section&nbsp;11 hereof
and except that the provisions of Section&nbsp;7 hereof shall not terminate and shall remain in effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Nothing contained herein shall relieve a defaulting Underwriter of any liability it may
have to the Company or any non-defaulting Underwriter for damages caused by its default.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.&nbsp;<U>Payment of Expenses</U>. (a)&nbsp;Whether or not the transactions contemplated by this
Agreement are consummated or this Agreement is terminated, the Company will pay or cause to be paid
all costs and expenses incident to the performance of its obligations hereunder, including without
limitation, (i)&nbsp;the costs incident to the authorization, issuance, sale, preparation and delivery
of the Securities and any taxes payable in that connection; (ii)&nbsp;the costs incident to the
preparation, printing and filing under the Securities Act of the Registration Statement, the
Preliminary Prospectus, any Issuer Free Writing Prospectus, any Time of Sale Information and the
Prospectus (including all exhibits, amendments and supplements thereto) and the distribution
thereof; (iii)&nbsp;the costs of reproducing and distributing each of the Transaction Documents; (iv)
the fees and expenses of the Company&#146;s counsel and independent accountants; (v)&nbsp;the fees and
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->27<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">expenses incurred in connection with the registration or qualification and determination of
eligibility for investment of the Securities under the laws of such jurisdictions as the
Representatives may designate and the preparation, printing and distribution of a Blue Sky
Memorandum (including the related fees and expenses of counsel for the Underwriters); (vi)&nbsp;any fees
charged by the rating agencies for rating the Securities; (vii)&nbsp;the fees and expenses of the
Trustee and the paying agent (including related fees and expenses of any counsel to such parties);
(viii)&nbsp;all expenses and application fees incurred in connection with any filing with, and clearance
of the offering by, the Financial Industry Regulatory Authority; (ix)&nbsp;all expenses incurred by the
Company in connection with any &#147;road show&#148; presentation to potential investors; and (x)&nbsp;all
expenses and application fees related to the listing of the Underlying Shares on the Exchange;
provided, however, that except as provided in Section&nbsp;7 or this Section&nbsp;11, the Underwriters shall
pay their own costs and expenses, including without limitation the fees and disbursements of their
counsel and any advertising expenses (other than with respect to any road show presentation)
connected with any offers they make.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;If (i)&nbsp;this Agreement is terminated pursuant to Section&nbsp;9, (ii)&nbsp;the Company for any reason
fails to tender the Securities for delivery to the Underwriters or (iii)&nbsp;the Underwriters decline
to purchase the Securities for any reason permitted under this Agreement, the Company agrees to
reimburse the Underwriters for all out-of-pocket costs and expenses (including the fees and
expenses of their counsel) reasonably incurred by the Underwriters in connection with this
Agreement and the offering contemplated hereby.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.&nbsp;<U>Persons Entitled to Benefit of Agreement</U>. This Agreement shall inure to the
benefit of and be binding upon the parties hereto and their respective successors and the officers
and directors and any controlling persons referred to herein, and the affiliates of each
Underwriter referred to in Section&nbsp;7 hereof. Nothing in this Agreement is intended or shall be
construed to give any other person any legal or equitable right, remedy or claim under or in
respect of this Agreement or any provision contained herein. No purchaser of Securities from any
Underwriter shall be deemed to be a successor merely by reason of such purchase.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13.&nbsp;<U>Survival</U>. The respective indemnities, rights of contribution, representations,
warranties and agreements of the Company and the Underwriters contained in this Agreement or made
by or on behalf of the Company or the Underwriters pursuant to this Agreement or any certificate
delivered pursuant hereto shall survive the delivery of and payment for the Securities and shall
remain in full force and effect, regardless of any termination of this Agreement or any
investigation made by or on behalf of the Company or the Underwriters.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14.&nbsp;<U>Certain Defined Terms</U>. For purposes of this Agreement, (a)&nbsp;except where otherwise
expressly provided, the term &#147;affiliate&#148; has the meaning set forth in Rule&nbsp;405 under the Securities
Act; (b)&nbsp;the term &#147;business day&#148; means any day other than a day on which banks are permitted or
required to be closed in New York City; and (c)&nbsp;the term &#147;subsidiary&#148; has the meaning set forth in
Rule&nbsp;405 under the Securities Act.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->28<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.&nbsp;<U>Miscellaneous</U>. (a) <I>Authority of the Representatives. </I>Any action by the
Underwriters hereunder may be taken by the Representatives on behalf of the Underwriters, and any
such action taken by the Representatives shall be binding upon the Underwriters.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <I>Notices. </I>All notices and other communications hereunder shall be in writing and shall be
deemed to have been duly given if mailed or transmitted and confirmed by any standard form of
telecommunication. Notices to the Underwriters shall be given to the Representatives c/o J.P.
Morgan Securities Inc., Equity-Linked Capital Markets, 383 Madison Avenue, New York, New York 10179
(fax: (212)&nbsp;622-8358; Attention: Equity-Linked Capital Markets) and Citigroup Global Markets
Inc., General Counsel, 390 Greenwich Street, New York, New York 10013 (fax: (212)&nbsp;816-7912;
Attention: General Counsel). Notices to the Company shall be given to it at 1000 Six PPG Place,
Pittsburgh, Pennsylvania 15222, (fax: (412)&nbsp;394-2837); Attention: Jon D. Walton.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <I>Governing Law. </I>This Agreement shall be governed by and construed in accordance with the
laws of the State of New York.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <I>Counterparts. </I>This Agreement may be signed in counterparts (which may include
counterparts delivered by any standard form of telecommunication), each of which shall be an
original and all of which together shall constitute one and the same instrument.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <I>Amendments or Waivers. </I>No amendment or waiver of any provision of this Agreement, nor any
consent or approval to any departure therefrom, shall in any event be effective unless the same
shall be in writing and signed by the parties hereto.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <I>Headings. </I>The headings herein are included for convenience of reference only and are not
intended to be part of, or to affect the meaning or interpretation of, this Agreement.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;<I>signature page follows</I>&#093;
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->29<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">If the foregoing is in accordance with your understanding, please indicate your acceptance of this
Agreement by signing in the space provided below.
</DIV>






<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>


<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Very truly yours,</TD>
    <TD>&nbsp;</TD>
</TR>
<tr><td>&nbsp;</td></tr>

<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">ALLEGHENY TECHNOLOGIES<BR>
INCORPORATED,<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">by:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Jon D. Walton
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Jon D. Walton&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>

    <TD colspan="2" nowrap align="left">Title:&nbsp;&nbsp;Executive Vice President, Human
Resources,<Br> Chief Legal and Compliance
Officer,<Br> General Counsel and Corporate Secretary&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Accepted as of the date first written above.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">J.P. MORGAN SECURITIES INC.

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="48%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">By:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Michael O&#146;Donovan
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Authorized Signatory
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left">CITIGROUP GLOBAL MARKETS INC.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">By:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ &#091;illegible&#093;
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Authorized Signatory
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left">Each for itself and on behalf of the
several Underwriters listed
in Schedule&nbsp;I hereto.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;<I>signature page to the Convertible Underwriting Agreement</I>&#093;
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><U>Schedule&nbsp;I</U>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="76%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Maximum Principal Amount</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Principal Amount of</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">of Option Securities to be</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Underwritten Securities</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Purchased if Over-allotment</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000">Underwriters</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">to be Purchased</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">Option is exercised</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">J.P. Morgan Securities Inc.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">111,020,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">127,673,000</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Citigroup Global Markets Inc.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">111,020,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">127,673,000</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Merrill Lynch, Pierce,
Fenner &#038; Smith Incorporated</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">31,990,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">36,788,500</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">PNC Capital Markets LLC</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">15,960,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">18,354,000</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Mitsubishi UFJ Securities
(USA), Inc.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">12,810,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">14,731,500</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Credit Suisse Securities
(USA)&nbsp;LLC</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">12,810,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">14,731,500</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Goldman, Sachs &#038; Co.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">12,810,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">14,731,500</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Morgan Stanley &#038; Co.
Incorporated</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">12,810,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">14,731,500</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Wachovia Capital Markets, LLC</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">12,810,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">14,731,500</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">BNY Mellon Capital Markets,
LLC</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">7,980,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">9,177,000</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">HSBC Securities (USA)&nbsp;Inc.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">7,980,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">9,177,000</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Total</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">350,000,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">402,500,000</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><U>Schedule&nbsp;IIA</U>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>Issuer Free Writing Prospectuses</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">A. Free writing prospectus filed with the Commission on May&nbsp;28, 2009, substantially in the form of
Schedule&nbsp;III.
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><U>Schedule&nbsp;IIB</U>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>Electronic Road Shows</B></U>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><U>Schedule&nbsp;III</U>
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Filed Pursuant to Rule&nbsp;433<BR>
Registration Statement No.&nbsp;333-159479
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Pricing Term Sheet</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>Allegheny Technologies Incorporated</B>

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>$350,000,000 Convertible Notes due 2014</B>

</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">This term sheet to the preliminary prospectus supplement dated May&nbsp;26, 2009 should be read together
with the preliminary prospectus supplement before making a decision in connection with an
investment in the securities. The information in this term sheet supersedes the information
contained in the preliminary prospectus supplement to the extent that it is inconsistent therewith.
Terms used but not defined herein have the meaning ascribed to them in the preliminary prospectus
supplement.
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="48%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="50%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px"><B>Issuer:</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Allegheny Technologies Incorporated</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px"><B>Security:</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.25% Convertible Notes due 2014</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px"><B>Principal Amount:</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">$350,000,000 ($402,500,000 including over-allotment option)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px"><B>Trade Date:</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">May 28, 2009</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px"><B>Settlement Date:</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">June 2, 2009 (T&#043;3)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px"><B>Maturity:</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">June 1, 2014</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px"><B>Coupon:</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.25%</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px"><B>Price to public:</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">100% of face amount</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px"><B>Interest payment dates:</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">June 1 and December 1, commencing December 1, 2009</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px"><B>Underwriting discount:</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.00%</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px"><B>Net Proceeds to issuer, after deducting
underwriting discounts but before
estimated net offering expenses:</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">$339,500,000 ($390,425,000 including over-allotment option)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px"><B>Ranking:</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">After giving effect to this offering, the senior  notes offering</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">and the application of the proceeds therefrom as described under</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">the caption "Use of Proceeds," including to purchase our 8.375%</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">notes pursuant to the tender offer (assuming all the outstanding</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">8.375% notes are purchased pursuant to the tender offer), as of</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">March 31, 2009, we would have had an aggregate of approximately</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">$882.8 million of indebtedness outstanding ($933.7 million if the</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">underwriters exercise in full their option to purchase additional</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">notes).If</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="48%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="50%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">fewer than all the 8.375% notes are purchased in the</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">tender offer, our indebtedness will be higher.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px"><B>Capitalization:</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Based on the principal amount of the notes offered in this</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">offering (assuming no exercise of the option of the underwriters</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">to purchase additional convertible notes) and the senior  notes</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">offering, the following amounts will appear in the as adjusted</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">column of the Capitalization table:</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="right">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="50%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="80%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" colspan="3"><B>As of March 31, 2009</B></TD>

</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" colspan="3"><B>As Adjusted</B></TD>

</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" colspan="3"><B>(Dollars in millions)</B></TD>

</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:0px; text-indent:-0px">8.375% Notes due 2011, net(1)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px">9.375% Notes due 2019 (offered
concurrently)(2)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>$</TD>
    <TD align="right">344.3</TD>
    <TD>&nbsp;million</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:0px; text-indent:-0px">4.25% Convertible Notes due 2014
(offered hereby)(2)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>$</TD>
    <TD align="right">338.9</TD>
    <TD>&nbsp;million</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px">Total debt</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>$</TD>
    <TD align="right">882.8</TD>
    <TD>&nbsp;million</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:0px; text-indent:-0px">Total capitalization</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>$</TD>
    <TD align="right">2,895.6</TD>
    <TD>&nbsp;million</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<DIV align="right">
<DIV style="font-size: 3pt; margin-top: 16pt; margin-right: 38%; width: 20%; border-top: 1px solid #000000">&nbsp;</DIV>
</DIV>

<DIV align="right">

<TABLE width="50%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD width="96"></TD>
</TR>

<TR valign="top">
    <TD nowrap align="left">(1)</TD>
    <TD>&nbsp;</TD>
    <TD>Assumes the purchase of all 8.375% notes tendered in the tender offer.
</TD>
</TR>
<tr style="font-size: 3pt">
<td>&nbsp;</td>
</tr>
<TR valign="top">
    <TD nowrap align="left">(2)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;Net of estimated discounts and fees.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="48%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="50%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px"><B>Denominations:</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">$2,000 and integral multiples of $1,000 in excess thereof</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px"><B>CUSIP/ISIN:</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">01741R AD4 / US01741RAD44</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px"><B>Conversion rate:</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">23.9263 shares of common stock per bond</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px"><B>Conversion premium:</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">30.00%</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px"><B>Last reported sale price (May&nbsp;27, 2009):</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">$32.15</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px"><B>Joint Book-Running Managers:</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">J.P. Morgan Securities Inc.</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Citigroup Global Markets Inc.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px"><B>Joint Lead Manager:</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Merrill Lynch, Pierce, Fenner &#038; Smith Incorporated</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px"><B>Senior Co-Managers:</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PNC Capital Markets LLC</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Credit Suisse Securities (USA) LLC</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Goldman, Sachs &#038; Co.</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Mitsubishi UFJ Securities (USA), Inc.</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Morgan Stanley &#038; Co. Incorporated</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Wachovia Capital Markets, LLC</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px"><B>Co-Managers:</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BNY Mellon Capital Markets, LLC</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">HSBC Securities (USA) Inc.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->35<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Adjustment to Shares Delivered upon Conversion upon Certain Fundamental Changes</B>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If holder elects to convert notes in connection with a make-whole fundamental change, we will
increase the conversion rate for the notes surrendered for conversion by a number of additional
shares of our common stock, as described below.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth the hypothetical stock price and the number of additional
shares to be received per $1,000 principal amount of notes:
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Stock price on fundamental change date</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="9%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Effective date</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>$32.15</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>$40.00</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>$50.00</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>$60.00</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>$70.00</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>$80.00</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>$90.00</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>$100.00</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>$110.00</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>$120.00</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>$130.00</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>$140.00</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>$150.00</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">6/2/2009</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7.1778</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6.3989</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4.0680</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2.7512</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1.9456</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1.4227</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1.0672</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.8162</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.6336</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.4974</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.3936</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.3131</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.2498</TD>
    <TD>&nbsp;</TD>
</TR>
<tr><td>&nbsp;</td></tr>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">6/1/2010</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7.1778</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6.3021</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3.8812</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2.5482</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1.7544</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1.2527</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.9200</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.6905</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.5271</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.4073</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.3176</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.2491</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.1958</TD>
    <TD>&nbsp;</TD>
</TR>
<tr><td>&nbsp;</td></tr>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">6/1/2011</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7.1778</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5.9720</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3.4948</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2.1858</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1.4404</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.9897</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.7031</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.5131</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.3822</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.2891</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.2210</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.1701</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.1312</TD>
    <TD>&nbsp;</TD>
</TR>
<tr><td>&nbsp;</td></tr>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">6/1/2012</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7.1778</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5.3280</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2.8389</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1.6189</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.9810</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.6278</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.4214</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.2945</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.2125</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.1570</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.1179</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.0893</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.0676</TD>
    <TD>&nbsp;</TD>
</TR>
<tr><td>&nbsp;</td></tr>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">6/1/2013</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7.1778</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4.1101</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1.7098</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.7437</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.3503</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.1849</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.1111</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.0749</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.0547</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.0418</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.0326</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.0253</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.0193</TD>
    <TD>&nbsp;</TD>
</TR>
<tr><td>&nbsp;</td></tr>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">6/1/2014</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7.1778</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1.0737</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.0000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.0000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.0000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.0000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.0000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.0000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.0000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.0000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.0000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.0000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.0000</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The exact stock prices and effective dates may not be set forth in the table above, in which
case the following shall apply:
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(1)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>If the stock price is between two stock price amounts in the table or the effective
date is between two effective dates in the table, the number of additional shares by which
the conversion rate will be increased will be determined by a straight-line interpolation
between the number of additional shares set forth for the higher and lower stock price
amounts and the two dates, as applicable, based on a 365-day year.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(2)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>If the stock price is greater than $150.00 per share (subject to adjustment), no
additional shares will be added to the conversion rate.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(3)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>If the stock price is less than $32.15 per share (subject to adjustment), no additional
shares will be added to the conversion rate.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding the foregoing, in no event will the total number of shares of common stock
issuable upon conversion of the notes exceed 31.1041 per $1,000 principal amount of notes, subject
to adjustments in the same manner as the conversion rate as set forth under &#147;&#151;Conversion Rate
Adjustments.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition, if a holder of notes elects to convert its notes prior to the effective date of
any fundamental change, and the fundamental change does not occur, such holder will not be entitled
to an increased conversion rate in connection with such conversion.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our obligation to satisfy the additional shares requirement could be considered a penalty, in
which case the enforceability thereof would be subject to general principles of reasonableness and
equitable remedies.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B><I>Concurrent Senior Notes Offering and Tender Offer</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Concurrent with the offering of the notes being offered pursuant to this prospectus
supplement, we are also offering by separate prospectus supplement $350,000,000 principal amount of
our 9.375% Senior Notes due 2019, which we refer to as the &#147;senior notes offering&#148; and the &#147;senior
notes.&#148; Neither the completion of the senior notes offering nor the completion of this offering is
contingent on the completion of the other. The net proceeds of the
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->36<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">senior notes offering, after deducting the underwriting discount but before estimated net operating
expenses, will be approximately $344,939,000.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>We have filed a registration statement (including a preliminary prospectus supplement) with the SEC
for the offering to which this communication relates. Before you invest, you should read the
preliminary prospectus supplement included in that registration statement and other documents we
have filed with the SEC for more complete information about us and this offering. You may get
these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, we or
the underwriters will arrange to send you the prospectus if you request it by calling J.P. Morgan
Securities Inc. collect at 718-242-8002.</B>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->37<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><U>Schedule&nbsp;IV</U>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Persons signing Lock-Up Agreements</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">Diane C. Creel<BR>
James C. Diggs<BR>
Terry L. Dunlap<BR>
Richard L. Harshman<BR>
J. Brett Harvey<BR>
L. Patrick Hassey<BR>
Barbara S. Jeremiah<BR>
Michael J. Joyce<BR>
James E. Rohr<BR>
Louis J. Thomas<BR>
John D. Turner<BR>
Jon D. Walton<BR>
Dale G. Reid

</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><U>Exhibit&nbsp;A</U>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;FORM OF LOCK-UP AGREEMENT&#093;
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">&#091;<B>&#149;</B>&#093;, 2009
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">J.P. MORGAN SECURITIES INC.<BR>
CITIGROUP GLOBAL MARKETS INC.<BR>
As Representatives of<BR>
the several Underwriters listed in<BR>
Schedule&nbsp;I to the Underwriting<BR>
Agreement referred to below

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">c/o J.P. Morgan Securities Inc.<BR>
383 Madison Avenue<BR>
New York, NY 10179

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Citigroup Global Markets Inc.<BR>
390 Greenwich Street<BR>
New York, New York 10013

</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">Re:&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD> Allegheny Technologies Incorporated &#151; Convertible Notes Offering</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Ladies and Gentlemen:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The undersigned understands that you, as Representatives of the several Underwriters, propose
to enter into an Underwriting Agreement (the &#147;Underwriting Agreement&#148;) with Allegheny Technologies
Incorporated, a Delaware corporation (the &#147;Company&#148;), providing for the public offering (the
&#147;Public Offering&#148;) by the several Underwriters named in Schedule&nbsp;I to the Underwriting Agreement
(the &#147;Underwriters&#148;), of convertible senior notes of the Company (the &#147;Securities&#148;). Capitalized
terms used herein and not otherwise defined shall have the meanings set forth in the Underwriting
Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In consideration of the Underwriters&#146; agreement to purchase and make the Public Offering of
the Securities, and for other good and valuable consideration receipt of which is hereby
acknowledged, the undersigned hereby agrees that, without the prior written consent of the
Representatives on behalf of the Underwriters, the undersigned will not, during the period ending
90&nbsp;days after the date of the prospectus relating to the Public Offering (the &#147;Prospectus&#148;), (1)
offer, pledge, announce the intention to sell, sell, contract to sell, sell any option or contract
to purchase, purchase any option or contract to sell,
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or
indirectly, any shares of common stock, $0.10 per share par value, of the Company (the &#147;Common
Stock&#148;) or any securities convertible into or exercisable or exchangeable for Common Stock
(including without limitation, Common Stock which may be deemed to be beneficially owned by the
undersigned in accordance with the rules and regulations of the Securities and Exchange Commission
and securities which may be issued upon exercise of a stock option or warrant) or (2)&nbsp;enter into
any swap or other agreement that transfers, in whole or in part, any of the economic consequences
of ownership of the Common Stock, whether any such transaction described in clause (1)&nbsp;or (2)&nbsp;above
is to be settled by delivery of Common Stock or such other securities, in cash or otherwise or (3)
make any demand for or exercise any right with respect to the registration of any shares of Common
Stock or any security convertible into or exercisable or exchangeable for Common Stock without the
prior written consent of the Representatives, in each case other than (A)&nbsp;transfers of shares of
Common Stock (or stock options exercisable for shares of Common Stock) as a bona fide gift or gifts
(including, for the avoidance of doubt, charitable donations or gifts) or for estate planning
purposes, (B)&nbsp;distributions of shares of Common Stock to partners, members or stockholders of the
undersigned, (C)&nbsp;distributions or sales of shares of Common Stock acquired in open market
transactions by the undersigned after the date hereof and (D)&nbsp;sales of shares of Common Stock for
purposes of settling taxes owed in respect of the exercise of stock options that expire during the
90-day period referred to above and awards of restricted stock and restricted stock units that
occur during such period; <U>provided</U> that in the case of any transfer or distribution
pursuant to clause (A)&nbsp;or (B), each donee or distributee shall execute and deliver to the
Representatives a lock-up letter in the form of this paragraph; and <U>provided</U>,
<U>further</U>, that in the case of any sale, transfer or distribution pursuant to clauses (A) -
(D), no filing by any party (including, any donor, donee, transferor or transferee) under the
Securities Exchange Act of 1934, as amended, or other public announcement shall be required or
shall be made voluntarily in connection with such transfer or distribution (other than a filing on
a Form&nbsp;5 made after the expiration of the 90-day period referred to above). In addition, the
undersigned agrees that, without the prior written consent of the Representatives, it will not,
during the period ending 90&nbsp;days after the date of the Prospectus, make any demand for or exercise
any right with respect to, the registration of any shares of Common Stock or any security
convertible into or exercisable or exchangeable for Common Stock. Notwithstanding the foregoing,
if (1)&nbsp;during the last 17&nbsp;days of the 90-day restricted period, the Company issues an earnings
release or material news or a material event relating to the Company occurs; or (2)&nbsp;prior to the
expiration of the 90-day restricted period, the Company announces that it will release earnings
results during the 16-day period beginning on the last day of the 90-day period, the restrictions
imposed by this Letter Agreement shall continue to apply until the expiration of the 18-day period
beginning on the issuance of the earnings release or the occurrence of the material news or
material event.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In furtherance of the foregoing, the Company and any duly appointed transfer agent for the
registration or transfer of the Common Stock are hereby authorized to decline to make any transfer
of the Common Stock if such transfer would constitute a violation or breach of this Letter
Agreement.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->40<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The undersigned hereby represents and warrants that the undersigned has full power and
authority to enter into this Letter Agreement. All authority herein conferred or agreed to be
conferred and any obligations of the undersigned shall be binding upon the successors, assigns,
heirs or personal representatives of the undersigned.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The undersigned understands that, if the Underwriting Agreement does not become effective, or
if the Underwriting Agreement (other than the provisions thereof which survive termination) shall
terminate or be terminated prior to payment for and delivery of the Securities to be sold
thereunder, the undersigned shall be released from all obligations under this Letter Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The undersigned understands that the Underwriters are entering into the Underwriting Agreement
and proceeding with the Public Offering in reliance upon this Letter Agreement.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;<I>signature page follows</I>&#093;
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->41<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This lock-up agreement shall be governed by and construed in accordance with the laws of the
State of New York, without regard to the conflict of laws principles thereof.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 50%">Very truly yours,

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="48%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->42<!-- /Folio -->
</DIV>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>l36642aexv99w1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML>
<HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->


<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>Exhibit&nbsp;99.1</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="59%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="39%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><IMG src="l36642al3664201.gif" alt="(ATI LOGO)">
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>NEWS RELEASE</B><br><br>
<B>Contact:</B><br>
Dan L. Greenfield<br>
412-394-3004</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Allegheny Technologies Announces Pricing of Concurrent Senior Notes and<BR>
Convertible Notes Offerings</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Pittsburgh, PA &#151; May&nbsp;27, 2009<B> &#151; </B>Allegheny Technologies Incorporated (NYSE:ATI) announced today
that it has priced its concurrent public offerings of senior notes due 2019 and convertible notes
due 2014. The offerings are being made pursuant to the Company&#146;s shelf registration statement filed
with the Securities and Exchange Commission. Neither the completion of the senior notes offering
nor the convertible notes offering will be contingent on the completion of the other.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">ATI announced that it has agreed to sell $350,000,000 aggregate principal amount of 9.375% Senior
Notes due 2019 (the &#147;Senior Notes&#148;). ATI previously had announced an intention to sell $300,000,000
of Senior Notes. The Senior Notes will pay interest semi-annually in arrears at a rate of 9.375%
per year and will mature on June&nbsp;1, 2019, unless earlier repurchased. ATI intends to use the net
proceeds from the offering of the Senior Notes to purchase any and all of its outstanding 8.375%
Notes due 2011 (the &#147;8.375% Notes&#148;) pursuant to the terms of a tender offer by ATI for those 8.375%
Notes. As of today, there were $300&nbsp;million in aggregate principal amount of 8.375% Notes
outstanding. Any net proceeds from the offering of Senior Notes not used to purchase the 8.375%
Notes will be used for general corporate purposes.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">ATI also announced the pricing of its offering of $350,000,000 aggregate principal amount of 4.25%
Convertible Senior Notes due 2014 (the &#147;Convertible Notes&#148;). ATI has granted the underwriters a
30-day option to purchase up to an additional $52,500,000 aggregate principal amount of the
Convertible Notes on the same terms and conditions to cover over-allotments, if any. The
Convertible Notes will pay interest semi-annually in arrears at a rate of 4.25% per year and will
mature on June&nbsp;1, 2014, unless earlier repurchased or converted. Holders may convert their
Convertible Notes into shares of ATI&#146;s common stock at their option any time prior to the close of
business on the second scheduled trading day immediately preceding the maturity date. The
conversion rate will initially be 23.9263 shares of common stock per $1,000 principal amount of
Convertible Notes (representing an initial conversion price of approximately $41.80 per share of
common stock), subject to adjustment in certain circumstances. ATI intends to use the net proceeds
from the offering of Convertible Notes to manage its liabilities and other obligations, such as by
making voluntary contributions to its defined benefit pension trust and contributions to trusts
established to fund retiree medical benefits, and the balance for general corporate purposes.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Citi and J.P. Morgan Securities Inc. are the joint book-running managers for the Senior Notes
offering. J.P. Morgan Securities Inc. and Citi are the joint book-running managers for the
Convertible Notes offering.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor
shall there be any sale of any of the Senior Notes or Convertible Notes in any jurisdiction in
which such offer, solicitation or sale would be unlawful prior to registration or qualification
under the securities laws of any such jurisdiction. A registration statement relating to the Senior
Notes and Convertible Notes has been filed with the Securities and Exchange Commission.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Copies of the prospectus and Senior Notes prospectus supplement meeting the requirements of Section
10 of the Securities Act of 1933, as amended, may be obtained from Citi, Prospectus Department,
Brooklyn Army Terminal, 140 58<SUP style="font-size: 85%; vertical-align: text-top">th</SUP> Street, 8<SUP style="font-size: 85%; vertical-align: text-top">th</SUP> Floor, Brooklyn, New York 11220
or by telephone at 800-831-9146 and at www.sec.gov. Copies of the prospectus and Convertible Notes
prospectus supplement meeting the requirements of Section&nbsp;10 of the Securities Act of 1933, as
amended, may be obtained from J.P. Morgan Securities Inc., National Statement Processing,
Prospectus Library, 4 Chase Metrotech Center, CS Level, Brooklyn, New York 11245 or by telephone at
718 242-8002 and at www.sec.gov.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">ATI&#146;s obligation to accept any 8.375% Notes due 2011 tendered in its tender offer and to pay the
applicable consideration for them are set forth solely in the related Offer to Purchase and the
Letter of Transmittal. This news release is neither an offer to purchase nor a solicitation of an
offer to sell any 8.375% Notes due 2011. The tender offer is made only by, and pursuant to the
terms of, the Offer to Purchase, and the information in this news release is qualified by reference
to the Offer to Purchase and the related Letter of Transmittal. Subject to applicable law, ATI may
amend, extend or, subject to certain conditions, terminate the tender offer.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">This news release contains &#147;forward-looking statements&#148; within the meaning of the Private
Securities Litigation Reform Act of 1995. Certain statements in this news release relate to future
events and expectations and, as such, constitute forward-looking statements. Forward-looking
statements include those containing such words as &#147;anticipates,&#148; &#147;believes,&#148; &#147;estimates,&#148;
&#147;expects,&#148; &#147;would,&#148; &#147;should,&#148; &#147;will,&#148; &#147;will likely result,&#148; &#147;forecast,&#148; &#147;outlook,&#148; &#147;projects,&#148; and
similar expressions. Forward-looking statements are based on management&#146;s current expectations and
include known and unknown risks, uncertainties and other factors, many of which we are unable to
predict or control, that may cause our actual results, performance or achievements to materially
differ from those expressed or implied in the forward-looking statements. Important factors that
could cause actual results to differ materially from those in the forward-looking statements
include: (a)&nbsp;material adverse changes in economic or industry conditions generally, including
credit market conditions and related issues, and global supply and demand conditions and prices for
our specialty metals; (b)&nbsp;material adverse changes in the markets we serve, including the aerospace
and defense, construction and mining, automotive, electrical energy, chemical process industry, oil
and gas, medical and other markets; (c)&nbsp;our inability to achieve the level of cost savings,
productivity improvements, synergies, growth or other benefits anticipated by management, including
those anticipated from strategic investments and the integration of acquired businesses, whether
due to significant increases in energy, raw materials or employee benefits costs, the possibility
of project cost overruns or unanticipated costs and expenses, or other factors; (d)&nbsp;volatility of
prices and availability of supply of the raw materials that are critical to the manufacture of our
products; (e)&nbsp;declines in the value of our defined benefit pension plan assets or unfavorable
changes in laws or regulations that govern pension plan funding; (f)&nbsp;significant legal proceedings
or investigations adverse to us; (g)&nbsp;other risk factors summarized in our Annual Report on Form
10-K for the year ended December&nbsp;31, 2008, and in other reports filed with the Securities and
Exchange Commission. We assume no duty to update our forward-looking statements.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B><I>Building the World&#146;s Best Specialty Metals Company</I></B><B>&#153;</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Allegheny Technologies Incorporated is one of the largest and most diversified specialty metals
producers in the world with revenues of $5.3&nbsp;billion during 2008. ATI has approximately 9,600
full-time employees world-wide who use innovative technologies to offer global markets a wide range
of specialty metals solutions. Our major markets are aerospace and defense, chemical process
industry/oil and gas, electrical energy, medical, automotive, food equipment and appliance, machine
and cutting tools, and construction and mining. Our products include titanium and titanium alloys,
nickel-based alloys and superalloys, grain-oriented electrical steel, stainless and specialty
steels, zirconium, hafnium, and niobium, tungsten materials, and forgings and castings.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>l36642al3664201.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 l36642al3664201.gif
M1TE&.#EA\`",`.8``#HW-D1"0M/3TY^RR0PB:^7CXW2,L"@F);Z\N^SKZO3S
M\WY\>]W;VL[:Y3)0AQ@6%<W+RD]JF08%!8"`@*2CHI63D8V+BJZKJ<'`P)Z:
MF61B8E534FYK:;/"U?K[^[6SLH28N1DW>'1R<DU*2L7$Q(6$A%U:61A'?=;@
MZ9J8EZ"=FY"DP'AU<]?5TZBEI(%]>LC&QI"-C6:`J,&_OG!N;8B&A5=55%=X
MHL_.S>GN\W-P;F!=7-_>W9>5E+BVM4!>D?+U^$9%1(*!@4]-3&=E961@7UI8
M5XN)B.[R]L3!O\/"PK"NK@\Q<[RYM]K8U\K(R#\_/@TI;GMY>.?FY<;2X*JH
MIY*0D-'0T!$M<6MH9R\M+.'@X%)03X)_?MWE[$%`0#4R,J.@GN_O[K*PKQX<
M'(>$@DI(2.+H[\?#P`P+"R,_?<3#PX2#@TE'1Q(1$2(A(0H;6OGY^.GHZ,7.
MWA$/#O'P\/;V]K^_OXF'AQ,\=PPA:F%@8*"@H%MRGP```/___R'Y!```````
M+`````#P`(P```?_@'^"@X2%AH>(B8J+C(V.CY"1DI.4E9:7F)F:FYR=GI^-
M*"M(H*6FIZBIGGU1*ZJOL+&RJ!UY!#^SN;J[O(H>/WJW'KW$Q<:H*P1ZP2#'
MSL_0E#?*RB'1U]C9@SDAP<I1.=KBX\@K#8H&RP3K!`:+'2`#E'AI]61;A&LE
M^_S]_O\`JPB*T4\,N8.*'.AQ8*`!$$-VU'A;IR<*E4,-!N2I*$^2`C!^0OII
MHV#0!)$H4ZI<*3*((`DH6R"<:<A`%&]J0)`:E&PBM3XH"'5PH"P8KDE<4DJ`
M89*ETZ=^7/Z!*5(FS:M_.F#Q9A3$N3/`V+&KZ,I#AQM;*1*(0.F+TA1-_Z'*
M12F5:DBK6&?^$JLNA`P#:<6R^R$C0A3!!*(TDS3&C4H`<>?.K1LS[]45@?E&
MN8EX'6?!P0P,D\0RS1I!3BZH7LWZ@ET_;LJT;OWD967+,QMTZTS1I[(\3'RO
M4Q-44A.G7QR]3M[H-5[<Y.P8H`9ZL\^*,@Y7[RA)B],W+IJC9,[(.?295((C
M#G;3IX,?G?5@N2AI#=0AXD627V3^/$*%ZQ&@QF<5V22<'GG0%TD%*;V1DAOY
MA;2?(OWY1XX,PJWCP#3>8#%=@-Q!4L`0*#WPATH[E#>><K=9.`X2MJP7Q0WM
M$="!1*`1P$1QD9R$T@%_!)$2'7+PMV*$?CSG8O\V(`#'Q&<4G9`=`0Q1IPP3
M)YP0101G2+)'2A@(XA9*)ABI'XM5+9E-#@8PP0X3-T3@9C`(HA`"''W(H!83
M/T2P$7LG=/#(<6`*DH529DJ(YEUJ1D-%'T3YI,9?$81P6!1>R)#''`-N1EBE
MU`430A\**F)"2E`4^8<3!Z3$!X5'JIAFH\9X,(">&7X#0@=`@!!"1[5$X`4*
M($!9G0PK=)F(@RC=08@0*3T01R+++9HDK<2($BEO?`DXP&B">$`%")EQNTX(
M-U#Q4"$\I&1#(3Z\Y@<)U,::Z+78[K+";N8&Z``A!O:['I^&T)%2#(4HP$9*
M7-1[)I)*YAL+$`-$\(/_L;Q5M*&R@@"QP@]J6,FM'DQ$,`"/@MR1TAZ'8*"2
M$XA4"['$O9SA@'491Y''#QUTT)`@#=P@SP"6]LN$7X<4,*9(61S2@KP9Q&PO
MK+/2S,L9-X3@YE@5G2`T"!$$TP$5*P"!!0$G&+""`7F<S96.6/0A*"(JIT3#
M!'CGC?>7*`4@]<.R,FHU,5[,(2<U6X(\5AY(_`#'"A&,A<6&3+C-A!H=S*&(
M'5)(QI(*A\@<.+Z#$V,6"#<?-E%7A_TPW76)Y:'V3HI<D(;G*TE5B.CW1ESZ
M+BBHEV.QRT2AVX'&.^(C[@]>80CO5`O^.S$@B$P1$Q\J4QBW,H2SB`=M,)_[
M__-3.RS]]+S@F.,/`'HV@/57EHI(!BJ-4,3]^.>/_P,H21`F(=`S'^G0IXLY
M"*];JA-+!$[`FRAH;A%+"PD7ZM`($:3D`"491`#_=CX"SJ)Z&0H!OR@2!<!T
M1C&,4`H/'$$!E=!+@^7CX``]&(OC!4@[H'%`N2@2`B\H(GP_>D0<%I"2IL$0
M<+VC82XZ<,"Q)"97&/N&*Q*A$K@\PCXH<<,*;8/$Z,U0B:KH@XRRU$2Q8"$/
M"51+#Q%!A)3X+1+RPL,1%34S,,)"*UR)`A,<8`XJ=,,W)`,!"@;0!UN\30:'
MN(*\/B")#[AQCGZ8D`!]9\=2K.!246"(.001AYYTZ_]G?Z`8V'!XE$(XLF_3
M(DU*CL!%.HZ.DI7\A$(VM`(?%L).L'M@(0SP@XU$P1!3`$!*)D")4]&EE9&T
M%BQCV0D^S0T1P%A=*1&Q`@><H!!XB)8E'".2`Q1@*C$,78N8R8L.$(@)SX3$
M%N[`3G8RI1(X:"<[#8(!>>+`$?5L9P;)V8O(%04+_`QH)WJ"'8$:-!-(",%P
M:'?0ADZ""B?0PS0=2M%'("%D?:BH1B$Q@!^@;*,@3<2Z0DK2DIKTI"A-J4I7
MRM*6NO2E,(VI3&=*TYK:]*8XS:E.:[H!,M3F#S;@``P:Q@@8/(`!F##!`Y:Z
MU#(EX@D/V*(C+*"%1L3@`??_=,0&C'B-#?PT&CX(20_$9(0[0*$1*ENF(RY0
M@@"\@0TEN(`B7`:S1TS`1(S`@P0@\(@OO"L7:TB#!18!A?]%(P!^>(,;G/>%
MLI[U`S0(0ALX\`<(1#8(1;"!RJ`0A!&D(`$JV$$0@E"#.G2!"&8(@@B.L(%[
M%D`#""#$!,[ZARIP(0A#@%D31B!9#KCLMD&0PA^XL(/4FJ`.D!TM"YQPUS^4
M8;0;Z$$=+F"#T9I`"`P8P@6<8`+<6D``54CM"*0PA4'XU0D;V,-HA8L`X.X`
MN9=E06U'T`8-;.`(J=V!$Q+0`]Z:809`-8$9$B"$T>[!!<+40A?P&P03P(4"
MJ37#_P$,^XP$2$`".I!`&/[06+/^09@!<,L%6.`',)Q*`C@H\0Z\0P(_/,`(
M0DJ!6TQ@!!>GP0AQ>($?K"B(V?Z!`6_0@@FT<(`,O.$!.Q#FEX0,!@D(P,5&
M0.P'Z$`&&/M!!'?M@1\`L`/^L8`.;S""=X+08B&0R`0BD``1H$"&'9#A`7CQ
MJ\NT8(0F&_4!W?6#!:@<93V?)`"(C4J-`0"M`!CAS5N0`)ZM,)(NFP"Q6@!Q
ME_V``PEH8<5^H+`SA!D$#?B!91T^:U38F5@H`.D/)I"`RI;PAQ;"P`\:N`,?
M)%""+VA`$'XPP0CF]88#2/4//B:B#DCMA[W^`0=0.(D5_O_0@GGY@0:5]4,-
M_)"B/]`A"'?5@1]`!P$_0,$/1A#$M<N\978^0`-NL0('7F5>&[ALV2UX@,KD
M^@<M>.?6UN;"2:Z@,LH&221\+8$?8""!#?S!"F"X@Q#><`27U4#@5KB#MN\@
M@65_P'_1J#1*M&"'4)_H`5`(^0:2+8@CJ/I:KWYUR$-.@2\XZT0I$/BK==?C
MLX9/"RL_,B'HRFQGCW4J-3@`(X.$[0=$5@`O$6:U1TMNG+,<`:VZLD'$Y&X_
MP"S>*B-$&PZ`CR#UH+E9%T00'(37$DA@*C()J[?I8`&'"QP,(7<Y;?]0V&BT
M&``M:($%_"`%CX-;$.'^`AD$T8;_D\LDY7Z0XQ]VX`.7XSH%$'BS'V(KV[,2
M\><V`(D2_D`"$W#`ZCUO\<\E,.UP_^$!(\BV'Z+6;)"8_@%D]@.T="`(#9A@
M!RIX`DA>SN&J7UW>JQ?$#D#2!4$\@`-@]\,!D!J$VTE@A69G@`1:X(3$UB;9
M;B>#\Q!@!"4\0*XMU'0Q%+`#.GSS#RX;[0XPD)Q6Z0"Q/C@4<8O-\R=(X`E^
MT$(/A)2!`/Q/`J`3`\567K*5'`5P``?0!;TF!8IU!-\6`Q*`5-7W:E8D6*TR
M!-JV`$+P`%7@;3U`!MMV`!+0`X@5!*_&!M[1`S;@!QN`@#T@3+S76$H0@:OR
M`%/P`'30_P6G$@:MP@$@D0(;^`=U`P4[$$D7\&DLX`8/8&%.4`"*50.(-0(=
MR`6G$@0]T"J*]`8]X"";5V$LP`:#P`!%8`45X`(,($<^8`-JN`!_L`1O8&AI
M$(%%D`!_4``<4`!28`(V8`128`=6@%1_0`-\I3)L6`ACH'A"8`1!%5L7L`=[
MV`4\P`$&D0!%L`5$\$(L,`-7P`)&X&`%\`'R)06*:`,LD`!9``8V\&U!L`4:
MT`1+L`,VL`-&L`5AH(9[(`)3]P<6H`*1.(GR50%J:`0ZH``40&,.]@>@*(1^
M$`.P*`4%4`=9H(<:@'0<0(=CH(>=:`(?((ME8`&PR(=_P`*P6/\$1/!KEG$2
MR.<'="`)8F`%7Q(UO(`&EG8'PE0$LA!V%44"3?8`;0"(ZC1R]-8+5P@3D"$+
MR`92<<`#N8@;"K`%/``N.H4')M`&4D`!NP`#K"0(8E`!+_0(%-"%.T4)!;!K
M:3!\=,!CGF`%DD0(9C<(\49,D$!REL`'`5!7-=5BJ?(']G=V6R`";W`!`F`'
M3Y`"WG0'*G``1L!7?P`#!\`%3+$%&&`#]_0";[`!+5`'28%T5P``/\F29R<(
M+_D'5S`$!\`'=O`'2:`%;\!J?[`%`'``5$5,:_`&;S!L=G`'4X<!Y74!!_`&
M<'$%&#!R!@,7,W``0;!Y4`D%+3`%0_#_!D-PEB<%+4G@DD_0!!*0!GL0A_$6
M$D<0$E'W`@+G5I'T>;`F3*U2<3!!`0(G$D(P"`*'/UR0!A/@2%K@%B6@`GZ`
MF7Y`!-('&R$Q`2Z36'?A!R_G!ST@<&\`$T4`$GZP:[OY>5_@&$>PFC5P.VZ1
M!BAU$OXH?-*F`*=2!`\```S0F320`"1F!HK%`P50>$)2`PD0:0E08Q-0!'Y0
M``#@!DW@!```!JZI$A-`8DJ0`&YP`%K&`PP022G@!U4@!Q7@!@"`6&$P!320
M),2):U_G!E.0H!8`$DV@`!RP5UK@!@DPDDCI!Q0@!LHGH-!V4B>AE'_@`K4&
M`*IR`#KP`$UC_W+T%H=^L&S`E@8KR`-Q,`(/$)U^,`&?%V]T\`5?0`<&)PAF
MUP-0N@!IL`$.HJ0PH0)D$`#>,0030`=3]P5:H&B"X`(46IP54`9N`*9^P`)@
ML(3`ME>PH:3\$P024"1"0I8O@%().@*"H``B"*9(]P1OD`4/T)HF9Y$'>CLL
M,"TD)DR<YP=D8`,.8J1)\@"1:@,'(%].^I7,]F+>T0:22@9?(`%&L&M?,`%I
MP%=3T*:.08<MU&QRE01^P`$/(`$V(&)@\$83`*<^:@-:0`9#\)46```:`!,H
M56D2<``"('\[D*Q*$!)X4*A_T)ETT`/6R3]2$*P'T$:/&@!*X!U$X/]I$"""
M*F`%8KJI+OD`$[!W&A!6:?`%IL%H6D!$8*`$!G,`*E,&`O`E3T,'=Y`4M.H&
M3H!8=::K)HI8-+`&EQFL+T$'),`_*=5L%\:"T_(E:?`&->`$TMJ9OKEL!9";
M%_8'VO8'"C"A=@$%:3`$&$`&<0@`Y_<'+0F6ZOH';T`'!@,!"/`&SN<'-N!I
M]2`!$U`'.GL[27(H5!$#`LA-!=MC<7@%R1D2#!"S+'"9SZ93)M>1VI!6(0D*
M5TL.6KNUGD`"0M!UXL`#$T"'8`L+ZW0'9*L)[(0!%)2VIA`$!R`3+W!A$E`F
M&79AX:8"<7BN@F`&5"$!^!$`?(H(M9H&;B#_`60P!@%P871`N']`!'9!@QIT
M861P80@0!&`HMY&P!&80$G=P!2'A!#46!FY1!:WR`1N@9]XA`N;UE;N'`)1W
M"'&8,M+F>/]V**=&IF]`",FDC!D@DY[["%)@`_R#`8Y$>V/@!P%`!P$@!BDF
M`E#@L@*P5+&[0CY@!"U`!"(0!#8@`%L0`.$A"+=[;+G[<FWD%F.@D59`!,#+
M'"Z3`LFV!1N@I&9@D>CV!5SP`06P`$KZ!1;IN7[U87XPB!2*,">2!C(YJH.0
M!6X@FWR`=+5I`1(0`)_7ON9+G'SP)17P!1%W!S6[:S##;W>``:IR(EIP!V.0
MF120;'?@!GLP6T+0_T+)]@!N8$&GJ@4T![8%[*C*V&S%R<`PZ<"#L`8A5V)B
M4)M_T+H4.PBW`P5*RC)0X'1FP`(G`3,T4,7!AVMT$'<6F6Q7P`%W8`9IH(\`
M8!!5L`3PR@<*U\-;6\`+`Q=I16VXY@8-S*EI@&]=`&Y,'&C"!<6<*B:\!VR@
MQYV@@VL3DFRW<P`3\`4M1G/PFC<#++<%K#+OP@?/=@!0L`4I]@%+>@7-6Y!_
M((+T4@:Y5IMAX`9T20<`9KZ#S&&%K&5F(`@7MVV#$+R#D&QBV@1OH%YN$!Z(
MU2JO0@0/X#QR&P!E(@8@2`0'8(-"P@6_6@`6U`81W`2#$#Z.[`9D@`!@$/\$
MOXH`8>`'^"$($5P(_D<(=0`21,`"#B(!Y3L5;S0(`2`$CC$!(/$&,P"IV@8`
M59`&![`#>+R=6TL!&HP`>7,:+9`WX8$!>9-5@\`'>",$`A$&%,`&%ED`;%`#
M@Q`#&3D(%-"V?V"V>H,'>('1A?"1))TW"3`!0H`W=*AP>..BQ5O3-GW3.-U2
M!:`WLPEL3H`#Y=4"YCC2,#D)8ONRAT`!>B,$%!0#$T#3@[`%0G!/"I,WK,9<
M+NT#<8`#>(`W53"B%8`W*-G2>=.YQP:<*PW3./#2$U#)!T4";X`W7&!I=O``
M*B"MC64(^"@)TX:UAC!V$V#,:ZI(+%@(=H`!C`;_%R[S`'0)!6(0N0!@,!G@
M&!'L!R\`$BSK!_[8;!?[!OPI"!8T`0^+PR&1`D(B@GY`@&]-6W%PI#I0!A?[
M`IF;!2Y@LP"0!"K#!72P6'^@`H&L`Y5)`V1`!F*@`W1`HV$P;39`!UHPU$27
MRR(@!$DZ(06@HU&C,E\U;P?G;2.1`!U(JRF"FT[5<[!+"&1:I(-0?730;/BQ
M!'Y`>PU%`EIP!4Y0!=YQH#1PL3'@($)"N(Q;-T1[!(]KH3["!6Y!VD&PFMZ!
MG7\=!%/0!)UC!#76+M4V"`70@7"Q/&2`!UM0`H+`:"R`!XQ$GV5@10QB>JTF
M$@_`2&'`/^@M"!N0!N'Q_]YBZ;P.U6)NX!AO,%@[AM=&X#)#8`$5<`$J`Q<6
M!H5?:9R[^M,.*@ADD.#S`K.Q+':L'!([T,?PB[V%4.1O6@97F`9%X@)<\`8N
M^P=38`.6!C.OI806@+0Q\'DZT`,X3`]^<`4R.09T\'KG)DQ_]=9:D$];U..M
MV5AUX!V?5@-':!6T-N`G\G4FXDBF-UI]+>6'$`0)=\)R\"4:L'`52@A<S@-*
M,"T6!`-;"*D4]`&>YK(>@.K%1A`B00%P^P?3UBI@,`%O\`6ODDWL5@-V@>(&
M10)SE\LIX.-B<`=&4&L2\'E14P>+GN0O;2);\`;X]LV3'K.%,%J$L*1'<`0U
M0/_F6[YC?]`#%'"6%A16A!8F$)`&#\`&WV14:<`%!J$$>=,&`4!!]`,`(=<J
M;P!MB/4_=[``E+JBJVT(.T8&!]!X8""`;X`#PE1C="`%B*4"C_L"PF0"S<5A
M5Z9CI!7E+<D"#"YVNA-6<P<%>#4(7'X26<`"9.`&887!',`!]',`+\\!2>$&
M+P_?,.X'M$W,&EGK+Z$[B_L"M^,##@4#DD2<;/``@,;-7:#N=%`%*G-A:4`#
M8K`$J+UC0C!XLJZXCA$$%EP;]/`'%D0(9E#+@L"P@R`$2[%S`%B':6"S8+`&
M=2,2`H@2S"(2A)!HN2E8V0Z3$E#A]`-F'%W37P`&-?#_)2QC"!DPY3F-%5(P
MN*J=]Z?1^-!A!TH]`>]$^=&0`32@`Y.I^5@Q<X/`Q(*0`"F!\X)P`8N+=*"/
M#:(O"*2OC`CC!&Y0SH,0NK+7^JX?%:-/'BIC!`:!`ZR/&I;V!6^PD+I_#*]?
M;^0A!F[!W'>P3Q\F`3[@AC:9_,K/^[`_(2I0`VUD^R<B`9:>>-C_#"TFO]I/
M=WX@"'+0*H.08H8Y_N7O#/9'!T*``(>"'WQ@!;@)"%\?%&D2?WP?`'X%?W\8
M?A88$XR-E9:7F)F:FYR=GI^@H:*CI*6E%VY^JD&-7V]_9!*J:2I_7T%^.Y82
M7$(2$*;!PL/$Q<;'PG(P)"13_XU.3HTM)##1?TX,$!Z6.&)3.''(XN/DY>;G
MZ.GJZ^SM[N_P\?+SHPHD=0K6G74PZU-/HR#T\P2!$KV#""_XN8,AP*<[?H9!
M<?%)1T11#RYV>C`!H4=Z"ADZ]`1QF(0:%36"ROAI`Y^/,#E-,6'ECY0V`A($
M"<*E!8L@:'!L&''D3Y4V2YP$P=,HRP,)!S*X6-C03I&G`%S$.0)``ITV92#&
M`I#DSY*G(V;\87%`@@05"[B(^>.BS0$_$L+P$.%VR!4Q5MP>2&+QJ9L,:&R`
M<=NEP`(W$A[T^).Q@!&W`'C$D4)'`I@V%(Q0^/.A+10T<184`N.C4@$6;@,\
M46"C,_\8'`+:/.6RH9"(F,02N*KSQ4^,):K(N$B#=X*$-&[^[/'3)8"$&(W\
M<#BBY3K5`&7\`!#QQD\&J!P428!X(,L;+G7</"#R@,X5*&E*F/EBP<^%/UW=
M(0$14V@P(!=^@!&#'U"X]P`'?FAQ!!UN6.''&RZ4-X1X0VCA!Q\9[>"'$'L\
M\`:$&TCAX00<+4$'`'R00<=404`(0"5$^,&3&P=4X8<('#SP0!,Z+N!'&AVJ
M!)PI%/AA17DB`/#&=-.IPE<;?J107AO05=*&$!,$(<$1W^&RQP0BEN"'$G^(
MT1U$C$PP07@!3!!`EE\`9,L6$F@!@00C_''2'_C)24<:$_C_$<T=1U@DQQ]@
M!'"!!%G\`2&$6_R1@A\LZGA`(T;084,:F:K`*4<],#B!AUE$.`$'3+4BP5P4
MR.G'%39!XF0+/_Z!AY)+DD)"@GY\P1P'!;Q!A[%'`K#%D5#1(5XC$/CA!A1@
MO)%!F=="`<47)1C2"!3K722G"!%Z"\4'7U32;J+2WB$H2E"\H6X7B4:SQ1T:
M7!3I!:Q8ZD>XC6S:Z4Z@ZOA`(]NR.$&J]GK+@@C%I5&IK(U<<<4$;BC@JY.*
M\BKOIL$*H\!=/ZIBQA_H0G&%*AVI,H*/?M3R!T319$#&MB(%\08/?S3!@A%^
M(/`'#V2D4=(?<KXPXA\J</!$NZV0_Z8*&'7,2VB@?]`@Q01I/"J$>/Y*&C"$
M:F::*@49^=R(#6Z,"G2J#AML%`T0=/$'#HNYZP<#?P1!QMC_]:NF$R)K"FS)
MHK3JQQAIO#%7HGO\41X&?]R51G^?CJWF!B:HLL%W9)(!X75NN)%%*N4V(F?F
M#T#AQP%74&W+'P4P5T$CS%71+Q1FB-?D`2/PJ(.X_Y[MQP?6FI$*"1FA:\.=
M9J3J1O&G3G#%&Q)L^`:16D`(!D1XM/K%"+,K=("'`#R"^$**,RY,&V;,]-L?
M%`1!T4T"_'%$$%?(C=[JXH0V#,$$9@B""((@``%(P28[`2`,!!>$[N#A"FUH
M!!\H,H:=:*$`5P]LQ`/MD!&CX2\(0JA#"7:R@$;DCR<\"`/7=""%)X0P`V90
M`!XBB"LCM*$`1-C)"+:`@#>\07!.$LT?9L!#!;`A@CX00!#^L\(@L.`/=7AA
MI7(SA0(P,&@KDY\8-96&`TP``&G8W2@2D*.+P2-56IC``0XSQCJJ`P,C\-9D
D2+$%*,A%'F*8P!>^$`!<V?&0B$RD(A?)R$8Z\I&0/$<@```[
`
end
</TEXT>
</DOCUMENT>
</SUBMISSION>
